e10vk
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
FOR THE FISCAL
YEAR ENDED DECEMBER 31,
2009
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 1-31719
MOLINA HEALTHCARE,
INC.
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
13-4204626
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
200
Oceangate, Suite 100, Long Beach, California 90802
(Address
of principal executive offices)
(562) 435-3666
(Registrants
telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, $0.001 Par Value
|
|
New York Stock Exchange
|
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. o Yes þ No
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. o Yes þ No
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
þ Yes o No
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files).
o Yes o No
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. þ
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer o
|
Accelerated
filer þ
|
Non-accelerated
filer o
|
Smaller
reporting
company o
|
(Do not check if a smaller
reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). o Yes þ No
The aggregate market value of Common Stock held by
non-affiliates of the registrant as of June 30, 2009, the
last business day of our most recently completed second fiscal
quarter, was approximately $255 million (based upon the
closing price for shares of the registrants Common Stock
as reported by the New York Stock Exchange, Inc. on
June 30, 2009).
As of March 5, 2010, approximately 25,700,000 shares
of the registrants Common Stock, $0.001 par value per
share, were outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the registrants Proxy Statement for the 2010
Annual Meeting of Stockholders to be held on May 4, 2010,
are incorporated by reference into Part III of this
Form 10-K.
MOLINA
HEALTHCARE, INC.
Table of
Contents
Form 10-K
PART I
Overview
We are a multi-state managed care organization that arranges for
the delivery of health care services to persons eligible for
Medicaid, Medicare, and other government-sponsored programs for
low-income families and individuals. We conduct our business
primarily through licensed health plans in the states of
California, Florida, Michigan, Missouri, New Mexico, Ohio,
Texas, Utah, and Washington. The health plans are locally
operated by our respective wholly owned subsidiaries in those
states, each of which is licensed as a health maintenance
organization. Our revenues are derived primarily from premium
revenues paid to our health plans by the relevant state Medicaid
authority, which revenues are jointly financed by the federal
and state governments. Increasingly, we also derive revenues
from the federal Centers for Medicare and Medicaid Services, or
CMS, in connection with our Medicare services. As of
December 31, 2009, approximately 1,455,000 members were
enrolled in our health plans.
The payments made to our health plans generally represent an
agreed upon amount per member per month, or a
capitation amount, which is paid regardless of
whether the member utilizes any medical services in that month
or whether the member utilizes medical services in excess of the
capitation amount. Each of our health plans is thus financially
at risk for the medical care of its members. Each
health plan contracts with health care providers in the relevant
communities or states in which it operates, including primary
care physicians, specialist physicians, physician groups,
hospitals, and other medical care providers. These health care
providers then provide medical care to the health plans
enrolled members. Various core administrative functions of our
health plans primarily claims processing,
information systems, and finance are centralized at
our corporate parent in Long Beach, California. Our California
health plan also operates 17 of its own primary care community
clinics; we have a Virginia subsidiary which manages three
county-owned primary care community clinics in Fairfax County,
Virginia; and our Washington health plan recently began
operating its own behavioral health clinic.
Dr. C. David Molina founded our Company in 1980 under the
name Molina Medical Centers as a provider
organization serving the Medicaid population in Southern
California through a network of primary care clinics. Since
then, we have increased our membership through the
start-up
development of new health plan operations, the acquisition of
existing health plans, and internal or organic growth. Key
milestones in our history have included the following:
|
|
|
Year
|
|
Milestone
|
|
1980
|
|
Molina Medical Centers founded in Los Angeles, California by
Dr. C. David Molina
|
1985
|
|
Obtained HMO license in California
|
1994
|
|
Acquired minority interest in Michigan health plan
|
1997
|
|
Utah health plan established as start-up operation
|
1999
|
|
Incorporated in California as American Family Care,
Inc., parent of the California and Utah health plan
subsidiaries
Acquired controlling interest in Michigan and Washington health
plans
|
2000
|
|
Company name changed to Molina Healthcare, Inc., a California
corporation
|
2003
|
|
Reincorporated in Delaware, and completed initial public
offering and listing of shares for trading on the New York Stock
Exchange under the symbol, MOH
|
2004
|
|
Acquired the New Mexico health plan
|
2005
|
|
Ohio health plan established as start-up operation
|
2006
|
|
The California, Michigan, Utah, and Washington health plans
began operating Medicare Advantage Special Needs plans
|
|
|
Acquired the Cape Health Plan in Michigan, merging it into the
Michigan health plan
|
|
|
Texas health plan established as start-up operation
|
2007
|
|
The California, Michigan, New Mexico, Texas, Utah, and
Washington health plans began enrolling members in Medicare
Advantage plans with prescription drug coverage, or MA-PD
plans
Acquired the Missouri health plan
|
1
|
|
|
Year
|
|
Milestone
|
|
2008
|
|
The New Mexico and Texas health plans began operating Medicare
Advantage Special Needs plans
|
|
|
Florida health plan established as a start-up operation
|
2009
|
|
The Ohio health plan began operating a Medicare Advantage
Special Needs plan
|
On January 18, 2010, we entered into a definitive agreement
to acquire the Health Information Management, or HIM, business
of Unisys Corporation. The HIM business provides design,
development, implementation, and business process outsourcing
solutions to state governments for their Medicaid Management
Information Systems, or MMIS. MMIS is a core tool used to
support the administration of state Medicaid and other health
care entitlement programs. The HIM business currently holds MMIS
contracts with the states of Idaho, Louisiana, Maine, New
Jersey, and West Virginia, as well as a contract to provide drug
rebate administration services for the Florida Medicaid program.
The acquisition is expected to close in the first half of 2010.
We intend to operate the HIM business under the name, Molina
Medicaid Solutions.
Our principal executive offices are located at 200 Oceangate,
Suite 100, Long Beach, California 90802, and our telephone
number is
(562) 435-3666.
Our website is www.molinahealthcare.com.
Information contained on our website or linked to our website is
not incorporated by reference into, or as part of, this annual
report. Unless the context otherwise requires, references to
Molina Healthcare, the Company,
we, our, and us herein refer
to Molina Healthcare, Inc. and its subsidiaries. Our annual
reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and all amendments to these reports, are available free of
charge on our website, www.molinahealthcare.com, as soon
as reasonably practicable after such reports are electronically
filed with or furnished to the Securities and Exchange
Commission, or SEC. Information regarding our officers and
directors, and copies of our Code of Business Conduct and
Ethics, Corporate Governance Guidelines, and our Audit,
Compensation, and Corporate Governance and Nominating Committee
Charters, are also available on our website. Such information is
also available in print upon the request of any stockholder to
our Investor Relations Department at the address of our
executive offices set forth above. In accordance with New York
Stock Exchange, or NYSE, rules, on May 11, 2009, we filed
the annual certification by our Chief Executive Officer
certifying that he was unaware of any violation by us of the
NYSEs corporate governance listing standards at the time
of the certification.
Our
Industry
The Medicaid and CHIP Programs. Established in
1965, the Medicaid program is an entitlement program funded
jointly by the federal and state governments and administered by
the states. The Medicaid program provides health care benefits
to low-income families and individuals. Each state establishes
its own eligibility standards, benefit packages, payment rates,
and program administration within broad federal statutory and
regulatory guidelines. The most common state-administered
Medicaid program is the Temporary Assistance for Needy Families
program, or TANF (often pronounced TAN-if). TANF is
the successor to the Aid to Families with Dependent Children
program, or AFDC, and most enrolled members are mothers and
their children. Another common state-administered Medicaid
program is for the aged, blind, or disabled, or ABD Medicaid
members, who do not qualify under other Medicaid coverage
categories. Although state programs must meet minimum federal
standards, states have significant flexibility in determining
eligibility thresholds, the amount of covered services, and
payment rates for providers.
In addition, the Childrens Health Insurance Program, known
widely by the acronym CHIP, is a joint federal and state
matching program that provides health care coverage to children
whose families earn too much to qualify for Medicaid coverage,
but not enough to afford commercial health insurance. States
have the option of administering CHIP through their Medicaid
programs.
The federal government pays a portion of the costs that states
incur to provide services to Medicaid enrollees. The proportion
of states costs that the federal government pays is based
on the federal medical assistance percentage, or
FMAP. The percentage for each state is determined through a
formula that assigns a higher federal reimbursement rate to
states that have lower income per capita (and vice versa)
relative to the national average. Prior to the implementation of
the American Recovery and Reinvestment Act of 2009, or ARRA, the
average matching rate that the federal government paid was
57 percent nationwide; states contributed the remaining
43 percent. The federal matching rates have both a floor
2
(50 percent) and a ceiling (83 percent). The matching
rates for CHIP are approximately one-third higher than those
under Medicaid. Generally, states have more programmatic
flexibility in CHIP than in Medicaid.
As part of ARRA, enacted on February 17, 2009, states were
scheduled to receive approximately $87 billion in
assistance for their Medicaid programs through a temporary
increase in the FMAP match rate. The funding is effective from
October 1, 2008 to December 31, 2010. Under ARRA,
every state has received a minimum FMAP increase of
6.2 percent. The balance of funding is based on
unemployment rates in the states. In order to receive this
additional FMAP increase, states may not reduce Medicaid
eligibility levels below the eligibility levels that were in
place on July 1, 2008. Medicaid is classified as an
entitlement, and therefore there is no limit on the federal
funds that may be expended. Federal payments for Medicaid are
limited only by the amount states are willing and able to spend.
Nevertheless, budgetary constraints at both the federal and
state levels may limit the benefits paid and the number of
members served by Medicaid. CHIP, however, is a capped
allotment. Pursuant to the Childrens Health Insurance
Program Reauthorization Act of 2009 enacted on February 4,
2009, CHIP was reauthorized and expanded to cover up to a total
of 11 million children by 2011. The legislation also
provided an additional $32.8 billion in funding over the
next four-and-a-half years, and allows states to expand coverage
up to 300 percent of the federal poverty level. CHIP will
continue to be funded at an enhanced match, with a minimum
federal amount of 65 percent.
On March 10, 2010, the United States Senate approved
legislation which would allocate $25 billion to the
extension by six months of the 6.2% increase in the FMAP
provided under ARRA. If this legislation is passed by the House
and signed into law by President Obama, the increased FMAP paid
to the states will continue through June 30, 2011.
Medicaid Managed Care. Under traditional
fee-for-service
Medicaid programs, health care services are made available to
beneficiaries in an uncoordinated manner. These beneficiaries
typically have minimal access to preventive care such as
immunizations, and access to primary care physicians is limited.
As a consequence, treatment is often postponed until medical
conditions become more severe, leading to higher utilization of
costly emergency room services. In addition, because providers
are paid on a
fee-for-service
basis where additional services rendered result in additional
revenues, they lack incentives to monitor utilization and
control costs.
In an effort to improve quality and provide more uniform and
more cost-effective care, many states have implemented Medicaid
managed care programs. Such programs seek to improve access to
coordinated health care services, including preventive care, and
to control health care costs. Under Medicaid managed care
programs, a health plan receives capitation payments for the
covered health care services. The health plan, in turn, arranges
for the provision of the covered health care services by
contracting with a network of providers, including both
physicians and hospitals, who agree to provide the covered
services to the health plans members. The health plan also
monitors quality of care and implements preventive programs,
thereby striving to improve access to care while more
effectively controlling costs.
Over the past decade, the federal government has expanded the
ability of state Medicaid agencies to explore and, in many
cases, to mandate the use of managed care for Medicaid
beneficiaries. If Medicaid managed care is not mandatory,
individuals entitled to Medicaid may choose either the
fee-for-service
Medicaid program or a managed care plan, if available. All
states in which we operate have mandatory Medicaid managed care
programs.
Medicare Advantage Plans. During 2009, each of
our health plans in California, Michigan, New Mexico, Ohio,
Texas, Utah, and Washington operated Medicare Advantage plans,
each of which included a mandatory Part D prescription drug
benefit. Our Medicare Advantage special needs plans, or SNPs,
operate under the trade name, Molina Medicare Options Plus, and
serve those beneficiaries who are dually eligible for both
Medicare and Medicaid, such as low-income seniors and people
with disabilities. Our Medicare Advantage Prescription Drug
plans, or MA-PDs, operate under the trade name, Molina Medicare
Options. Although our MA-PD benefit plans do not exclusively
enroll dual eligible beneficiaries, the plans benefit
structure is designed to appeal to lower income beneficiaries.
We believe offering these Medicare plans is consistent with our
historical mission of serving low-income and medically
underserved families and individuals. None of our health plans
operate a Medicare Advantage private
fee-for-service
plan. Total enrollment in our Medicare Advantage plans at
December 31, 2009 was approximately 12,000 members. Our
2009 premium revenues from Medicare across all health plans
represented approximately 3.7% of our total premium revenues.
3
Other Government Programs for Low Income
Individuals. In certain instances, states have
elected to provide medical benefits to individuals and families
who do not qualify for Medicaid. Such programs are often
administered in a manner similar to Medicaid and CHIP, but
without federal matching funds. At December 31, 2009, our
Washington health plan served approximately 20,000 such members
under one such program, that states Basic Health
Plan.
Our
Approach
We focus on serving financially vulnerable families and
individuals who receive health care benefits through
government-sponsored programs within a managed care model. These
families and individuals generally represent diverse cultures
and ethnicities. Many have had limited educational opportunities
and do not speak English as their first language. Lack of
adequate transportation is common. We believe we are
well-positioned to capitalize on the growth opportunities in
serving these members. Our approach to managed care is based on
the following key attributes:
Experience. For 30 years we have focused
on serving Medicaid beneficiaries as both a health plan and as a
provider. We have developed and forged strong relationships with
the constituents whom we serve members, providers,
and government agencies. Our ability to deliver quality care and
to establish and maintain provider networks, as well as our
administrative efficiency, has allowed us to compete
successfully for government contracts. We have a strong record
of obtaining and renewing contracts and have developed
significant expertise as a government contractor.
Administrative Efficiency. We have centralized
and standardized various functions and practices across all of
our health plans to increase administrative efficiency. The
steps we have taken include centralizing claims processing and
information services onto a single platform. We have
standardized medical management programs, pharmacy benefits
management contracts, and health education programs. In
addition, we have designed our administrative and operational
infrastructure to be scalable for cost-effective expansion into
new and existing markets.
Proven Expansion Capability. We have
successfully replicated our business model through the
acquisition of health plans, the
start-up
development of new operations, and the transition of members
from other health plans. The successful integration of our New
Mexico and Missouri health plans demonstrated our ability to
expand into states in which we had not previously had any
presence. The establishment of our health plans in Utah, Ohio,
and Texas reflects our ability to replicate our business model
on a
start-up
basis in new states, while contract acquisitions in California,
Michigan, and Washington have demonstrated our ability to expand
our operations within states in which we were already operating.
Flexible Care Delivery Systems. Our systems
for delivery of health care services are diverse and readily
adaptable to different markets and changing conditions. We
arrange health care services through contracts with providers
that include independent physicians and medical groups,
hospitals, ancillary providers and, in California, our own
clinics. Our systems support multiple contracting models, such
as
fee-for-service,
capitation, per diem, case rates, and diagnostic related groups,
or DRGs. Our provider network strategy is to contract with
providers that are best-suited, based on expertise, proximity,
cultural sensitivity, and experience, to provide services to the
members we serve.
Our California health plan operates 17 company-owned
primary care clinics in California. In addition, in 2008, our
unlicensed subsidiary in Virginia began to manage the Fairfax
County Community Health Care Network. This network consists of
three county-owned clinics, providing comprehensive medical
services to over 16,000 of Fairfax Countys uninsured
residents. In 2010, our Washington health plan teamed with
Compass Health to launch Molina Medical at Compass
Health, a treatment center focused on integrating primary
care and behavioral health services. We believe that our clinics
serve a useful role in providing certain communities with access
to primary care and providing us with insights into physician
practice patterns, first-hand knowledge of the needs of our
members, and a platform to pilot new programs.
Cultural and Linguistic Expertise. We have
30 years of experience developing targeted health care
programs for culturally diverse Medicaid members, and believe we
are well-qualified to successfully serve these populations. We
contract with a diverse network of community-oriented providers
who have the capabilities to address the linguistic and cultural
needs of our members. We educate employees and providers about
the differing needs among
4
our members. We develop member education materials in a variety
of media and languages and ensure that the literacy level is
appropriate for our target audience.
Medical Management. We believe that our
experience as a health care provider has helped us to improve
medical outcomes for our members while at the same time
enhancing the cost-effectiveness of care. We monitor
day-to-day
medical management to provide appropriate care to our members,
contain costs, and ensure an efficient delivery network. We have
developed disease management and health education programs that
address the particular health care needs of our members. We have
established pharmacy management programs and policies that have
allowed us to manage our pharmaceutical costs effectively. For
example, our staff pharmacists educate our providers on the use
of generic drugs rather than brand drugs.
Our
Strategy
Our objective is to be an innovative health care leader while
delivering competitive returns for our investors. We seek to
provide quality care and accessible services in an efficient and
caring manner to Medicaid, CHIP, Medicare, and other financially
vulnerable members. To achieve these objectives, we intend to:
Focus on serving financially vulnerable families and
individuals. We believe that the Medicaid and
low-income Medicare population, which is characterized by
significant ethnic diversity, requires unique services to meet
its health care needs. Our 30 years of experience in
serving this population has provided us significant expertise in
meeting the unique needs of our members.
Increase our membership. We have grown our
membership through a combination of acquisitions,
start-up
health plans, serving new populations, and internal or organic
growth. Increasing our membership provides the opportunity to
grow and diversify our revenues, increase profits, enhance
economies of scale, and strengthen our relationships with
providers and government agencies. We will continue to seek to
grow our membership by expanding within existing markets and
entering new strategic markets.
|
|
|
|
|
Expand within existing markets. We expect to
grow in existing markets by expanding our service areas and
provider networks, increasing awareness of the Molina brand
name, extending our services to new populations, maintaining
positive provider relationships, and integrating members from
other health plans.
|
|
|
|
Enter new strategic markets. We intend to
enter new markets by acquiring existing businesses or building
our own operations. We will focus our expansion in markets with
competitive provider communities, supportive regulatory
environments, significant size and, where possible, mandated
Medicaid managed care enrollment.
|
Provide quality cost-effective care. We will
use our information systems, strong provider networks, and
first-hand provider experience to further develop and utilize
effective medical management and other programs that address the
distinct needs of our members. While improving the quality of
care, these programs also facilitate the cost-effective delivery
of that care. To document our commitment to quality, each Molina
Healthcare health plan has adopted goals: (1) to achieve or
continue accreditation by the National Committee for Quality
Assurance, or NCQA, and (2) to achieve scores under the
Healthcare Effectiveness Data and Information Set, or HEDIS, at
the 75th percentile for Medicaid plans. It is our goal to
be the health plan of choice, recognized for the quality and
accessibility of our services. Financially vulnerable families
and individuals covered by government programs have
traditionally faced long-standing barriers to accessing care
that include language, culture, and literacy. We want to be
known for our ability to help others overcome these barriers.
Among physicians, hospitals, and other providers, we want to be
known for prompt and accurate payment of claims and sound
medical decisions.
Leverage operational efficiencies. Our
centralized administrative infrastructure, flexible information
systems, and dedication to controlling administrative costs
provide economies of scale. We believe our administrative
infrastructure has significant expansion capacity, allowing us
to integrate new members from expansion within existing markets
and entry into new markets.
5
Our
Health Plans
As of December 31, 2009, our health plans were located in
California, Florida, Michigan, Missouri, New Mexico, Ohio,
Texas, Utah, and Washington. Additionally, we operate three
county primary care clinics in Virginia. As of December 31,
2009, we ceased serving members in Nevada. An overview of our
health plans and their principal governmental program contracts
with the relevant state authority is provided below:
|
|
|
|
|
State
|
|
Expiration Date
|
|
Contract Description or Covered Program
|
|
California
|
|
3-31-12
|
|
Subcontract with Health Net for services to Medi-Cal members
under Health Nets Los Angeles County Two-Plan Model
Medi-Cal contract with the California Department of Health
Services (DHS).
|
California
|
|
12-31-12
|
|
Medi-Cal contract for Sacramento Geographic Managed Care Program
with DHS.
|
California
|
|
3-31-11
|
|
Two Plan Model Medi-Cal contract for Riverside and
San Bernardino Counties (Inland Empire) with DHS.
|
California
|
|
6-30-10
|
|
Medi-Cal contract for San Diego Geographic Managed Care
Program with DHS.
|
California
|
|
6-30-10
|
|
Healthy Families contract (Californias CHIP program) with
California Managed Risk Medical Insurance Board (MRMIB).
|
Florida
|
|
8-31-12
|
|
Medicaid contract with the Florida Agency for Health Care
Administration.
|
Michigan
|
|
9-30-10
|
|
Medicaid contract with state of Michigan.
|
Missouri
|
|
6-30-10
|
|
Medicaid contract with the Missouri Department of Social
Services.
|
New Mexico
|
|
6-30-11
|
|
Salud! Medicaid Managed Care Program contract (including CHIP)
with New Mexico Human Services Department (HSD).
|
Ohio
|
|
6-30-10
|
|
Medicaid contract with Ohio Department of Job and Family
Services (ODJFS).
|
Texas
|
|
8-31-10
|
|
Medicaid contract with Texas Health and Human Services
Commission (HHSC).
|
Utah
|
|
6-30-10
|
|
Medicaid and CHIP contracts with Utah Department of Health.
|
Washington
|
|
12-31-10
|
|
Basic Health Plan and Basic Health Plus Programs contract with
Washington State Health Care Authority (HCA).
|
Washington
|
|
6-30-10
|
|
Healthy Options Program (including Medicaid and CHIP) contract
with state of Washington Department of Social and Health
Services.
|
In addition to the foregoing, our health plans in California,
Michigan, New Mexico, Ohio, Texas, Utah, and Washington have
entered into a standardized form of contract with CMS with
respect to their operation of a MA SNP, and our health plans in
California, Michigan, New Mexico, Ohio, Texas, Utah, and
Washington have also entered into a standardized form of
contract with CMS with respect to their operations of a MA-PD
plan. These contracts are renewed annually and were most
recently renewed as of January 1, 2010.
Our health plan subsidiaries have generally been successful in
obtaining the renewal by amendment of their contracts in each
state prior to the actual expiration of their contracts.
However, there can be no assurance that these contracts will
continue to be renewed.
Our contracts with state and local governments determine the
type and scope of health care services that we arrange for our
members. Generally, our contracts require us to arrange for
preventive care, office visits, inpatient and outpatient
hospital and medical services, and pharmacy benefits. We are
usually paid a negotiated per member per month amount, or PMPM,
with the PMPM amount varying from contract to contract.
Generally, that amount is higher in states where we are required
to offer more extensive health benefits. We are also paid an
additional amount for each newborn delivery in Michigan,
Missouri, New Mexico, Ohio, Texas, and Washington. In general,
either party may terminate our state contracts with or without
cause upon 30 days to nine months prior written notice. In
addition, most of these contracts contain renewal options that
are exercisable by the state.
California. As of December 31, 2009, our
California health plan served 351,000 members. Our plan serves
the counties of Los Angeles, Riverside, San Bernardino,
San Diego, and Sacramento. Our Medi-Cal members in
6
Los Angeles County are served pursuant to a subcontract we have
entered into with Health Net, with Health Net in turn
contracting with the state. Our California health plan also
operates 17 of its own primary care community clinics.
Florida. As of December 31, 2009, our
Florida plan served approximately 50,000 members, and operated
in 7 of the states 67 counties.
Michigan. As of December 31, 2009, our
Michigan health plan served 223,000 members, and operated in
46 of the states 83 counties, including the Detroit
metropolitan area.
Missouri. As of December 31, 2009, our
Missouri health plan served 78,000 members, and operated in 57
of the states 114 counties.
New Mexico. As of December 31, 2009, our
New Mexico health plan served 94,000 members, and operated in
all of New Mexicos 33 counties.
Ohio. As of December 31, 2009, our Ohio
health plan served 216,000 members, and operated in 50 of the
states 88 counties.
Texas. As of December 31, 2009, our Texas
health plan served 40,000 members, serving STAR and CHIP members
in 11 counties and STAR PLUS members in 13 counties. STAR stands
for State of Texas Access Reform, and is Texas Medicaid
managed care program. STAR PLUS is the Texas Medicaid managed
care program serving ABDs and includes a long-term care
component.
Utah. As of December 31, 2009, our Utah
health plan served 69,000 members including 4,000 Medicare
Advantage SNP members. Our Utah health plan serves Medicaid
members in 25 of the states 29 counties, including the
Salt Lake City metropolitan area, and CHIP members in all 29
counties.
Virginia. On July 1, 2008, Molina
Healthcare of Virginia, Inc. began to operate the Fairfax County
Community Health Care Network. This network consists of three
county clinics, and, as of December 31, 2009, provided
comprehensive medical services to over 16,000 of the
countys uninsured residents.
Washington. As of December 31, 2009, our
Washington health plan served 334,000 members, and operated in
34 of the states 39 counties. In February 2010, our
Washington health plan began operating a behavioral health
clinic under the name, Molina Medical at Compass Health.
Provider
Networks
We arrange health care services for our members through
contracts with providers that include independent physicians and
groups, hospitals, ancillary providers, and our own clinics. Our
strategy is to contract with providers in those geographic areas
and medical specialties necessary to meet the needs of our
members. We also strive to ensure that our providers have the
appropriate cultural and linguistic experience and skills.
7
The following table shows the total approximate number of
primary care physicians, specialists, and hospitals
participating in our network as of December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Primary Care
|
|
|
|
|
|
|
Physicians
|
|
Specialists
|
|
Hospitals
|
|
California
|
|
|
3,015
|
|
|
|
7,320
|
|
|
|
72
|
|
Florida
|
|
|
707
|
|
|
|
931
|
|
|
|
60
|
|
Michigan
|
|
|
2,491
|
|
|
|
5,351
|
|
|
|
71
|
|
Missouri
|
|
|
2,001
|
|
|
|
6,156
|
|
|
|
96
|
|
New Mexico
|
|
|
1,568
|
|
|
|
6,549
|
|
|
|
63
|
|
Ohio
|
|
|
1,828
|
|
|
|
11,581
|
|
|
|
106
|
|
Texas
|
|
|
1,369
|
|
|
|
5,421
|
|
|
|
61
|
|
Utah
|
|
|
1,261
|
|
|
|
3,936
|
|
|
|
39
|
|
Washington
|
|
|
3,089
|
|
|
|
6,256
|
|
|
|
88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
17,329
|
|
|
|
53,501
|
|
|
|
656
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Physicians. We contract with both primary care
physicians and specialists, many of whom are organized into
medical groups or independent practice associations, or IPAs.
Primary care physicians provide office-based primary care
services. Primary care physicians may be paid under capitation
or
fee-for-service
contracts and may receive additional compensation by providing
certain preventive services. Our specialists care for patients
for a specific episode or condition, usually upon referral from
a primary care physician, and are usually compensated on a
fee-for-service
basis. When we contract with groups of physicians on a capitated
basis, we monitor their solvency.
Hospitals. We generally contract with
hospitals that have significant experience dealing with the
medical needs of the Medicaid population. We reimburse hospitals
under a variety of payment methods, including
fee-for-service,
per diems, diagnostic-related groups, or DRGs, capitation, and
case rates.
Primary Care Clinics. Our California health
plan operates 17 company-owned primary care clinics in
California staffed by our physicians, physician assistants, and
nurse practitioners. These clinics are located in neighborhoods
where our members live, and provide us a first-hand opportunity
to understand the special needs of our members. The clinics
assist us in developing and implementing community education,
disease management, and other programs. The clinics also give us
direct clinic management experience that enables us to better
understand the needs of our contracted providers. In addition,
we have a non-licensed subsidiary in Virginia which manages
three health care clinics for Fairfax County, and our Washington
health plan recently opened a behavioral health clinic.
Medical
Management
Our experience in medical management extends back to our roots
as a provider organization. Primary care physicians are the
focal point of the delivery of health care to our members,
providing routine and preventive care, coordinating referrals to
specialists, and assessing the need for hospital care. This
model has proven to be an effective method for coordinating
medical care for our members. The underlying challenge we face
is to coordinate health care so that our members receive timely
and appropriate care from the right provider at the appropriate
cost. In support of this goal, and to ensure medical management
consistency among our various state health plans, we
continuously refine and upgrade our medical management efforts
at both the corporate and subsidiary levels.
We seek to ensure quality care for our members on a
cost-effective basis through the use of certain key medical
management and cost control tools. These tools include
utilization management, case and health management, and provider
network and contract management.
Utilization Management. We continuously review
utilization patterns with the intent to optimize quality of care
and ensure that only appropriate services are rendered in the
most cost-effective manner. Utilization management, along with
our other tools of medical management and cost control, is
supported by a centralized corporate medical informatics
function which utilizes third-party software and data
warehousing tools to convert
8
data into actionable information. We use a predictive modeling
capability that supports a proactive case and health management
approach both for us and our affiliated physicians.
Case and Health Management. We seek to
encourage quality, cost-effective care through a variety of case
and health management programs, including disease management
programs, educational programs, and pharmacy management programs.
Disease Management Programs. We develop
specialized disease management programs that address the
particular health care needs of our members. motherhood
matters!sm
is a comprehensive program designed to improve pregnancy
outcomes and enhance member satisfaction. breathe with
ease!sm
is a multi-disciplinary disease management program that provides
health education resources and case management services to
assist physicians caring for asthmatic members between the ages
of three and fifteen. Healthy Living with
Diabetessm
is a diabetes disease management program. Heart Health
Living is a cardiovascular disease management program
for members who have suffered from congestive heart failure,
angina, heart attack, or high blood pressure.
Educational Programs. Educational programs are
an important aspect of our approach to health care delivery.
These programs are designed to increase awareness of various
diseases, conditions, and methods of prevention in a manner that
supports our providers while meeting the unique needs of our
members. For example, we provide our members with information to
guide them through various episodes of care. This information,
which is available in several languages, is designed to educate
parents on the use of primary care physicians, emergency rooms,
and nurse call centers.
Pharmacy Management Programs. Our pharmacy
management programs focus on physician education regarding
appropriate medication utilization and encouraging the use of
generic medications. Our pharmacists and medical directors work
with our pharmacy benefits manager to maintain a formulary that
promotes both improved patient care and generic drug use. We
employ full-time pharmacists and pharmacy technicians who work
with physicians to educate them on the uses of specific drugs,
the implementation of best practices, and the importance of
cost-effective care.
Provider Network and Contract Management. The
quality, depth, and scope of our provider network are essential
if we are to ensure quality, cost-effective care for our
members. In partnering with quality, cost-effective providers,
we utilize clinical and financial information derived by our
medical informatics function, as well as the experience we have
gained in serving Medicaid members to gain insight into the
needs of both our members and our providers. As we grow in size,
we seek to strengthen our ties with high-quality, cost-effective
providers by offering them greater patient volume.
Plan
Administration and Operations
Management Information Systems. All of our
health plan information technology and systems operate on a
single platform. This approach avoids the costs associated with
maintaining multiple systems, improves productivity, and enables
medical directors to compare costs, identify trends, and
exchange best practices among our plans. Our single platform
also facilitates our compliance with current and future
regulatory requirements.
The software we use is based on client-server technology and is
scalable. We believe the software is flexible, easy to use, and
allows us to accommodate anticipated enrollment growth and new
contracts. The open architecture of the system gives us the
ability to transfer data from other systems without the need to
write a significant amount of computer code, thereby
facilitating the integration of new plans and acquisitions.
We have designed our corporate website with a focus on ease of
use and visual appeal. Our website has a secure ePortal which
allows providers, members, and trading partners to access
individualized data. The ePortal allows the following
self-services:
|
|
|
|
|
Provider Self Services. Providers have the
ability to access information regarding their members and
claims. Key functionalities include Check Member Eligibility,
View Claim, and View/Submit Authorizations.
|
9
|
|
|
|
|
Member Self Services. Members can access
information regarding their personal data, and can perform the
following key functionalities: View Benefits, Request New ID
Card, Print Temporary ID Card, and Request Change of Address/PCP.
|
|
|
|
File Exchange Services. Various trading
partners such as service partners, providers,
vendors, management companies, and individual IPAs
are able to exchange data files (such as those that may be
required by the Health Insurance Portability and Accountability
Act of 1996, or HIPAA, or any other proprietary format) with us
using the file exchange functionality.
|
Best Practices. We continuously seek to
promote best practices. Our approach to quality is broad,
encompassing traditional medical management and the improvement
of our internal operations. We have staff assigned full-time to
the development and implementation of a uniform, efficient, and
quality-based medical care delivery model for our health plans.
These employees coordinate and implement Company-wide programs
and strategic initiatives such as preparation of the HEDIS and
accreditation by the NCQA. We use measures established by the
NCQA in credentialing the physicians in our network. We
routinely use peer review to assess the quality of care rendered
by providers. At December 31, 2009, all of our eligible
health plans were accredited by the NCQA. Our Missouri plan will
begin the NCQA review and accreditation process in 2010, and our
Florida plan expects to apply for NCQA review as soon as it is
eligible.
Claims Processing. All of our health plans
operate on a single managed care platform for claims processing
(the QNXT 3.4 system), with the exception of our Missouri plan
which we expect will be migrated to the Molina standard platform
in the second quarter of 2010.
Compliance. Our health plans have established
high standards of ethical conduct. Our compliance programs are
modeled after the compliance guidance statements published by
the Office of the Inspector General of the U.S. Department
of Health and Human Services. Our uniform approach to compliance
makes it easier for our health plans to share information and
practices and reduces the potential for compliance errors and
any associated liability.
Disaster Recovery. We have established a
disaster recovery and business resumption plan, with
back-up
operating sites, to be deployed in the case of a major
disruptive event.
Competition
We operate in a highly competitive
environment. The Medicaid managed care industry
is fragmented, and the competitive landscape is subject to
ongoing changes as a result of business consolidations and new
strategic alliances. We compete with a large number of national,
regional, and local Medicaid service providers, principally on
the basis of size, location, and quality of provider network,
quality of service, and reputation. Competition can vary
considerably from state to state. Below is a general description
of our principal competitors for state contracts, members, and
providers:
|
|
|
|
|
Multi-Product Managed Care Organizations
National and regional managed care organizations
that have Medicaid members in addition to numerous commercial
health plan and Medicare members.
|
|
|
|
Medicaid HMOs National and regional managed
care organizations that focus principally on providing health
care services to Medicaid beneficiaries, many of which operate
in only one city or state.
|
|
|
|
Prepaid Health Plans Health plans that
provide less comprehensive services on an at-risk basis or that
provide benefit packages on a non-risk basis.
|
|
|
|
Primary Care Case Management Programs
Programs established by the states through
contracts with primary care providers to provide primary care
services to Medicaid beneficiaries, as well as to provide
limited oversight of other services.
|
We will continue to face varying levels of competition. Health
care reform proposals may cause organizations to enter or exit
the market for government sponsored health programs. However,
the licensing requirements and bidding and contracting
procedures in some states may present partial barriers to entry
into our industry.
We compete for government contracts, renewals of those
government contracts, members, and providers. State agencies
consider many factors in awarding contracts to health plans.
Among such factors are the health plans provider network,
medical management, degree of member satisfaction, timeliness of
claims payment, and financial resources.
10
Potential members typically choose a health plan based on a
specific provider being a part of the network, the quality of
care and services available, accessibility of services, and
reputation or name recognition of the health plan. We believe
factors that providers consider in deciding whether to contract
with a health plan include potential member volume, payment
methods, timeliness and accuracy of claims payment, and
administrative service capabilities.
Regulation
Our health plans are highly regulated by both state and federal
government agencies. Regulation of managed care products and
health care services varies from jurisdiction to jurisdiction,
and changes in applicable laws and rules can occur frequently.
Regulatory agencies generally have discretion to issue
regulations and interpret and enforce laws and rules.
To operate a health plan in a given state, we must apply for and
obtain a certificate of authority or license from that state.
Our operating health plans are licensed to operate as health
maintenance organizations, or HMOs, in each of California,
Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, and
Washington. In those states we are regulated by the agency with
responsibility for the oversight of HMOs which, in most cases,
is the state department of insurance. In California, however,
the agency with responsibility for the oversight of HMOs is the
Department of Managed Health Care. Licensing requirements are
the same for us as they are for health plans serving commercial
or Medicare members. We must demonstrate that our provider
network is adequate, that our quality and utilization management
processes comply with state requirements, and that we have
adequate procedures in place for responding to member and
provider complaints and grievances. We must also demonstrate
that we can meet requirements for the timely processing of
provider claims, and that we can collect and analyze the
information needed to manage our quality improvement activities.
In addition, we must prove that we have the financial resources
necessary to pay our anticipated medical care expenses and the
infrastructure needed to account for our costs.
Each of our health plans is required to file quarterly reports
on its operating results with the appropriate state regulatory
agencies. These reports are accessible for public viewing. Each
health plan undergoes periodic examinations and reviews by the
state in which it operates. The health plans generally must
obtain approval from the state before declaring dividends in
excess of certain thresholds. Each health plan must maintain its
net worth at an amount determined by statute or regulation. The
minimum statutory net worth requirements differ by state, and
are generally based on statutory minimum risk-based capital, or
RBC, requirements. The RBC requirements are based on guidelines
established by the National Association of Insurance
Commissioners, or NAIC, and are administered by the states. Our
Michigan, Missouri, New Mexico, Ohio, Texas, Utah, and
Washington health plans are subject to RBC requirements. Any
acquisition of another plans members or its state
contracts must also be approved by the state, and our ability to
invest in certain financial securities may be prescribed by
statute.
In addition, we are also regulated by each states
department of health services or the equivalent agency charged
with oversight of Medicaid and CHIP. These agencies typically
require demonstration of the same capabilities mentioned above
and perform periodic audits of performance, usually annually.
Medicaid. Medicaid was established under the
U.S. Social Security Act to provide medical assistance to
the poor. Although both the federal and state governments
jointly fund it, Medicaid is a state-operated and
state-implemented program. Our contracts with the state Medicaid
programs impose various requirements on us in addition to those
imposed by applicable federal and state laws and regulations.
Within broad guidelines established by the federal government,
each state:
|
|
|
|
|
establishes its own member eligibility standards;
|
|
|
|
determines the type, amount, duration, and scope of services;
|
|
|
|
sets the rate of payment for health care services; and
|
|
|
|
administers its own program.
|
We obtain our Medicaid contracts in different ways. Some states,
such as Washington, award contracts to any applicant
demonstrating that it meets the states requirements. Other
states, such as California, engage in a competitive bidding
process. In all cases, we must demonstrate to the satisfaction
of the state Medicaid program that
11
we are able to meet the states operational and financial
requirements. These requirements are in addition to those
required for a license and are targeted to the specific needs of
the Medicaid population. For example:
|
|
|
|
|
We must measure provider access and availability in terms of the
time needed to reach the doctors office using public
transportation;
|
|
|
|
Our quality improvement programs must emphasize member education
and outreach and include measures designed to promote
utilization of preventive services;
|
|
|
|
We must have linkages with schools, city or county health
departments, and other community-based providers of health care,
to demonstrate our ability to coordinate all of the sources from
which our members may receive care;
|
|
|
|
We must be able to meet the needs of the disabled and others
with special needs;
|
|
|
|
Our providers and member service representatives must be able to
communicate with members who do not speak English or who are
deaf; and
|
|
|
|
Our member handbook, newsletters, and other communications must
be written at the prescribed reading level, and must be
available in languages other than English.
|
In addition, we must demonstrate that we have the systems
required to process enrollment information, to report on care
and services provided, and to process claims for payment in a
timely fashion. We must also have the financial resources needed
to protect the state, our providers, and our members against the
insolvency of one of our health plans.
Once awarded, our contracts generally have terms of one to three
years, with renewal options at the discretion of the states. Our
contracts generally set forth the requirements for operating in
the Medicaid sector, and include provisions relating to:
eligibility; enrollment and disenrollment processes; covered
services; eligible providers; subcontractors; record-keeping and
record retention; periodic financial and informational
reporting; quality assurance; marketing; financial standards;
timeliness of claims payments; health education and wellness and
prevention programs; safeguarding of member information; fraud
and abuse detection and reporting; grievance procedures; and
organization and administrative systems. A health plans
compliance with these requirements is subject to monitoring by
state regulators. A health plan is subject to periodic
comprehensive quality assurance evaluation by the insurance
department of the jurisdiction that licenses the health plan,
and must submit periodic utilization reports and other
information to state or county Medicaid authorities. Health
plans are not permitted to enroll members directly, and are
permitted to market only in accordance with strict guidelines.
Most health plans must also submit quarterly and annual
statutory financial statements and utilization reports, as well
as many other reports in accordance with individual state
requirements.
Medicare. Medicare is a federal program that
provides eligible persons age 65 and over and some disabled
persons a variety of hospital, medical insurance, and
prescription drug benefits. Medicare is funded by Congress, and
administered by CMS. Medicare beneficiaries have the option to
enroll in a Medicare Advantage plan. Under Medicare Advantage,
managed care plans contract with CMS to provide benefits that
are comparable to original Medicare in exchange for a fixed PMPM
that varies based on the county in which a member resides, the
demographics of the member, and the members health
condition.
The Medicare Prescription Drug, Improvement and Modernization
Act of 2003, or MMA, made numerous changes to the Medicare
program, including expanding the Medicare program to include a
prescription drug benefit. Since 2006, Medicare beneficiaries
have had the option of selecting a new prescription drug benefit
from an existing Medicare Advantage plan. The drug benefit,
available to beneficiaries for a monthly premium, is subject to
certain cost sharing depending upon the specific benefit design
of the selected plan. Plans are not required to offer the same
benefits, but are required to provide coverage that is at least
actuarially equivalent to the standard drug coverage delineated
in the MMA.
On July 15, 2008, the Medicare Improvements for Patients
and Providers Act, or MIPPA, became law and, in September 2008,
CMS promulgated implementing regulations. MIPPA impacts a broad
range of Medicare activities and impacts all types of Medicare
managed care plans. MIPPA and subsequent CMS guidance place
12
prohibitions and limitations on certain sales and marketing
activities of Medicare Advantage plans. Among other things,
Medicare Advantage plans are not permitted to make unsolicited
outbound calls to potential members or engage in other forms of
unsolicited contact, establish appointments without documented
consent from potential members, or conduct sales events in
certain provider-based settings. MIPPA also establishes certain
restrictions on agent and broker compensation.
HIPAA. In 1996, Congress enacted HIPAA. All
health plans are subject to HIPAA, including ours. HIPAA
generally requires health plans to:
|
|
|
|
|
Establish the capability to receive and transmit electronically
certain administrative health care transactions, like claims
payments, in a standardized format,
|
|
|
|
Afford privacy to patient health information, and
|
|
|
|
Protect the privacy of patient health information through
physical and electronic security measures.
|
ARRA further expands the coverage of HIPAA by, among other
things, extending the privacy and security provisions, mandating
new regulations around electronic medical records, expanding
enforcement mechanisms, allowing the state attorneys general to
bring enforcement actions and increasing penalties for
violations.
Fraud and Abuse Laws. Federal and state
governments have made investigating and prosecuting health care
fraud and abuse a priority. Fraud and abuse prohibitions
encompass a wide range of activities, including kickbacks for
referral of members, billing for unnecessary medical services,
improper marketing, and violations of patient privacy rights.
Companies involved in public health care programs such as
Medicaid are often the subject of fraud and abuse
investigations. The regulations and contractual requirements
applicable to participants in these public-sector programs are
complex and subject to change. Although we believe that our
compliance efforts are adequate, we will continue to devote
significant resources to support our compliance efforts.
Employees
As of December 31, 2009, we had approximately
2,800 employees. Our employee base is multicultural and
reflects the diverse Medicaid and Medicare membership we serve.
We believe we have good relations with our employees. None of
our employees is represented by a union.
Item
X: Executive Officers of the Registrant
J. Mario Molina, M.D., 51, has served as President and
Chief Executive Officer since succeeding his father and company
founder, Dr. C. David Molina, in 1996. He has also served
as Chairman of the Board since 1996. Prior to that, he served as
Medical Director from 1991 through 1994 and was Vice President
responsible for provider contracting and relations, member
services, marketing and quality assurance from 1994 to 1996. He
earned an M.D. from the University of Southern California and
performed his medical internship and residency at the Johns
Hopkins Hospital. Dr. Molina is the brother of John C.
Molina.
John C. Molina, J.D., 45, has served in the role of Chief
Financial Officer since 1995. He also has served as a director
since 1994. Mr. Molina has been employed by us for over
30 years in a variety of positions. Mr. Molina is a
past president of the California Association of Primary Care
Case Management Plans. He earned a Juris Doctorate from the
University of Southern California School of Law. Mr. Molina
is the brother of J. Mario Molina, M.D.
Mark L. Andrews, Esq., 52, has served as Chief Legal
Officer and General Counsel since 1998. He also has served as a
member of the Executive Committee of our company since 1998.
Before joining our company, Mr. Andrews was a partner at
Wilke, Fleury, Hoffelt, Gould & Birney of Sacramento,
California, where he chaired that firms health care and
employment law departments and represented Molina as outside
counsel from 1994 through 1997. Mr. Andrews holds a Juris
Doctorate degree from Hastings College of the Law.
Terry P. Bayer, 59, has served as our Chief Operating Officer
since November 2005. She had formerly served as our Executive
Vice President, Health Plan Operations since January 2005.
Ms. Bayer has 26 years of health care management
experience, including staff model clinic administration,
provider contracting, managed care operations, disease
management, and home care. Prior to joining us, her professional
experience included regional
13
responsibility at FHP, Inc. and multi-state responsibility as
Regional Vice-President at Maxicare; Partners National Health
Plan, a joint venture of Aetna Life Insurance Company and
Voluntary Hospital Association (VHA); and Lincoln National. She
has also served as Executive Vice President of Managed Care at
Matria Healthcare, President and Chief Operating Officer of
Praxis Clinical Services, and as Western Division President
of AccentCare. She holds a Juris Doctorate from Stanford
University, a Masters degree in Public Health from the
University of California, Berkeley, and a Bachelors degree
in Communications from Northwestern University.
James W. Howatt, 63, has served as our Chief Medical Officer
since May 2008. Dr. Howatt formerly served as the chief
medical officer of Molina Healthcare of Washington. Prior to
joining Molina Healthcare in February 2006, Dr. Howatt was
Western Regional Medical Director for Humana, where he was
responsible for the coordination and oversight of quality,
utilization management, credentialing, and accreditation for
Humanas activities west of Kansas City. Previously, he was
Vice President and CMO of Humana Arizona, where he was
responsible for leading a variety of medical management
functions and worked closely with the companys sales
division to develop customer-focused benefit structures.
Dr. Howatt also served as CMO for Humana TRICARE, where he
oversaw a $2.5 billion health care operation that served
three million beneficiaries and comprised a professional network
of 40,000 providers, 800 institutions, and 13 medical directors.
Dr. Howatt received B.S. and M.D. degrees from the
University of California, San Francisco, and also holds a
Master of Business Administration degree with an emphasis in
Health Management from the University of Phoenix. He interned
and completed his residency program in family practice at
Ventura County Hospital in Ventura, California. Dr. Howatt
is a board-certified family physician and a member of the
American College of Managed Care Medicine.
RISK
FACTORS
Safe
Harbor Statement under the Private Securities Litigation Reform
Act of 1995
This annual report on
Form 10-K
and the documents we incorporate by reference in this report
contain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the
Securities Act), and Section 21E of the
Securities Exchange Act of 1934, as amended (the Exchange
Act). Other than statements of historical fact, all
statements that we include in this report and in the documents
we incorporate by reference may be deemed to be forward-looking
statements for purposes of the Securities Act and the Exchange
Act. Such forward-looking statements may be identified by words
such as anticipates, believes,
could, estimates, expects,
guidance, intends, may,
outlook, plans, projects,
seeks, will, or similar words or
expressions.
Investing in our securities involves a high degree of risk.
Before making an investment decision, you should carefully read
and consider the following risk factors, as well as the other
information we include or incorporate by reference in this
report and the information in the other reports we file with the
SEC. Such risk factors should be considered not only with regard
to the information contained in this annual report, but also
with regard to the information and statements in the other
periodic or current reports we file with the SEC, as well as our
press releases, presentations to securities analysts or
investors, or other communications made by or with the approval
of one of our executive officers. We cannot guarantee that we
will actually achieve the results contemplated or disclosed in
our forward-looking statements. Such statements may turn out to
be wrong due to the inherent uncertainties associated with
future events. Accordingly, you should not place undue reliance
on our forward-looking statements, which reflect
managements analyses, judgments, beliefs, or expectations
only as of the date they are made.
If any of the events described in the following risk factors
actually occur, our business, results of operations, financial
condition, cash flows, or prospects could be materially
adversely affected. The risks and uncertainties described below
are those that we currently believe may materially affect us.
Except to the extent otherwise required by federal securities
laws, we do not undertake to address or update forward-looking
statements in future filings or communications regarding our
business or operating results, and do not undertake to address
how any of these factors may have caused results to differ from
discussions or information contained in previous filings or
communications.
14
Risks
Related to our Health Plan Business
State
and federal budget deficits may result in Medicaid, CHIP, or
Medicare funding cuts or changes in member eligibility
thresholds or criteria which could compress our profit
margins.
With the exception of the relatively small portion of our
revenues which come from Medicare, nearly all of our premium
revenues come from the joint federal and state funding of the
Medicaid and CHIP programs. Due to high unemployment levels,
Medicaid enrollment levels and Medicaid costs are continuing to
increase at the same time that state budgets are suffering from
unprecedented deficits. In June 2009, 46.9 million members
were enrolled in the Medicaid program throughout the nation,
nearly 3.3 million more than in June 2008, representing the
largest one-year increase since the inception of the Medicaid
program. Because governmental health care programs account for
such a large portion of state budgets, efforts to contain
overall government spending and to achieve a balanced budget
often result in significant political pressure being directed at
the funding for these health care programs. The National
Association of State Medicaid Directors estimates that state
budget shortfalls in the coming fiscal year, which begins in
July in most states, will total $140 billion. Because
Medicaid is one of the largest expenditures in every state
budget, and one of the fastest-growing, it will likely be a
prime target for cost-containment efforts. Thus, the sufficiency
of the funding under our various state contracts, or the rates
we expect to be paid during the course of a year, will be in
jeopardy during 2010 while the state budget crises persist. All
of the states in which we currently operate our health plans are
currently facing significant budgetary pressures. Moreover,
because Medicaid enrollment often lags behind unemployment,
increases in Medicaid enrollment in 2010 could be even greater
than it was in 2009, putting even greater pressure on state
budgets.
As part of the American Recovery and Reinvestment Act of 2009,
or ARRA, the federal government increased the amount of funding
for federal Medicaid matching by approximately $87 billion
for the period between October 1, 2008 and
December 31, 2010. The actual matching percentage is
computed from a formula that takes into account the average per
capita income for each state relative to the national average,
and a states unemployment rate. As a result of the passage
of this legislation, the share of Medicaid costs that are paid
for by the federal government has gone up, and the share of
costs that are paid for by the states has gone down. However, in
order for states to receive these increased federal matching
funds, they must first budget for and actually spend their own
state dollars to cover their additional Medicaid and CHIP
members. Medicaid spending will therefore be driven by
states available revenues. State governments may have
insufficient funds to fully fund these programs or provide for
expanded enrollment. As a result, states may seek to cut or
revise health care programs, optional benefits, eligibility
criteria and thresholds, or provider rates, causing the funding
of one or more of our state contracts to be curtailed or cut
off. In addition, the timing of payments we receive may be
impacted by state budget shortfalls. In addition, the
$87 billion in increased Medicaid funding provided by ARRA
will expire as of December 31, 2010, in the middle of many
states fiscal years. On March 10, 2010, the United
States Senate approved legislation which would allocate
$25 billion to the extension by six months of the 6.2%
increase in the FMAP provided under ARRA. If this legislation is
passed by the House and signed into law by President Obama, the
increased FMAP paid to the states will continue through
June 30, 2011. Unless increased Medicaid funding similar to
that provided under ARRA is renewed, the impending loss of this
federal funding may cause states to curtail their health care
programs or to slash membership in the middle of their fiscal
year. Such an action could result in the abrupt loss of a
significant number of our enrollees.
Because of their budget deficits, some of the states in which we
operate may unexpectedly reduce the rates paid to our health
plans or carve out certain elements of their Medicaid benefits,
thereby undermining the assumptions used to generate our
earnings projections. For instance, effective October 1,
2009, the state of Missouri carved out pharmacy from its
Medicaid benefit package, and effective February 1, 2010
the state of Ohio did likewise with its pharmacy benefit. The
provision of this benefit by our Missouri and Ohio health plans,
respectively, had previously been a significant source of
earnings for those health plans. Many states have moved to cut
optional benefits in the face of budgetary pressures. There is a
risk that cutting such benefits may drive Medicaid patients into
expensive emergency rooms, further exacerbating the cost of the
Medicaid program to a state. Any unexpected rate cuts or changes
in benefit packages could have a material adverse effect on our
business, financial condition, cash flows, or results of
operations.
15
Our
profitability depends on our ability to accurately predict and
effectively manage our medical care costs.
Our profitability depends to a significant degree on our ability
to accurately predict and effectively manage our medical care
costs. Historically, our medical care cost ratio, meaning our
medical care costs as a percentage of our premium revenue, has
fluctuated substantially, and has also varied across our state
health plans. Because the premium payments we receive are
generally fixed in advance and we operate with a narrow profit
margin, relatively small changes in our medical care cost ratio
can create significant changes in our overall financial results.
For example, if our overall medical care ratio for 2009 of 86.8%
had been one percentage point higher, or 87.8%, our earnings for
2009 would have been $0.18 per diluted share rather than our
actual 2009 earnings of $1.19 per diluted share, an 85%
reduction in our earnings.
Factors that may affect our medical care costs include the level
of utilization of health care services, increases in hospital
costs, an increased incidence or acuity of high dollar claims
related to catastrophic illnesses or medical conditions such as
hemophilia for which we do not have adequate reinsurance
coverage, increased maternity costs, payment rates that are not
actuarially sound, changes in state eligibility certification
methodologies, unexpected patterns in the annual flu season,
relatively low levels of hospital and specialty provider
competition in certain geographic areas, increases in the cost
of pharmaceutical products and services, changes in health care
regulations and practices, epidemics, new medical technologies,
and other various external factors. Many of these factors are
beyond our control and could reduce our ability to accurately
predict and effectively manage the costs of providing health
care services. This was demonstrated in the third and fourth
quarters of 2009, when our medical costs exceeded our previous
estimates as a result of much higher utilization due to
widespread influenza-related illness across the Companys
health plans, higher medical costs associated with our rapid
enrollment growth and the higher costs associated with new
members, and higher emergency room costs. The inability to
forecast and manage our medical care costs or to establish and
maintain a satisfactory medical care cost ratio, either with
respect to a particular state health plan or across the
consolidated entity, could have a material adverse effect on our
business, financial condition, cash flows, or results of
operations.
Our
business may be negatively affected by the enactment of health
care or health insurance reforms.
In response to escalating health care costs and the large and
growing number of uninsured Americans, legislative proposals
that would reform the health care system have been advanced by
Congress and state legislatures and are currently pending at the
federal and state levels. These proposals include policy changes
that could fundamentally change the dynamics of the health care
industry, such as having the federal government assume a larger
role in the health care industry, or effecting a fundamental
restructuring of the Medicare or Medicaid programs. These
proposals may also affect certain aspects of our business,
including our enrollment levels, our required payment of excise
or premium taxes, our contracting with providers, provider
reimbursement methods and payment rates, coverage
determinations, mandated benefits, minimum medical expenditures,
claims payment and processing, drug utilization and patient
safety efforts, collection, use, disclosure, maintenance, and
disposal of individually identifiable health information or
personal health records. One proposal for partially financing
the cost of health care reform is to assess an excise tax on the
revenues of health plans based on their market share. If adopted
as proposed, such an excise tax would have a significant impact
on our profitability.
We cannot predict if any of these initiatives will ultimately
become law, or, if enacted, what their terms or the regulations
promulgated pursuant to such laws will be. But their enactment
could increase our costs, expose us to expanded liability, and
require us to revise the ways in which we conduct business or
put us at risk for loss of business. In addition, our operating
results could be adversely affected by such changes even if we
correctly predict their occurrence.
A
failure to accurately estimate incurred but not reported medical
care costs may negatively impact our results of
operations.
Because of the time lag between when medical services are
actually rendered by our providers and when we receive, process,
and pay a claim for those medical services, we must continually
estimate our medical claims liability at particular points in
time, and establish claims reserves related to such estimates.
Our estimated reserves
16
for such incurred but not paid, or IBNP medical care
costs, are based on numerous assumptions. We estimate our
medical claims liabilities using actuarial methods based on
historical data adjusted for claims receipt and payment
experience (and variations in that experience), changes in
membership, provider billing practices, health care service
utilization trends, cost trends, product mix, seasonality, prior
authorization of medical services, benefit changes, known
outbreaks of disease or increased incidence of illness such as
influenza, provider contract changes, changes to Medicaid fee
schedules, and the incidence of high dollar or catastrophic
claims. Our ability to accurately estimate claims for our newer
lines of business or populations, such as with respect to
Medicare Advantage or ABD Medicaid members, is impacted by the
more limited experience we have had with those populations.
Finally, with regard to the new Medicaid and CHIP members we
expect to enroll in 2010 through organic growth due primarily to
the recession, new members may be disproportionately costly due
to high utilization in their first several months of Medicaid or
CHIP membership as a result of their previously having been
uninsured and therefore not seeking or deferring medical
treatment.
The IBNP estimation methods we use and the resulting reserves
that we establish are reviewed and updated, and adjustments, if
deemed necessary, are reflected in the current period. Given the
numerous uncertainties inherent in such estimates, our actual
claims liabilities for a particular quarter or other period
could differ significantly from the amounts estimated and
reserved for that quarter or period. Our actual claims
liabilities have varied and will continue to vary from our
estimates, particularly in times of significant changes in
utilization, medical cost trends, and populations and markets
served.
If our actual liability for claims payments is higher than
estimated, our earnings per share in any particular quarter or
annual period could be negatively affected. Our estimates of
IBNP may be inadequate in the future, which would negatively
affect our results of operations for the relevant time period.
Furthermore, if we are unable to accurately estimate IBNP, our
ability to take timely corrective actions may be limited,
further exacerbating the extent of the negative impact on our
results.
If our
government contracts are not renewed or are terminated, or if
the responsive bids of our health plans for new Medicaid
contracts are not successful, our premium revenues could be
materially reduced and our operating results could be negatively
impacted.
Our government contracts generally run for periods of one year
to four years, and may be successively extended by amendment for
additional periods if the relevant state agency so elects. Our
current contracts expire on various dates over the next several
years. There is no guarantee that any of our government
contracts will be renewed or extended. Moreover, our contracts
may be subject to periodic competitive bidding. In the event the
responsive bids of our health plans are not successful, we will
lose our Medicaid contract in the applicable state, and our
premium revenues could be materially reduced as a result.
Alternatively, even if our responsive bids are successful, they
may be based upon assumptions regarding enrollment, utilization,
medical costs, or other factors which could result in the
Medicaid contract being less profitable than we had expected or
had previously been the case.
In addition, all of our contracts may be terminated for cause if
we breach a material provision of the contract or violate
relevant laws or regulations. Our contracts with the states are
also subject to cancellation by the state in the event of
unavailability of state or federal funding. In some
jurisdictions, such cancellation may be immediate and in other
jurisdictions a notice period is required. In addition, most
contracts are terminable without cause. We may face increased
competition as other plans, many with greater financial
resources and greater name recognition, attempt to enter our
markets through the contracting process. If we are unable to
renew, successfully re-bid, or compete for any of our government
contracts, or if any of our contracts are terminated or renewed
on less favorable terms, our business, financial condition, cash
flows, or results of operations could be adversely affected.
Restrictions
and covenants in our credit facility may limit our ability to
make certain acquisitions or reduce our liquidity and capital
resources.
To provide liquidity, we have a $200 million senior secured
credit facility that matures in May 2012. As of
December 31, 2009, we had no outstanding indebtedness under
our credit facility. Our credit facility imposes numerous
restrictions and covenants, including prescribed consolidated
leverage and fixed charge coverage ratios,
17
net worth requirements, and acquisition limitations that
restrict our financial and operating flexibility, including our
ability to make certain acquisitions above specified values and
declare dividends without lender approval. As a result of the
restrictions and covenants imposed under our credit facility,
our growth strategy may be negatively impacted by our inability
to act with complete flexibility, or our inability to use our
credit facility in the manner intended. If we are in default at
a time when funds under the credit facility are required to
finance an acquisition, or if a proposed acquisition does not
satisfy the pro forma financial requirements under our credit
facility, we may be unable to use the credit facility in the
manner intended, and our operations, liquidity, and capital
resources could be materially adversely affected.
Adverse
equity and credit market conditions may have a material adverse
affect on our liquidity or our ability to obtain financing on
acceptable terms.
The securities and credit markets have been experiencing
significant volatility and disruption over the past eighteen
months. The availability of credit from virtually all types of
lenders has been significantly affected. Such conditions may
persist throughout 2010. In the event we need access to
additional capital to pay our operating expenses, make payments
on our indebtedness, pay capital expenditures, fund net worth
requirements, or fund acquisitions, our ability to obtain such
capital may be limited and the cost of any such capital may be
significant.
Our access to additional financing will depend on a variety of
factors such as prevailing economic and equity and credit market
conditions, the general availability of credit, our credit
ratings and credit capacity, and perceptions of our financial
prospects. Similarly, our access to funds may be impaired if
regulatory authorities take negative actions against us. If a
combination of these factors were to occur, our internal sources
of liquidity may prove to be insufficient, and in such case we
may not be able to successfully obtain additional financing on
favorable terms or at all.
We
derive our premium revenues from a relatively small number of
state health plans.
We currently derive our premium revenues from nine state health
plans. If we were unable to continue to operate in any of those
nine states, or if our current operations in any portion of the
states we are in were significantly curtailed, our revenues
could decrease materially. Our reliance on operations in a
limited number of states could cause our revenue and
profitability to change suddenly and unexpectedly depending on
an abrupt loss of membership, significant rate reductions, a
loss of a material contract, legislative actions, changes in
Medicaid eligibility methodologies, catastrophic claims, an
epidemic or an unexpected increase in utilization, general
economic conditions, and similar factors in those states. Our
inability to continue to operate in any of the states in which
we currently operate, or a significant change in the nature of
our existing operations, could adversely affect our business,
financial condition, cash flows, or results of operations.
Portions
of our premium revenue are subject to accounting estimates or
retroactive adjustment.
Certain elements of the premium revenue earned by our Florida,
New Mexico, Ohio, Texas, and Utah health plans, and by our
Medicare Advantage plans, are subject to accounting estimates.
Such estimates may subsequently prove to be inaccurate or may
require adjustment based upon factual developments. If our
accounting estimates with respect to our anticipated premiums
are inaccurate or previously recognized premiums require
retroactive adjustment, the change in our revenues could have a
material adverse effect on our business, financial condition,
cash flows, or results of operations.
Minimum
medical cost floors could limit our profitability.
Our New Mexico health plan is subject to a minimum medical
expense level as a percentage of the premium revenue it
receives. Our Florida health plan is subject to minimum
behavioral health expense levels as a percentage of its
behavioral health premium revenues. In both states, premium
revenue recoupment may occur if these levels are not met. In
addition, our Ohio health plan is subject to certain limits on
its administrative costs, and our Texas health plan is required
to pay an experience rebate to the state of Texas in the event
its profits exceed certain established levels. Other states may
adopt similar medical cost floors. For instance, a proposal has
been made in the
18
state of Washington to establish a minimum medical cost floor of
86% of premiums received. These regulatory requirements or new
requirements could limit our ability to increase or maintain our
overall profits as a percentage of revenues. Moreover, state
governments may disagree with our interpretation or application
of the contract provisions governing these medical cost floor
requirements, which could result in our having to adjust the
amount of our obligations under these provisions. Any changes to
the terms of these provisions, or the adoption of new or similar
provisions, could adversely affect our business, financial
condition, cash flows, or results of operations.
Failure
to attain profitability in any new
start-up
operations could negatively affect our results of
operations.
Start-up
costs associated with a new business can be substantial. For
example, to obtain a certificate of authority to operate as a
health maintenance organization in most jurisdictions, we must
first establish a provider network, have infrastructure and
required systems in place, and demonstrate our ability to obtain
a state contract and process claims. Often we are also required
to contribute significant capital to fund mandated net worth
requirements, performance bonds or escrows, or contingency
guaranties. If we were unsuccessful in obtaining the certificate
of authority, winning the bid to provide services, or attracting
members in sufficient numbers to cover our costs, any new
business of ours would fail. We also could be required by the
state to continue to provide services for some period of time
without sufficient revenue to cover our ongoing costs or to
recover our significant
start-up
costs.
Even if we are successful in establishing a profitable health
plan in a new state, increasing membership, revenues, and
medical costs will trigger increased mandated net worth
requirements which could substantially exceed the net income
generated by the health plan. Rapid growth in an existing state
will also create increased net worth requirements. In such
circumstances we may not be able to fund on a timely basis or at
all the increased net worth requirements with our available cash
resources. The expenses associated with starting up a health
plan in a new state or expanding a health plan in an existing
state could have an adverse impact on our business, financial
condition, cash flows, or results of operations.
Difficulties
in executing our acquisition strategy could adversely affect our
business.
The acquisitions of other health plans and the assignment and
assumption of Medicaid contract rights of other health plans
have accounted for a significant amount of our growth over the
last several years. Although we cannot predict with certainty
our rate of growth as the result of acquisitions, we believe
that additional acquisitions of all sizes will be important to
our future growth strategy. Many of the other potential
purchasers of these assets particularly operators of
large commercial health plans have significantly
greater financial resources than we do. Also, many of the
sellers may insist on selling assets that we do not want, such
as commercial lines of business, or may insist on transferring
their liabilities to us as part of the sale of their companies
or assets. Even if we identify suitable targets, we may be
unable to complete acquisitions on terms favorable to us or
obtain the necessary financing for these acquisitions. Further,
to the extent we complete an acquisition, we may be unable to
realize the anticipated benefits from such acquisition because
of operational factors or difficulty in integrating the
acquisition with our existing business. This may include
problems involving the integration of:
|
|
|
|
|
additional employees who are not familiar with our operations or
our corporate culture,
|
|
|
|
new provider networks which may operate on terms different from
our existing networks,
|
|
|
|
additional members who may decide to transfer to other health
care providers or health plans,
|
|
|
|
disparate information, claims processing, and record keeping
systems,
|
|
|
|
internal controls and accounting policies, including those which
require the exercise of judgment and complex estimation
processes, such as estimates of claims incurred but not
reported, accounting for goodwill, intangible assets,
stock-based compensation, and income tax matters, and
|
|
|
|
new regulatory schemes, relationships, practices, and compliance
requirements.
|
Also, we are generally required to obtain regulatory approval
from one or more state agencies when making acquisitions. In the
case of an acquisition of a business located in a state in which
we do not already operate, we would be required to obtain the
necessary licenses to operate in that state. In addition,
although we may already
19
operate in a state in which we acquire a new business, we would
be required to obtain regulatory approval if, as a result of the
acquisition, we will operate in an area of that state in which
we did not operate previously. We may be unable to obtain the
necessary governmental approvals or comply with these regulatory
requirements in a timely manner, if at all. For all of the above
reasons, we may not be able to consummate our proposed
acquisitions as announced from time to time to sustain our
pattern of growth or to realize benefits from completed
acquisitions.
In order to close on the acquisition of the HIM business, the
parties must first obtain regulatory approvals from each of the
states of West Virginia, Louisiana, New Jersey, Idaho, Maine,
and Florida, as well as various consents to assignment of
contract by various vendors. In addition, the parties must also
satisfy numerous other conditions to closing. There can be no
assurances that the parties will be successful in obtaining the
necessary state approvals or contract assignments. In the event
the parties are unable to satisfy all of the closing conditions,
the Company may be unable to close on its acquisition of the HIM
business.
Ineffective
management of our growth may negatively affect our business,
financial condition, or results of operations.
Depending on acquisitions and other opportunities, we expect to
continue to grow our membership and to expand into other
markets. In fiscal year 2006, we had total premium revenue of
$2.0 billion. In fiscal year 2009, we had total premium
revenue of $3.7 billion, an increase of 84% over a
four-year span. Continued rapid growth could place a significant
strain on our management and on other Company resources. Our
ability to manage our growth may depend on our ability to
strengthen our management team and attract, train, and retain
skilled employees, and our ability to implement and improve
operational, financial, and management information systems on a
timely basis. If we are unable to manage our growth effectively,
our financial condition and results of operations could be
materially and adversely affected. In addition, due to the
initial substantial costs related to acquisitions, rapid growth
could adversely affect our short-term profitability and
liquidity.
Any
changes to the laws and regulations governing our business, or
the interpretation and enforcement of those laws or regulations,
could cause us to modify our operations and could negatively
impact our operating results.
Our business is extensively regulated by the federal government
and the states in which we operate. The laws and regulations
governing our operations are generally intended to benefit and
protect health plan members and providers rather than managed
care organizations. The government agencies administering these
laws and regulations have broad latitude in interpreting and
applying them. These laws and regulations, along with the terms
of our government contracts, regulate how we do business, what
services we offer, and how we interact with members and the
public. For instance, some states mandate minimum medical
expense levels as a percentage of premium revenues. These laws
and regulations, and their interpretations, are subject to
frequent change. The interpretation of certain contract
provisions by our governmental regulators may also change.
Changes in existing laws or regulations, or their
interpretations, or the enactment of new laws or regulations,
could reduce our profitability by imposing additional capital
requirements, increasing our liability, increasing our
administrative and other costs, increasing mandated benefits,
forcing us to restructure our relationships with providers, or
requiring us to implement additional or different programs and
systems. Changes in the interpretation of our contracts could
also reduce our profitability if we have detrimentally relied on
a prior interpretation.
We
face periodic routine and non-routine reviews, audits, and
investigations by government agencies, and these reviews and
audits could have adverse findings, which could negatively
impact our business.
We are subject to various routine and non-routine governmental
reviews, audits, and investigations. Violation of the laws,
regulations, or contract provisions governing our operations, or
changes in interpretations of those laws, could result in the
imposition of civil or criminal penalties, the cancellation of
our contracts to provide managed care services, the suspension
or revocation of our licenses, the exclusion from participation
in government sponsored health programs, or the revision and
recoupment of past payments made based on audit findings. If we
become subject to material fines or if other sanctions or other
corrective actions were imposed upon us, we might suffer a
substantial reduction in profitability, and might also lose one
or more of our government contracts and as a result lose
significant numbers of members and amounts of revenue. In
addition, government receivables are subject to government audit
and negotiation, and government contracts are vulnerable to
disagreements with the government. The final amounts we
ultimately receive under government contracts may be different
from the amounts we initially recognize in our financial
statements.
20
Our
business depends on our information and medical management
systems, and our inability to effectively integrate, manage, and
keep secure our information and medical management systems,
could disrupt our operations.
Our business is dependent on effective and secure information
systems that assist us in, among other things, processing
provider claims, monitoring utilization and other cost factors,
supporting our medical management techniques, and providing data
to our regulators. Our providers also depend upon our
information systems for membership verifications, claims status,
and other information. If we experience a reduction in the
performance, reliability, or availability of our information and
medical management systems, our operations, ability to pay
claims, and ability to produce timely and accurate reports could
be adversely affected. In addition, if the licensor or vendor of
any software which is integral to our operations were to become
insolvent or otherwise fail to support the software
sufficiently, our operations could be negatively affected.
Our information systems and applications require continual
maintenance, upgrading, and enhancement to meet our operational
needs. Moreover, our acquisition activity requires transitions
to or from, and the integration of, various information systems.
If we experience difficulties with the transition to or from
information systems or are unable to properly implement,
maintain, upgrade or expand our system, we could suffer from,
among other things, operational disruptions, loss of members,
difficulty in attracting new members, regulatory problems, and
increases in administrative expenses.
Our business requires the secure transmission of confidential
information over public networks. Advances in computer
capabilities, new discoveries in the field of cryptography, or
other events or developments could result in compromises or
breaches of our security systems and member data stored in our
information systems. Anyone who circumvents our security
measures could misappropriate our confidential information or
cause interruptions in services or operations. The internet is a
public network, and data is sent over this network from many
sources. In the past, computer viruses or software programs that
disable or impair computers have been distributed and have
rapidly spread over the internet. Computer viruses could be
introduced into our systems, or those of our providers or
regulators, which could disrupt our operations, or make our
systems inaccessible to our members, providers, or regulators.
We may be required to expend significant capital and other
resources to protect against the threat of security breaches or
to alleviate problems caused by breaches. Because of the
confidential health information we store and transmit, security
breaches could expose us to a risk of regulatory action,
litigation, possible liability and loss. Our security measures
may be inadequate to prevent security breaches, and our business
operations would be negatively impacted by cancellation of
contracts and loss of members if security breaches are not
prevented.
Because
our corporate headquarters are located in Southern California,
our business operations may be significantly disrupted as a
result of a major earthquake.
Our corporate headquarters is located in Long Beach, California.
In addition, the claims of our health plans are also processed
in Long Beach. Southern California is exposed to a statistically
greater risk of a major earthquake than most other parts of the
country. If a major earthquake were to strike the Los Angeles
and Long Beach area, our corporate functions and claims
processing could be significantly impaired for a substantial
period of time. Although we have established a disaster recovery
and business resumption plan with
back-up
operating sites to be deployed in the case of such a major
disruptive event, there can be no assurances that the disaster
recovery plan will be successful or that the business operations
of all our health plans, including those that are remote from
any such event, would not be substantially impacted by a major
Southern California earthquake.
If we
are unable to maintain good relations with the physicians,
hospitals, and other providers with whom we contract, or if we
are unable to enter into cost-effective contracts with such
providers, our profitability could be adversely
affected.
We contract with physicians, hospitals, and other providers as a
means to assure access to health care services for our members,
to manage health care costs and utilization, and to better
monitor the quality of care being delivered. In any particular
market, providers could refuse to contract with us, demand
higher payments, or take other actions which could result in
higher health care costs, disruption to provider access for
current members, a decline in our growth rate, or difficulty in
meeting regulatory or accreditation requirements.
21
The Medicaid program generally pays doctors and hospitals at
levels well below those of Medicare and private insurance. Large
numbers of doctors, therefore, do not accept Medicaid patients.
In the face of fiscal pressures, some states may reduce rates
paid to providers, which may further discourage participation in
the Medicaid program.
In some markets, certain providers, particularly hospitals,
physician/hospital organizations, and some specialists, may have
significant market positions or even monopolies. If these
providers refuse to contract with us or utilize their market
position to negotiate favorable contracts which are
disadvantageous to us, our profitability in those areas could be
adversely affected.
Some providers that render services to our members are not
contracted with our plans. In those cases, there is no
pre-established understanding between the provider and our plan
about the amount of compensation that is due to the provider. In
some states, the amount of compensation is defined by law or
regulation, but in most instances it is either not defined or it
is established by a standard that is not clearly translatable
into dollar terms. In such instances, providers may believe they
are underpaid for their services and may either litigate or
arbitrate their dispute with our plan. The uncertainty of the
amount to pay and the possibility of subsequent adjustment of
the payment could adversely affect our business, financial
position, cash flows, or results of operations.
The
insolvency of a delegated provider could obligate us to pay
their referral claims which could have an adverse effect on our
business, cash flows, or results of operations.
Circumstances may arise where providers to whom we have
delegated risk, due to insolvency or other circumstances, are
unable to pay claims they have incurred with third parties in
connection with referral services provided to our members. The
inability of delegated providers to pay referral claims presents
us with both immediate financial risk and potential disruption
to member care. Depending on states laws, we may be held
liable for such unpaid referral claims even though the delegated
provider has contractually assumed such risk. Additionally,
competitive pressures may force us to pay such claims even when
we have no legal obligation to do so. To reduce the risk that
delegated providers are unable to pay referral claims, we
monitor the operational and financial performance of such
providers. We also maintain contingency plans that include
transferring members to other providers in response to potential
network instability. In certain instances, we have required
providers to place funds on deposit with us as protection
against their potential insolvency. These funds are frequently
in the form of segregated funds received from the provider and
held by us or placed in a third-party financial institution.
These funds may be used to pay claims that are the financial
responsibility of the provider in the event the provider is
unable to meet these obligations. However, there can be no
assurances that these precautionary steps will fully protect us
against the insolvency of a delegated provider. Liabilities
incurred or losses suffered as a result of provider insolvency
could have an adverse effect on our business, financial
condition, cash flows, or results of operations.
Regulatory
actions and negative publicity regarding Medicaid managed care
and Medicare Advantage may lead to programmatic changes and
intensified regulatory scrutiny and regulatory
burdens.
Several of our health care competitors have recently been
involved in governmental investigations and regulatory actions
which have resulted in significant volatility in the price of
their stock. In addition, there has been negative publicity and
proposed programmatic changes regarding Medicare Advantage
private
fee-for-service
plans, a part of the Medicare Advantage program in which the
Company does not participate. These actions and the resulting
negative publicity could become associated with or imputed to
the Company, regardless of the Companys actual regulatory
compliance or programmatic participation. Such an association,
as well as any perception of a recurring pattern of abuse among
the health plan participants in government programs and the
diminished reputation of the managed care sector as a whole,
could result in public distrust, political pressure for changes
in the programs in which the Company does participate,
intensified scrutiny by regulators, additional regulatory
requirements and burdens, increased stock volatility due to
speculative trading, and heightened barriers to new managed care
markets and contracts, all of which could have a material
adverse effect on our business, financial condition, cash flows,
or results of operations.
22
If a
state fails to renew its federal waiver application for mandated
Medicaid enrollment into managed care or such application is
denied, our membership in that state will likely
decrease.
States may only mandate Medicaid enrollment into managed care
under federal waivers or demonstrations. Waivers and programs
under demonstrations are approved for two-year periods and can
be renewed on an ongoing basis if the state applies. We have no
control over this renewal process. If a state does not renew its
mandated program or the federal government denies the
states application for renewal, our business would suffer
as a result of a likely decrease in membership.
We
face claims related to litigation which could result in
substantial monetary damages.
We are subject to a variety of legal actions, including medical
malpractice actions, provider disputes, employment related
disputes, and breach of contract actions. In the event we incur
liability materially in excess of the amount for which we have
insurance coverage, our profitability would suffer. In addition,
our providers involved in medical care decisions are exposed to
the risk of medical malpractice claims. Providers at the 17
primary care clinics we operate in California are employees of
our California health plan. As a direct employer of physicians
and ancillary medical personnel and as an operator of primary
care clinics, our California plan is subject to liability for
negligent acts, omissions, or injuries occurring at one of its
clinics or caused by one of its employees. We maintain medical
malpractice insurance for our clinics in the amount of
$1 million per occurrence, and an annual aggregate limit of
$3 million, errors and omissions insurance in the amount of
$15 million per occurrence and in aggregate for each policy
year, and such other lines of coverage as we believe are
reasonable in light of our experience to date. However, given
the significant amount of some medical malpractice awards and
settlements, this insurance may not be sufficient or available
at a reasonable cost to protect us from damage awards or other
liabilities. Even if any claims brought against us were
unsuccessful or without merit, we would have to defend ourselves
against such claims. The defense of any such actions may be
time-consuming and costly, and may distract our
managements attention. As a result, we may incur
significant expenses and may be unable to effectively operate
our business.
Furthermore, claimants often sue managed care organizations for
improper denials of or delays in care, and in some instances
improper authorizations of care. Claims of this nature could
result in substantial damage awards against us and our providers
that could exceed the limits of any applicable medical
malpractice insurance coverage. Successful malpractice or tort
claims asserted against us, our providers, or our employees
could adversely affect our financial condition and profitability.
We cannot predict the outcome of any lawsuit with certainty.
While we currently have insurance coverage for some of the
potential liabilities relating to litigation, other such
liabilities may not be covered by insurance, the insurers could
dispute coverage, or the amount of insurance could be
insufficient to cover the damages awarded. In addition,
insurance coverage for all or certain types of liability may
become unavailable or prohibitively expensive in the future or
the deductible on any such insurance coverage could be set at a
level which would result in us effectively self-insuring cases
against us.
Although we establish reserves for litigation as we believe
appropriate, we cannot assure you that our recorded reserves
will be adequate to cover such costs. Therefore, the litigation
to which we are subject could have a material adverse effect on
our business, financial condition, cash flows, or results of
operations, and could prompt us to change our operating
procedures.
We are
subject to competition which negatively impacts our ability to
increase penetration in the markets we serve.
We operate in a highly competitive environment and in an
industry that is subject to ongoing changes from business
consolidations, new strategic alliances, and aggressive
marketing practices by other managed care organizations. We
compete for members principally on the basis of size, location,
and quality of provider network, benefits supplied, quality of
service, and reputation. A number of these competitive elements
are partially dependent upon and can be positively affected by
the financial resources available to a health plan. Many other
organizations with which we compete, including large commercial
plans, have substantially greater financial and
23
other resources than we do. For these reasons, we may be unable
to grow our membership, or may lose members to other health
plans.
If
state regulators do not approve payments of dividends and
distributions by our subsidiaries, it may negatively affect our
business strategy.
We are a corporate parent holding company and hold most of our
assets at, and conduct most of our operations through direct
subsidiaries. As a holding company, our results of operations
depend on the results of operations of our subsidiaries.
Moreover, we are dependent on dividends or other intercompany
transfers of funds from our subsidiaries to meet our debt
service and other obligations. The ability of our subsidiaries
to pay dividends or make other payments or advances to us will
depend on their operating results and will be subject to
applicable laws and restrictions contained in agreements
governing the debt of such subsidiaries. In addition, our health
plan subsidiaries are subject to laws and regulations that limit
the amount of dividends and distributions that they can pay to
us without prior approval of, or notification to, state
regulators. In California, our health plan may dividend, without
notice to or approval of the California Department of Managed
Health Care, amounts by which its tangible net equity exceeds
130% of the tangible net equity requirement. Our other health
plans must give thirty days advance notice and the opportunity
to disapprove extraordinary dividends to the
respective state departments of insurance for amounts over the
lesser of (a) ten percent of surplus or net worth at the
prior year end or (b) the net income for the prior year.
The discretion of the state regulators, if any, in approving or
disapproving a dividend is not clearly defined. Health plans
that declare non-extraordinary dividends must usually provide
notice to the regulators ten or fifteen days in advance of the
intended distribution date of the non-extraordinary dividend.
The aggregate amounts our health plan subsidiaries could have
paid us at December 31, 2009, 2008, and 2007 without
approval of the regulatory authorities were approximately
$9.0 million, $7.6 million, and $18.7 million,
respectively. If the regulators were to deny or significantly
restrict our subsidiaries requests to pay dividends to us,
the funds available to our company as a whole would be limited,
which could harm our ability to implement our business strategy.
For example, we could be hindered in our ability to make debt
service payments under our credit facility
and/or our
senior convertible notes.
Unforeseen
changes in regulations or pharmaceutical market conditions may
impact our revenues and adversely affect our results of
operations.
A significant category of our health care costs relate to
pharmaceutical products and services. Evolving regulations and
state and federal mandates regarding coverage may impact the
ability of our health plans to continue to receive existing
price discounts on pharmaceutical products for our members.
Other factors affecting our pharmaceutical costs include, but
are not limited to, the price of pharmaceuticals, geographic
variation in utilization of new and existing pharmaceuticals,
and changes in discounts. The unpredictable nature of these
factors may have an adverse effect on our business, financial
condition, cash flows, or results of operations.
Failure
to maintain effective internal controls over financial reporting
could have a material adverse effect on our business, operating
results, and stock price.
The Sarbanes-Oxley Act of 2002 requires, among other things,
that we maintain effective internal control over financial
reporting. In particular, we must perform system and process
evaluation and testing of our internal controls over financial
reporting to allow management to report on, and our independent
registered public accounting firm to attest to, our internal
controls over financial reporting as required by
Section 404 of the Sarbanes-Oxley Act of 2002. Our future
testing, or the subsequent testing by our independent registered
public accounting firm, may reveal deficiencies in our internal
controls over financial reporting that are deemed to be material
weaknesses. Our compliance with Section 404 will continue
to require that we incur substantial accounting expense and
expend significant management time and effort. Moreover, if we
are not able to continue to comply with the requirements of
Section 404 in a timely manner, or if we or our independent
registered public accounting firm identifies deficiencies in our
internal control over financial reporting that are deemed to be
material weaknesses, the market price of our stock could decline
and we could be subject to sanctions or investigations by the
NYSE, SEC or other regulatory authorities, which would require
additional financial and management resources.
24
Volatility
of our stock price could adversely affect
stockholders.
Since our initial public offering in July 2003, the sales price
of our common stock has ranged from a low of $16.12 to a high of
$53.23. A number of factors will continue to influence the
market price of our common stock, including:
|
|
|
|
|
state and federal budget pressures,
|
|
|
|
changes in expectations as to our future financial performance
or changes in financial estimates, if any, of public market
analysts,
|
|
|
|
announcements relating to our business or the business of our
competitors,
|
|
|
|
changes in government payment levels,
|
|
|
|
adverse publicity regarding health maintenance organizations and
other managed care organizations,
|
|
|
|
government action regarding member eligibility,
|
|
|
|
changes in state mandatory programs,
|
|
|
|
conditions generally affecting the managed care industry or our
provider networks,
|
|
|
|
the success of our operating or acquisition strategy, including
our acquisition of the HIM business of Unisys Corporation,
|
|
|
|
the operating and stock price performance of other comparable
companies in the health care industry,
|
|
|
|
the termination of our Medicaid or CHIP contracts with state or
county agencies, or subcontracts with other Medicaid managed
care organizations that contract with such state or county
agencies,
|
|
|
|
regulatory or legislative change, and
|
|
|
|
general economic conditions, including unemployment rates,
inflation, and interest rates.
|
Our stock may not trade at the same levels as the stock of other
health care companies or the market in general. Also, if the
trading market for our stock does not continue to develop,
securities analysts may not maintain or initiate research
coverage of our Company and our shares, and this could depress
the market for our shares.
Members
of the Molina family own a majority of our capital stock,
decreasing the influence of other stockholders on stockholder
decisions.
Members of the Molina family, either directly or as trustees or
beneficiaries of Molina family trusts, in the aggregate own or
are entitled to receive upon certain events approximately 57% of
our capital stock. Our president and chief executive officer, as
well as our chief financial officer, are members of the Molina
family, and they are also on our board of directors. Because of
the amount of their shareholdings, Molina family members, if
they were to act as a group with the trustees of their family
trusts, have the ability to significantly influence all matters
submitted to stockholders for approval, including the election
and removal of directors, amendments to our charter, and any
merger, consolidation, or sale of our Company. A significant
concentration of share ownership can also adversely affect the
trading price for our common stock because investors often
discount the value of stock in companies that have controlling
stockholders. Furthermore, the concentration of share ownership
in the Molina family could delay or prevent a merger or
consolidation, takeover, or other business combination that
could be favorable to our stockholders. Finally, the interests
and objectives of the Molina family may be different from those
of our company or our other stockholders, and they may vote
their common stock in a manner that is contrary to the vote of
our other stockholders.
It may
be difficult for a third party to acquire our Company, which
could inhibit stockholders from realizing a premium on their
stock price.
We are subject to the Delaware anti-takeover laws regulating
corporate takeovers. These provisions may prohibit stockholders
owning 15% or more of our outstanding voting stock from merging
or combining with us. In
25
addition, any change in control of our state health plans would
require the approvals of the applicable insurance regulator in
each state in which we operate.
Our certificate of incorporation and bylaws also contain
provisions that could have the effect of delaying, deferring, or
preventing a change in control of our Company that stockholders
may consider favorable or beneficial. These provisions could
discourage proxy contests and make it more difficult for our
stockholders to elect directors and take other corporate
actions. These provisions could also limit the price that
investors might be willing to pay in the future for shares of
our common stock. These provisions include:
|
|
|
|
|
a staggered board of directors, so that it would take three
successive annual meetings to replace all directors,
|
|
|
|
prohibition of stockholder action by written consent, and
|
|
|
|
advance notice requirements for the submission by stockholders
of nominations for election to the board of directors and for
proposing matters that can be acted upon by stockholders at a
meeting.
|
In addition, changes of control are often subject to state
regulatory notification, and in some cases, prior approval.
We do
not anticipate paying any cash dividends in the foreseeable
future.
We have not declared or paid any dividends since our initial
public offering in July 2003. While we have in the past and may
again use our available cash to repurchase our securities, we do
not anticipate declaring or paying any cash dividends in the
foreseeable future.
Changes
in accounting may affect our results of
operations.
U.S. generally accepted accounting principles
(GAAP) and related implementation guidelines and
interpretations can be highly complex and involve subjective
judgments. Changes in these rules or their interpretation, the
adoption of new pronouncements or the application of existing
pronouncements to our business could significantly affect our
results of operations.
Our
investments in auction rate securities are subject to risks that
may cause losses and have a material adverse effect on our
liquidity.
As of December 31, 2009, our investments in auction rate
securities included amounts designated as
available-for-sale
securities totaling $26.9 million par value (fair value of
$23.0 million). As a result of the changes in fair value of
auction rate securities designated as
available-for-sale,
we recorded unrealized gains of $0.8 million
($0.5 million, net of tax) to accumulated other
comprehensive income for the year ended December 31, 2009,
and we recorded unrealized losses of $7.6 million
($4.7 million, net of tax) to other comprehensive loss for
the year ended December 31, 2008. We deem the cumulative
unrealized losses on these securities to be temporary and
attribute the decline in value to liquidity issues, as a result
of the failed auction market, rather than to credit issues. Any
future fluctuation in fair value related to these instruments
that we deem to be temporary, including any recoveries of
previous write-downs, would be recorded to accumulated other
comprehensive loss. If we determine that any future valuation
adjustment was
other-than-temporary,
we would record a charge to earnings as appropriate. For our
investments in auction rate securities, we do not intend to
sell, nor is it more likely than not that we will be required to
sell, these investments before recovery of their cost. However,
if we were to sell these investments before recovery of their
cost, we would be required to record a charge to earnings for
any accumulated losses, which would impact our earnings for the
quarter in which such event occurred.
The
value of our investments is influenced by varying economic and
market conditions, and a decrease in value could have an adverse
effect on our results of operations, liquidity and financial
condition.
Our investments consist solely of investment-grade debt
securities. The unrestricted portion of this portfolio is
designated primarily as
available-for-sale.
Our non-current restricted investments are designated as
held-to-maturity.
Available-for-sale
investments are carried at fair value, and the unrealized gains
or losses are included in accumulated other comprehensive loss
as a separate component of stockholders equity, unless the
decline in value is deemed to be
other-than-temporary
and we do not have the intent and ability to hold such
securities until their full
26
cost can be recovered. Trading securities are carried at fair
value and any realized gains or losses are included as a
component of earnings. For our
available-for-sale
investments and
held-to-maturity
investments, if a decline in value is deemed to be
other-than-temporary
and we do not have the intent and ability to hold such security
until its full cost can be recovered, the security is deemed to
be
other-than-temporarily
impaired and it is written down to fair value and the loss is
recorded as an expense.
In accordance with applicable accounting standards, we review
our investment securities to determine if declines in fair value
below cost are
other-than-temporary.
This review is subjective and requires a high degree of
judgment. We conduct this review on a quarterly basis, using
both quantitative and qualitative factors, to determine whether
a decline in value is
other-than-temporary.
Such factors considered include the length of time and the
extent to which market value has been less than cost, the
financial condition and near term prospects of the issuer,
recommendations of investment advisors and forecasts of
economic, market or industry trends. This review process also
entails an evaluation of our ability and intent to hold
individual securities until they mature or full cost can be
recovered.
The current economic environment and recent volatility of the
securities markets increase the difficulty of assessing
investment impairment and the same influences tend to increase
the risk of potential impairment of these assets. Over time, the
economic and market environment may further deteriorate or
provide additional insight regarding the fair value of certain
securities, which could change our judgment regarding
impairment. This could result in realized losses relating to
other-than-temporary
declines or losses related to our trading securities to be
recorded as an expense. Given the current market conditions and
the significant judgments involved, there is continuing risk
that further declines in fair value may occur and material
other-than-temporary
impairments or trading security losses may result in realized
losses in future periods which could have an adverse effect on
our business, financial condition, cash flows, or results of
operations.
Another
flu epidemic in 2010 or other kind of epidemic in one or more of
the states in which we operate a health plan could significantly
increase utilization rates and medical costs.
Our results during 2009 were significantly impacted by the
widespread incidence of the H1N1 flu in the states in which we
operate our health plans. The recurrence in 2010 of the H1N1
flu, another variant of the flu, or the outbreak and rapid
spread of any other highly contagious and potentially virulent
disease, could increase the utilization rates among our members,
resulting in significantly increased outpatient, inpatient,
emergency room, and pharmacy costs.
An
unauthorized disclosure of sensitive or confidential member
information could have an adverse effect on our
business.
As part of our normal operations, we collect, process, and
retain confidential member information. We are subject to
various federal and state laws and rules regarding the use and
disclosure of confidential member information, including HIPAA
and the Gramm-Leach-Bliley Act. The American Recovery and
Reinvestment Act of 2009 further expands the coverage of HIPAA
by, among other things, extending the privacy and security
provisions, mandating new regulations around electronic medical
records, expanding enforcement mechanisms, allowing the state
Attorneys General to bring enforcement actions and increasing
penalties for violations. Despite the security measures we have
in place to ensure compliance with applicable laws and rules,
our facilities and systems, and those of our third party service
providers, may be vulnerable to security breaches, acts of
vandalism, computer viruses, misplaced or lost data, programming
and/or human
errors or other similar events. Any security breach involving
the misappropriation, loss or other unauthorized disclosure or
use of confidential member information, whether by us or a third
party, could have a material adverse effect on our business,
financial condition, cash flows, or results of operations.
Unanticipated
changes in our tax rates or exposure to additional income tax
liabilities could affect our profitability.
We are subject to income taxes in the United States. Our
effective tax rate could be adversely affected by changes in the
mix of earnings in states with different statutory tax rates,
changes in the valuation of deferred tax assets and liabilities,
changes in U.S. tax laws and regulations, and changes in
our interpretations of tax laws, including pending tax
27
law changes. In addition, we are subject to the routine
examination of our income tax returns by the Internal Revenue
Service and other local and state tax authorities. We regularly
assess the likelihood of outcomes resulting from these
examinations to determine the adequacy of our estimated income
tax liabilities. Adverse outcomes from tax examinations, or the
accounting reversal of any tax benefits or revenue previously
recognized by the Company, could have an adverse effect on our
provision for income taxes, estimated income tax liabilities, or
results of operations.
We are
dependent on our executive officers and other key
employees.
Our operations are highly dependent on the efforts of our
executive officers. The loss of their leadership, knowledge, and
experience could negatively impact our operations. Replacing
many of our executive officers might be difficult or take an
extended period of time because a limited number of individuals
in the managed care industry have the breadth and depth of
skills and experience necessary to operate and expand
successfully a business such as ours. Our success is also
dependent on our ability to hire and retain qualified
management, technical, and medical personnel. We may be
unsuccessful in recruiting and retaining such personnel which
could negatively impact our operations.
Risks
Related to the Operation of the Health Information Management
Business
The following risk factors are contingent upon the successful
closing of our acquisition of the HIM business of Unisys
Corporation, which is expected to close in the first half of
2010. We intend to operate the HIM business under the name,
Molina Medicaid Solutions.
We
have not previously operated a health information management
business.
Our Company and senior management personnel have not previously
operated a health information management business such as the
HIM business, and there may be various aspects of the business
with which we are unfamiliar. Although we expect most of the
existing HIM business personnel to join our Company to continue
to operate the HIM business, our lack of familiarity with the
day-to-day
operational issues of the HIM business, as well as our lack of
experience in responding to requests for proposal to secure new
HIM or MMIS business, may negatively impact the growth, future
prospects, and the overall profitability of the HIM business.
We may
have difficulty integrating the HIM business and its
operations.
In connection with the acquisition of the HIM business, we are
hiring approximately 900 new employees. These employees were not
previously familiar with our operations or our corporate
culture. In addition, to operate the HIM business, we will be
required to develop new internal controls, accounting policies,
accounting infrastructure, regulatory schemes, compliance
requirements, and disclosure controls. Our inability to
effectively integrate the new HIM business could have a material
adverse effect on our business, financial condition, cash flows,
or results of operations.
We may
be unable to retain or renew the state government contracts of
the HIM business on terms consistent with our expectations or at
all.
The HIM business currently has management contracts in only six
states. If, after the closing, we were unable to continue to
operate in any of those six states, or if the HIM business
current operations in any of those six states were significantly
curtailed, the revenues and cash flows of the HIM business could
decrease materially, and as a result our profitability would be
negatively impacted.
If we
have underestimated the operating cost and capital outlay
projections for the HIM business, our profitability could be
adversely affected.
In negotiating the purchase price for the HIM business, we
estimated the operating costs and capital outlays required to
operate the business as a Molina entity. In the event we have
underestimated the costs associated with the HIM business, the
profitability of that business may be significantly less than
expected.
28
Because
of the complexity and duration of the services and systems
required to be delivered under the government contracts of the
HIM business, there are substantial risks associated with full
performance under the contracts.
The state contracts of the HIM business typically require
significant investment in the early stages that is expected to
be recovered through billings over the life of the contracts.
These contracts involve the construction of new computer systems
and communications networks and the development and deployment
of complex technologies. Substantial performance risk exists
under each contract. Some or all elements of service delivery
under these contracts are dependent upon successful completion
of the design, development, construction, and implementation
phases. Any increased or unexpected costs or unanticipated
delays in connection with the performance of these contracts,
including delays caused by factors outside our control, could
make these contracts less profitable or unprofitable, which
could have an adverse effect on our overall business, financial
conditions, cash flows, or results of operations.
If we
fail to comply with our state government contracts or government
contracting regulations, our business may be adversely
affected.
The contracts of the HIM business with state government
customers may include unique and specialized performance
requirements. In particular, contracts with state government
customers are subject to various procurement regulations,
contract provisions, and other requirements relating to their
formation, administration, and performance. Any failure to
comply with the specific provisions in our customer contracts or
any violation of government contracting regulations could result
in the imposition of various civil and criminal penalties, which
may include termination of the contracts, forfeiture of profits,
suspension of payments and the imposition of fines, and
suspension from future government contracting. Further, any
negative publicity related to the HIM business state
government contracts or any proceedings surrounding them may
damage our business by affecting our ability to compete for new
contracts. The termination of a state government contract, our
suspension from government work, or any negative impact on our
ability to compete for new contracts, could have an adverse
effect on our business, financial conditions, cash flows, or
results of operations.
System
security risks and systems integration issues that disrupt our
internal operations or information technology services provided
to customers could adversely affect our financial results or
damage our reputation.
Experienced computer programmers and hackers may be able to
penetrate our network security and misappropriate our
confidential information or that of third parties, create system
disruptions or cause shutdowns. Computer programmers and hackers
also may be able to develop and deploy viruses, worms, and other
malicious software programs that attack our products or
otherwise exploit any security vulnerabilities of our products.
In addition, sophisticated hardware and operating system
software and applications that we produce or procure from third
parties may contain defects in design or manufacture, including
bugs and other problems that could unexpectedly
interfere with the operation of the system. The costs to us to
eliminate or alleviate security problems, bugs, viruses, worms,
malicious software programs and security vulnerabilities could
be significant, and the efforts to address these problems could
result in interruptions, delays, cessation of service, and loss
of existing or potential government customers.
The HIM business routinely processes, stores, and transmits
large amounts of data for our clients, including sensitive and
personally identifiable information. Breaches of our security
measures could expose us, our customers, or the individuals
affected to a risk of loss or misuse of this information,
resulting in litigation and potential liability for us and
damage to our brand and reputation. Accordingly, we could lose
existing or potential government customers for outsourcing
services or other information technology solutions or incur
significant expenses in connection with our customers
system failures or any actual or perceived security
vulnerabilities in our products. In addition, the cost and
operational consequences of implementing further data protection
measures could be significant.
Portions of our information technology infrastructure also may
experience interruptions, delays, or cessations of service or
produce errors in connection with systems integration or
migration work that takes place from time to
29
time. We may not be successful in implementing new systems and
transitioning data, which could cause business disruptions and
be more expensive, time consuming, disruptive, and
resource-intensive. Such disruptions could adversely impact our
ability to fulfill orders and interrupt other processes. Delayed
sales, lower margins, or lost government customers resulting
from these disruptions could adversely affect our financial
results, reputation, and stock price.
|
|
Item 1B:
|
Unresolved
Staff Comments
|
There are no unresolved comments from the staff of the
Securities and Exchange Commission which were received more than
180 days before the end of our 2009 fiscal year.
We lease a total of 51 facilities, including our corporate
headquarters at 200 Oceangate in Long Beach, California. We own
a 32,000 square-foot office building in Long Beach,
California, our 26,000 square-foot data center in
Albuquerque, New Mexico, and one of the community clinics in
Pomona, California. We believe our current facilities are
adequate to meet our operational needs for the foreseeable
future.
|
|
Item 3:
|
Legal
Proceedings
|
The health care industry is subject to numerous laws and
regulations of federal, state, and local governments. Compliance
with these laws and regulations can be subject to government
review and interpretation, as well as regulatory actions unknown
and unasserted at this time. Penalties associated with
violations of these laws and regulations include significant
fines and penalties, exclusion from participating in publicly
funded programs, and the repayment of previously billed and
collected revenues.
We are involved in legal actions in the ordinary course of
business, some of which seek monetary damages, including claims
for punitive damages, which are not covered by insurance. The
outcome of such legal actions is inherently uncertain.
Nevertheless, we believe that these actions, when finally
concluded and determined, are not likely to have a material
adverse effect on our consolidated financial position, results
of operations, or cash flows.
30
PART II
|
|
Item 5:
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Our common stock is listed on the New York Stock Exchange under
the trading symbol MOH. The high and low sales
prices of our common stock for specified periods are set forth
below:
|
|
|
|
|
|
|
|
|
Date Range
|
|
High
|
|
|
Low
|
|
|
2009
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
22.74
|
|
|
$
|
16.22
|
|
Second Quarter
|
|
$
|
25.75
|
|
|
$
|
18.11
|
|
Third Quarter
|
|
$
|
25.05
|
|
|
$
|
19.36
|
|
Fourth Quarter
|
|
$
|
23.49
|
|
|
$
|
17.05
|
|
2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
44.94
|
|
|
$
|
23.46
|
|
Second Quarter
|
|
$
|
30.50
|
|
|
$
|
22.68
|
|
Third Quarter
|
|
$
|
42.61
|
|
|
$
|
24.08
|
|
Fourth Quarter
|
|
$
|
32.45
|
|
|
$
|
16.12
|
|
As of March 5, 2010, there were 116 holders of record of
our common stock. We did not declare or pay any dividends in
2009, 2008, or 2007. While we have in the past and may again in
the future use our cash to repurchase our securities, we do not
anticipate declaring or paying any cash dividends in the
foreseeable future.
Moreover, our ability to pay dividends to stockholders is
dependent on cash dividends being paid to us by our
subsidiaries. Laws of the states in which we operate or may
operate our health plans, as well as requirements of the
government sponsored health programs in which we participate,
limit the ability of our health plan subsidiaries to pay
dividends to us. In addition, the terms of our credit facility
limit our ability to pay dividends.
Securities Authorized for Issuance Under Equity Compensation
Plans (as of December 31, 2009)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
Remaining Available for
|
|
|
Number of Securities to be
|
|
Weighted Average
|
|
Future Issuance
|
|
|
Issued Upon Exercise of
|
|
Exercise Price of
|
|
Under Equity Compensation
|
|
|
Outstanding Options,
|
|
Outstanding Options,
|
|
Plans (Excluding Securities
|
|
|
Warrants and Rights
|
|
Warrants and Rights
|
|
Reflected in Column (a))
|
Plan Category
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
|
650,739(1
|
)
|
|
$
|
30.25
|
|
|
|
3,801,382(2
|
)
|
|
|
|
(1) |
|
Options to purchase shares of our common stock issued under the
2000 Omnibus Stock and Incentive Plan and the 2002 Equity
Incentive Plan. Further grants under the 2000 Omnibus Stock and
Incentive Plan have been suspended. |
|
(2) |
|
Includes only shares remaining available to issue under the 2002
Equity Incentive Plan (the 2002 Incentive Plan) and
the 2002 Employee Stock Purchase Plan (the ESPP).
The 2002 Incentive Plan initially allowed for the issuance of
1.6 million shares of common stock. Beginning
January 1, 2004, shares available for issuance under the
2002 Incentive Plan automatically increase by the lesser of
400,000 shares or 2% of total outstanding capital stock on
a fully diluted basis, unless the board of directors
affirmatively acts to nullify the automatic increase. The
400,000 share increase on January 1, 2010 increased
the total number of shares reserved for issuance under the 2002
Incentive Plan to 4,400,000 shares. The ESPP initially
allowed for the issuance of 600,000 shares of common stock.
Beginning December 31, 2003, and each year until the
2.2 million maximum aggregate number of shares reserved for
issuance was reached on December 31, 2008, shares reserved
for issuance under the ESPP automatically increased by 1% of
total outstanding capital stock. |
31
STOCK
PERFORMANCE GRAPH
The following discussion shall not be deemed to be
soliciting material or to be filed with
the SEC nor shall this information be incorporated by reference
into any future filing under the Securities Act or the Exchange
Act, except to the extent that the Company specifically
incorporates it by reference into a filing.
The following line graph compares the percentage change in the
cumulative total return on our common stock against the
cumulative total return of the Standard & Poors
Corporation Composite 500 Index (the S&P 500)
and a peer group index for the five-year period from
December 31, 2004 to December 31, 2009. The graph
assumes an initial investment of $100 in Molina Healthcare, Inc.
common stock and in each of the indices.
The peer group index consists of Amerigroup Corporation (AGP),
Centene Corporation (CNC), Coventry Health Care, Inc. (CVH),
Health Net, Inc. (HNT), Humana, Inc. (HUM), UnitedHealth Group
Incorporated (UNH), and WellPoint, Inc. (WLP).
COMPARISON
OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among
Molina Healthcare, Inc, The S&P 500 Index
And A Peer Group
|
|
* |
$100 invested on 12/31/04 in stock or index, including
reinvestment of dividends. Fiscal year ending December 31.
|
32
|
|
Item 6.
|
Selected
Financial Data
|
SELECTED
FINANCIAL DATA
We derived the following selected consolidated financial data
(other than the data under the caption Operating
Statistics) for the five years ended December 31,
2009 from our audited consolidated financial statements. You
should read the data in conjunction with our consolidated
financial statements, related notes and other financial
information included herein. All dollars are in thousands,
except per share data. The data under the caption
Operating Statistics has not been audited.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1)(2)
|
|
|
2006(3)
|
|
|
2005
|
|
|
Statements of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue
|
|
$
|
3,660,207
|
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
|
$
|
1,985,109
|
|
|
$
|
1,639,884
|
|
Investment income
|
|
|
9,149
|
|
|
|
21,126
|
|
|
|
30,085
|
|
|
|
19,886
|
|
|
|
10,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
3,669,356
|
|
|
|
3,112,366
|
|
|
|
2,492,454
|
|
|
|
2,004,995
|
|
|
|
1,650,058
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
3,176,236
|
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
|
|
1,678,652
|
|
|
|
1,424,872
|
|
General and administrative expenses
|
|
|
399,149
|
|
|
|
344,761
|
|
|
|
285,295
|
|
|
|
229,057
|
|
|
|
163,342
|
|
Loss contract charge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
939
|
|
Impairment charge on purchased software(4)
|
|
|
|
|
|
|
|
|
|
|
782
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
38,110
|
|
|
|
33,688
|
|
|
|
27,967
|
|
|
|
21,475
|
|
|
|
15,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
3,613,495
|
|
|
|
2,999,761
|
|
|
|
2,394,127
|
|
|
|
1,929,184
|
|
|
|
1,604,278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on purchase of convertible senior notes
|
|
|
1,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
57,393
|
|
|
|
112,605
|
|
|
|
98,327
|
|
|
|
75,811
|
|
|
|
45,780
|
|
Interest expense
|
|
|
(13,777
|
)
|
|
|
(13,231
|
)
|
|
|
(5,605
|
)
|
|
|
(2,353
|
)
|
|
|
(1,929
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
43,616
|
|
|
|
99,374
|
|
|
|
92,722
|
|
|
|
73,458
|
|
|
|
43,851
|
|
Provision for income taxes
|
|
|
12,748
|
|
|
|
39,776
|
|
|
|
34,996
|
|
|
|
27,731
|
|
|
|
16,255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
30,868
|
|
|
$
|
59,598
|
|
|
$
|
57,726
|
|
|
$
|
45,727
|
|
|
$
|
27,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.19
|
|
|
$
|
2.15
|
|
|
$
|
2.04
|
|
|
$
|
1.64
|
|
|
$
|
1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.19
|
|
|
$
|
2.15
|
|
|
$
|
2.03
|
|
|
$
|
1.62
|
|
|
$
|
0.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
25,843,000
|
|
|
|
27,676,000
|
|
|
|
28,275,000
|
|
|
|
27,966,000
|
|
|
|
27,711,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares and potential dilutive
common shares outstanding
|
|
|
25,984,000
|
|
|
|
27,772,000
|
|
|
|
28,419,000
|
|
|
|
28,164,000
|
|
|
|
28,023,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Statistics:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care ratio(5)
|
|
|
86.8
|
%
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
|
|
84.6
|
%
|
|
|
86.9
|
%
|
General and administrative expense ratio(6)
|
|
|
10.9
|
%
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
|
|
11.4
|
%
|
|
|
9.9
|
%
|
General and administrative expense ratio, excluding premium taxes
|
|
|
7.5
|
%
|
|
|
8.0
|
%
|
|
|
8.2
|
%
|
|
|
8.4
|
%
|
|
|
7.1
|
%
|
Members(7)
|
|
|
1,455,000
|
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
1,077,000
|
|
|
|
893,000
|
|
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1),(2)
|
|
|
2006(3)
|
|
|
2005
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
469,501
|
|
|
$
|
387,162
|
|
|
$
|
459,064
|
|
|
$
|
403,650
|
|
|
$
|
249,203
|
|
Total assets
|
|
|
1,245,235
|
|
|
|
1,148,068
|
|
|
|
1,170,016
|
|
|
|
864,475
|
|
|
|
659,927
|
|
Long-term debt (including current maturities)
|
|
|
158,900
|
|
|
|
164,873
|
|
|
|
160,166
|
|
|
|
45,000
|
|
|
|
|
|
Total liabilities
|
|
|
702,497
|
|
|
|
616,306
|
|
|
|
655,640
|
|
|
|
444,309
|
|
|
|
297,077
|
|
Stockholders equity
|
|
|
542,738
|
|
|
|
531,762
|
|
|
|
514,376
|
|
|
|
420,166
|
|
|
|
362,850
|
|
|
|
|
(1) |
|
The consolidated balance sheet and operating results have been
recast to reflect the adoption of FASB ASC Subtopic
470-20,
Debt with Conversion and Other Options. The cumulative
adjustments to reduce retained earnings were $3.4 million
as of January 1, 2009, and $604,000 as of January 1,
2008. Additionally, interest expense increased $4.5 million
for the year ended December 31, 2008, and $1.0 million
for the year ended December 31, 2007. |
|
(2) |
|
The balance sheet and operating results of the Mercy CarePlus
acquisition, relating to our Missouri health plan, have been
included since November 1, 2007, the effective date of the
acquisition. |
|
(3) |
|
The balance sheet and operating results of the Cape Health Plan
acquisition, relating to our Michigan health plan, have been
included since May 15, 2006, the effective date of the
acquisition. |
|
(4) |
|
Amount represents an impairment charge related to commercial
software no longer used for operations. |
|
(5) |
|
Medical care ratio represents medical care costs as a percentage
of premium revenue. The medical care ratio is a key operating
indicator used to measure our performance in delivering
efficient and cost effective health care services. Changes in
the medical care ratio from period to period result from changes
in Medicaid funding by the states, our ability to effectively
manage costs, and changes in accounting estimates related to
incurred but not reported claims. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations for further discussion. |
|
(6) |
|
General and administrative expense ratio represents such
expenses as a percentage of total revenue. |
|
(7) |
|
Number of members at end of period. |
34
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following discussion of our financial condition and results
of operations should be read in conjunction with the
Selected Financial Data and the accompanying
consolidated financial statements and the notes to those
statements appearing elsewhere in this report. This discussion
contains forward-looking statements that involve known and
unknown risks and uncertainties, including those set forth under
Item 1A Risk Factors, above.
Adoption
of Convertible Debt Accounting
Our 2008 and 2007 consolidated financial statements have been
recast to reflect the adoption of FASB Accounting Standards
Codification (ASC)
470-20,
Debt with Conversion and Other Options. This resulted in
additional interest expense of $4.5 million ($0.10 per
diluted share) for the year ended December 31, 2008, and
$1.0 million ($0.02 per diluted share) for the year ended
December 31, 2007.
Overview
Molina Healthcare, Inc. is a multi-state managed care
organization that arranges for the delivery of health care
services to persons eligible for Medicaid, Medicare, and other
government-sponsored programs for low-income families and
individuals. We conduct our business primarily through licensed
health plans in the states of California, Florida, Michigan,
Missouri, New Mexico, Ohio, Texas, Utah, and Washington.
Effective December 31, 2009, we terminated operations at
our small Medicare health plan in Nevada. The health plans are
locally operated by our respective wholly owned subsidiaries in
those states, each of which is licensed as a health maintenance
organization, or HMO.
On January 18, 2010, we entered into a definitive agreement
to acquire the Health Information Management, or HIM, business
of Unisys Corporation. The HIM business provides design,
development, implementation, and business process outsourcing
solutions to state governments for their Medicaid Management
Information Systems, or MMIS, a core tool used to support the
administration of state Medicaid and other health care
entitlement programs. The HIM business currently holds MMIS
contracts with the states of Idaho, Louisiana, Maine, New
Jersey, and West Virginia, as well as a contract to provide drug
rebate administration services for the Florida Medicaid program.
The acquisition is expected to close in the first half of 2010.
We intend to operate the HIM business under the name, Molina
Medicaid Solutions.
Our financial performance for 2009, 2008, and 2007 is briefly
summarized below (dollars in thousands, except per-share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2009
|
|
2008
|
|
2007
|
|
Earnings per diluted share
|
|
$
|
1.19
|
|
|
$
|
2.15
|
|
|
$
|
2.03
|
|
Premium revenue
|
|
$
|
3,660,207
|
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
Operating income
|
|
$
|
57,393
|
|
|
$
|
112,605
|
|
|
$
|
98,327
|
|
Net income
|
|
$
|
30,868
|
|
|
$
|
59,598
|
|
|
$
|
57,726
|
|
Medical care ratio
|
|
|
86.8
|
%
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
G&A expenses as a percentage of total revenue
|
|
|
10.9
|
%
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
Total ending membership
|
|
|
1,455,000
|
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
Revenue
Premium revenue is fixed in advance of the periods covered and,
except as described below, is not generally subject to
significant accounting estimates. For the year ended
December 31, 2009, we received approximately 92% of our
premium revenue as a fixed amount per member per month, or PMPM,
pursuant to our Medicaid contracts with state agencies, our
Medicare contracts with CMS, and our contracts with other
managed care organizations for which we operate as a
subcontractor. These premium revenues are recognized in the
month that members are entitled to receive health care services.
The state Medicaid programs and the federal Medicare program
periodically adjust premium rates.
The amount of the premiums paid to us may vary substantially
between states and among various government programs. PMPM
premiums for CHIP members of the are generally among our lowest,
with rates as low as
35
approximately $75 PMPM in California. Premium revenues for
Medicaid members are generally higher. Among the TANF Medicaid
population the Medicaid group that includes mostly
mothers and children PMPM premiums range between
approximately $100 in California to over $240 in Ohio. Among our
Medicaid ABD membership, PMPM premiums range from approximately
$320 in Utah to over $1,000 in Ohio. Contributing to the
variability in Medicaid rates among the states is the practice
of some states to exclude certain benefits from the managed care
contract (most often pharmacy and catastrophic case benefits)
and retain responsibility for those benefits at the state level.
Medicare premiums are almost $1,200 PMPM, with Medicare
revenue totaling $135.9 million, $95.1 million, and
$49.3 million, for the years ended December 31, 2009,
2008, and 2007, respectively.
For the year ended December 31, 2009, we received
approximately 5% of our premium revenue in the form of
birth income a one-time payment for the
delivery of a child from the Medicaid programs in
California (effective October 1, 2009), Michigan, Missouri,
Ohio, Texas, Utah (effective September 1, 2009), and
Washington. Such payments are recognized as revenue in the month
the birth occurs. Approximately 2.5% of our premium revenue for
the year ended December 31, 2009 was realized under a
Medicaid cost-plus reimbursement agreement with the state of
Utah that ended effective August 31, 2009. Effective
September 1, 2009, the Utah health plans contract
with the state of Utah became a prepaid capitation contract,
under which the plan is now paid a fixed PMPM amount, as in the
other states in which we operate.
Certain components of premium revenue are subject to accounting
estimates. Chief among these are:
|
|
|
|
|
Florida Health Plan Medical Cost Floor (Minimum) for
Behavioral Health. A portion of premium revenue
paid to our Florida health plan by the state of Florida may be
refunded to the state if certain minimum amounts are not spent
on defined behavioral health care costs. At December 31,
2009, we had not recorded any liability under the terms of this
contract provision. If the state of Florida disagrees with our
interpretation of the existing contract terms, an adjustment to
the amounts owed may be required. Any changes to the terms of
this provision, including revisions to the definitions of
premium revenue or behavioral health care costs, the period of
time over which performance is measured or the manner of its
measurement, or the percentages used in the calculations, may
affect the profitability of our Florida health plan.
|
|
|
|
|
|
New Mexico Health Plan Medical Cost Floors (Minimums) and
Administrative Cost and Profit Ceilings
(Maximums): A portion of premium revenue paid to
our New Mexico health plan by the state of New Mexico may
be refunded to the state if certain minimum amounts are not
spent on defined medical care costs, or if administrative costs
or profit (as defined) exceed certain amounts. Our contract with
the state of New Mexico requires that we spend a minimum
percentage of premium revenue on certain explicitly defined
medical care costs (the medical cost floor). Our contract is for
a three-year period, and the medical cost floor is based on
premiums and medical care costs over the entire contract period.
Effective July 1, 2008, our New Mexico health plan entered
into a new three year contract that, in addition to retaining
the medical cost floor, added certain limits on the amount our
New Mexico health plan can: (a) expend on administrative
costs; and (b) retain as profit. At December 31, 2009,
we had not recorded any liability under the terms of these
contract provisions. If the state of New Mexico disagrees with
our interpretation of the existing contract terms, an adjustment
to the amounts owed may be required. Any changes to the terms of
these provisions, including revisions to the definitions of
premium revenue, medical care costs, administrative costs or
profit, the period of time over which performance is measured or
the manner of its measurement, or the percentages used in the
calculations, may affect the profitability of our New Mexico
health plan.
|
|
|
|
New Mexico Health Plan At-Risk Premium
Revenue: Under our contract with the state of New
Mexico, up to 1% of our New Mexico health plans revenue
may be refundable to the state if certain performance measures
are not met. These performance measures are generally linked to
various quality of care and administrative measures dictated by
the state. Through December 31, 2009, our New Mexico health
plan had received $3.6 million in at-risk revenue for state
fiscal year 2009 and the first half of state fiscal year 2010
combined. We have recognized $2.2 million of that amount as
revenue through December 31, 2009, and recorded a liability
of approximately $1.4 million for the remainder.
|
|
|
|
|
|
Ohio Health Plan At-Risk Premium
Revenue: Under our contract with the state of
Ohio, up to 1% of our Ohio health plans revenue may be
refundable to the state if certain performance measures are not
met. These performance measures are generally linked to various
quality of care measures dictated by the state. Through
December 31, 2009, our Ohio health plan had received
$8.8 million in at-risk revenue for state fiscal year 2009
|
36
|
|
|
|
|
and the first half of state fiscal year 2010 combined. We have
recognized $7.5 million of that amount as revenue through
December 31, 2009 and recorded a liability of approximately
$1.3 million for the remainder.
|
|
|
|
|
|
Utah Health Plan Premium Revenue: Our Utah
health plan may be entitled to receive additional premium
revenue from the state of Utah as an incentive payment for
saving the state of Utah money in relation to
fee-for-service
Medicaid. In prior years, we estimated amounts we believed were
recoverable under our savings sharing agreement with the state
of Utah based on available information and our interpretation of
our contract with the state. The state may not agree with our
interpretation or our application of the contract language, and
it may also not agree with the manner in which we have processed
and analyzed our member claims and encounter records. Thus, the
ultimate amount of savings sharing revenue that we realize from
prior years may be subject to negotiation with the state. During
2007, as a result of an ongoing disagreement with the state of
Utah, we wrote off the entire receivable, totaling
$4.7 million. Our Utah health plan continues to assert its
claim to the amounts believed to be due under the savings share
agreement. When additional information is known, or resolution
is reached with the state regarding the appropriate savings
sharing payment amount for prior years, we will adjust the
amount of savings sharing revenue recorded in our financial
statements as appropriate in light of such new information or
agreement. No receivables for saving sharing revenue have been
established at December 31, 2009 and 2008.
|
|
|
|
Texas Health Plan Premium Revenue: The
contract entered into between our Texas health plan and the
state of Texas includes a profit-sharing agreement, where we pay
a rebate to the state of Texas if our Texas health plan
generates pretax income above a certain specified percentage, as
determined in accordance with a tiered rebate schedule. We are
limited in the amount of administrative costs that we may deduct
in calculating the rebate, if any. As of December 31, 2009,
we had an aggregate liability of approximately $2.0 million
accrued pursuant to our profit-sharing agreement with the state
of Texas for the 2009 and 2010 contract years (ending August 31
of each year). During 2009, we paid the state of Texas
$4.9 million relating to the 2008 and 2009 contract years,
and the 2008 contract year is now closed. Because the final
settlement calculations include a claims run-out period of
nearly one year, the amounts recorded, based on our estimates,
may be adjusted. We believe that the ultimate settlement will
not differ materially from our estimates.
|
|
|
|
Texas Health Plan At-Risk Premium
Revenue: Under our contract with the state of
Texas, up to 1% of our Texas health plans revenue may be
refundable to the state if certain performance measures are not
met. These performance measures are generally linked to various
quality of care measures dictated by the state. Through
December 31, 2009, our Texas health plan had received
$1.7 million in at-risk revenue for state fiscal year 2009
and the first half of state fiscal year 2010 combined. We have
recognized $1.2 million of that amount as revenue through
December 31, 2009, and recorded a liability of
approximately $0.5 million for the remainder.
|
|
|
|
|
|
Medicare Premium Revenue: Based on member
encounter data that we submit to CMS, our Medicare revenue is
subject to retroactive adjustment for both member risk scores
and member pharmacy cost experience for up to two years after
the original year of service. This adjustment takes into account
the acuity of each members medical needs relative to what
was anticipated when premiums were originally set for that
member. In the event that a member requires less acute medical
care than was anticipated by the original premium amount, CMS
may recover premium from us. In the event that a member requires
more acute medical care than was anticipated by the original
premium amount, CMS may pay us additional retroactive premium. A
similar retroactive reconciliation is undertaken by CMS for our
Medicare members pharmacy utilization. That analysis is
similar to the process for the adjustment of member risk scores,
but is further complicated by member pharmacy cost sharing
provisions attached to the Medicare pharmacy benefit that do not
apply to the services measured by the member risk adjustment
process. We estimate the amount of Medicare revenue that will
ultimately be realized for the periods presented based on our
knowledge of our members heath care utilization patterns
and CMS practices. To the extent that the premium revenue
ultimately received from CMS differs from recorded amounts, we
will adjust reported Medicare revenue. Based upon our knowledge
of member health care utilization patterns we have recorded a
liability of approximately $0.6 million related to the
potential recoupment of Medicare premium revenue at
December 31, 2009.
|
37
Historically, membership growth has been the primary reason for
our increasing annual premium revenues, although more recently
our revenues have also grown due to the more care-intensive
benefits and related higher premiums associated with our ABD and
Medicare members. We have increased our membership through both
internal growth and acquisitions. The following table sets forth
the approximate total number of members by state health plan as
of the dates indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
2009
|
|
2008
|
|
2007
|
|
Total Ending Membership by Health Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
351,000
|
|
|
|
322,000
|
|
|
|
296,000
|
|
Florida(1)
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
Michigan
|
|
|
223,000
|
|
|
|
206,000
|
|
|
|
209,000
|
|
Missouri
|
|
|
78,000
|
|
|
|
77,000
|
|
|
|
68,000
|
|
New Mexico
|
|
|
94,000
|
|
|
|
84,000
|
|
|
|
73,000
|
|
Ohio
|
|
|
216,000
|
|
|
|
176,000
|
|
|
|
136,000
|
|
Texas
|
|
|
40,000
|
|
|
|
31,000
|
|
|
|
29,000
|
|
Utah
|
|
|
69,000
|
|
|
|
61,000
|
|
|
|
55,000
|
|
Washington
|
|
|
334,000
|
|
|
|
299,000
|
|
|
|
283,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,455,000
|
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ending Membership by State for our Medicare
Advantage Special Needs Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
2,100
|
|
|
|
1,500
|
|
|
|
1,100
|
|
Michigan
|
|
|
3,300
|
|
|
|
1,700
|
|
|
|
1,100
|
|
New Mexico
|
|
|
400
|
|
|
|
300
|
|
|
|
|
|
Texas
|
|
|
500
|
|
|
|
400
|
|
|
|
|
|
Utah
|
|
|
4,000
|
|
|
|
2,400
|
|
|
|
1,900
|
|
Washington
|
|
|
1,300
|
|
|
|
1,000
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
11,600
|
|
|
|
7,300
|
|
|
|
4,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ending Membership by State for our Aged, Blind or
Disabled (ABD) Population:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
13,900
|
|
|
|
12,700
|
|
|
|
11,800
|
|
Florida(1)
|
|
|
8,800
|
|
|
|
|
|
|
|
|
|
Michigan
|
|
|
32,200
|
|
|
|
30,300
|
|
|
|
31,400
|
|
New Mexico
|
|
|
5,700
|
|
|
|
6,300
|
|
|
|
6,800
|
|
Ohio
|
|
|
22,600
|
|
|
|
19,000
|
|
|
|
14,900
|
|
Texas
|
|
|
17,600
|
|
|
|
16,200
|
|
|
|
16,000
|
|
Utah
|
|
|
7,500
|
|
|
|
7,300
|
|
|
|
6,800
|
|
Washington
|
|
|
3,200
|
|
|
|
3,000
|
|
|
|
2,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
111,500
|
|
|
|
94,800
|
|
|
|
90,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Florida health plan began enrolling members in December 2008. |
38
The following table provides details of member months (defined
as the aggregation of each months membership for the
period) by state for the years ended December 31, 2009,
2008, and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
2007
|
|
Total Member Months by Health Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
4,135,000
|
|
|
|
3,721,000
|
|
|
|
3,500,000
|
|
Florida(1)
|
|
|
386,000
|
|
|
|
|
|
|
|
|
|
Michigan
|
|
|
2,523,000
|
|
|
|
2,526,000
|
|
|
|
2,597,000
|
|
Missouri
|
|
|
927,000
|
|
|
|
910,000
|
|
|
|
136,000
|
|
New Mexico
|
|
|
1,042,000
|
|
|
|
970,000
|
|
|
|
803,000
|
|
Ohio
|
|
|
2,411,000
|
|
|
|
1,998,000
|
|
|
|
1,567,000
|
|
Texas
|
|
|
402,000
|
|
|
|
348,000
|
|
|
|
335,000
|
|
Utah
|
|
|
793,000
|
|
|
|
659,000
|
|
|
|
593,000
|
|
Washington
|
|
|
3,847,000
|
|
|
|
3,514,000
|
|
|
|
3,419,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
16,466,000
|
|
|
|
14,646,000
|
|
|
|
12,950,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Florida health plan began enrolling members in December 2008. |
Expenses
Our operating expenses include expenses related to the provision
of medical care services and general and administrative, or
G&A, expenses. Our results of operations are impacted by
our ability to effectively manage expenses related to health
care services and to accurately estimate costs incurred.
Expenses related to medical care services are captured in the
following four categories:
|
|
|
|
|
Fee-for-service: Physician
providers paid on a
fee-for-service
basis are paid according to a fee schedule set by the state or
by our contracts with the providers. We pay hospitals on a
fee-for-service
basis in a variety of ways, including by per diem amounts, by
diagnostic-related groups, or DRGs, as a percentage of billed
charges, and by case rates. We also pay a small portion of
hospitals on a capitated basis. We also have stop-loss
agreements with the hospitals with which we contract; under
certain circumstances, we pay escalated charges in connection
with these stop-loss agreements. Under all
fee-for-service
arrangements, we retain the financial responsibility for medical
care provided. Expenses related to
fee-for-service
contracts are recorded in the period in which the related
services are dispensed. The costs of drugs administered in a
physician or hospital setting that are not billed through our
pharmacy benefit managers are included in
fee-for-service
costs.
|
|
|
|
Capitation: Many of our primary care
physicians and a small portion of our specialists and hospitals
are paid on a capitated basis. Under capitation contracts, we
typically pay a fixed PMPM payment to the provider without
regard to the frequency, extent, or nature of the medical
services actually furnished. Under capitated contracts, we
remain liable for the provision of certain health care services.
Certain of our capitated contracts also contain incentive
programs based on service delivery, quality of care, utilization
management, and other criteria. Capitation payments are fixed in
advance of the periods covered and are not subject to
significant accounting estimates. These payments are expensed in
the period the providers are obligated to provide services. The
financial risk for pharmacy services for a small portion of our
membership is delegated to capitated providers.
|
|
|
|
Pharmacy: Pharmacy costs include all drug,
injectibles, and immunization costs paid through our pharmacy
benefit managers. As noted above, drugs and injectibles not paid
through our pharmacy benefit managers are included in
fee-for-service
costs, except in those limited instances where we capitate drug
and injectible costs.
|
|
|
|
Other: Other medical care costs include
medically related administrative costs, certain provider
incentive costs, reinsurance costs, and other health care
expense. Medically related administrative costs include, for
example, expenses relating to health education, quality
assurance, case management, disease management,
24-hour
on-call nurses, and a portion of our information technology
costs. Salary and benefit costs are a
|
39
|
|
|
|
|
substantial portion of these expenses. For the years ended
December 31, 2009, 2008 and 2007, medically related
administrative costs were approximately $74.6 million,
$75.9 million and $65.4 million, respectively.
|
The following table provides the details of our consolidated
medical care costs for the periods indicated (dollars in
thousands except PMPM amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Fee-for-service
|
|
$
|
2,077,489
|
|
|
$
|
126.14
|
|
|
|
65.4
|
%
|
|
$
|
1,709,806
|
|
|
$
|
116.69
|
|
|
|
65.2
|
%
|
|
$
|
1,343,911
|
|
|
$
|
103.77
|
|
|
|
64.6
|
%
|
Capitation
|
|
|
558,538
|
|
|
|
33.91
|
|
|
|
17.6
|
|
|
|
450,440
|
|
|
|
30.74
|
|
|
|
17.2
|
|
|
|
375,206
|
|
|
|
28.97
|
|
|
|
18.0
|
|
Pharmacy
|
|
|
414,785
|
|
|
|
25.18
|
|
|
|
13.1
|
|
|
|
356,184
|
|
|
|
24.31
|
|
|
|
13.6
|
|
|
|
270,363
|
|
|
|
20.88
|
|
|
|
13.0
|
|
Other
|
|
|
125,424
|
|
|
|
7.62
|
|
|
|
3.9
|
|
|
|
104,882
|
|
|
|
7.16
|
|
|
|
4.0
|
|
|
|
90,603
|
|
|
|
7.00
|
|
|
|
4.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,176,236
|
|
|
$
|
192.85
|
|
|
|
100.0
|
%
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
100.0
|
%
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our medical care costs include amounts that have been paid by us
through the reporting date as well as estimated liabilities for
medical care costs incurred but not paid by us as of the
reporting date. See Critical Accounting Policies
below for a comprehensive discussion of how we estimate such
liabilities. The following table provides the details of our
medical claims and benefits payable as of the dates indicated
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Fee-for-service
claims incurred but not paid (IBNP)
|
|
$
|
246,508
|
|
|
$
|
236,492
|
|
Capitation payable
|
|
|
39,995
|
|
|
|
28,111
|
|
Pharmacy
|
|
|
20,609
|
|
|
|
18,837
|
|
Other
|
|
|
9,404
|
|
|
|
9,002
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
316,516
|
|
|
$
|
292,442
|
|
|
|
|
|
|
|
|
|
|
G&A expenses largely consist of wage and benefit costs for
our employees, premium taxes, and other administrative expenses.
Some G&A services are provided locally, while others are
delivered to our health plans from a centralized location. The
primary centralized functions are claims processing, information
systems, finance and accounting services, and legal and
regulatory services. Locally provided functions include member
services, plan administration, and provider relations. G&A
expenses include premium taxes for each of our health plans in
California, Florida, Michigan, New Mexico, Ohio, Texas, and
Washington.
40
Results
of Operations
The following table sets forth selected consolidated operating
ratios. All ratios, with the exception of the medical care
ratio, are shown as a percentage of total revenue. The medical
care ratio is shown as a percentage of premium revenue because
there is a direct relationship between the premium revenue
earned and the cost of health care.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
Premium revenue
|
|
|
99.8
|
%
|
|
|
99.3
|
%
|
|
|
98.8
|
%
|
Investment income
|
|
|
0.2
|
|
|
|
0.7
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care ratio
|
|
|
86.8
|
%
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expense ratio, excluding premium taxes
|
|
|
7.5
|
%
|
|
|
8.0
|
%
|
|
|
8.2
|
%
|
Premium taxes included in general and administrative expenses
|
|
|
3.4
|
|
|
|
3.1
|
|
|
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total general and administrative expense ratio
|
|
|
10.9
|
%
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense ratio
|
|
|
1.0
|
%
|
|
|
1.1
|
%
|
|
|
1.1
|
%
|
Effective tax rate
|
|
|
29.2
|
%
|
|
|
40.0
|
%
|
|
|
37.7
|
%
|
Operating income
|
|
|
1.6
|
%
|
|
|
3.6
|
%
|
|
|
3.9
|
%
|
Net income
|
|
|
0.8
|
%
|
|
|
1.9
|
%
|
|
|
2.3
|
%
|
Year
Ended December 31, 2009 Compared with the Year Ended
December 31, 2008
The following table summarizes premium revenue, medical care
costs, medical care ratio, and premium taxes by health plan for
the periods indicated (PMPM amounts are in whole dollars; other
dollar amounts are in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2009
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
481,717
|
|
|
$
|
116.49
|
|
|
$
|
443,892
|
|
|
$
|
107.34
|
|
|
|
92.2
|
%
|
|
$
|
16,446
|
|
Florida(1)
|
|
|
102,232
|
|
|
|
264.94
|
|
|
|
95,936
|
|
|
|
248.62
|
|
|
|
93.8
|
|
|
|
16
|
|
Michigan
|
|
|
557,421
|
|
|
|
220.94
|
|
|
|
454,431
|
|
|
|
180.12
|
|
|
|
81.5
|
|
|
|
31,023
|
|
Missouri
|
|
|
230,222
|
|
|
|
248.25
|
|
|
|
191,585
|
|
|
|
206.59
|
|
|
|
83.2
|
|
|
|
|
|
New Mexico(2)
|
|
|
404,026
|
|
|
|
387.67
|
|
|
|
346,044
|
|
|
|
332.03
|
|
|
|
85.7
|
|
|
|
11,043
|
|
Ohio
|
|
|
803,521
|
|
|
|
333.33
|
|
|
|
691,402
|
|
|
|
286.82
|
|
|
|
86.1
|
|
|
|
47,849
|
|
Texas
|
|
|
134,860
|
|
|
|
335.69
|
|
|
|
110,794
|
|
|
|
275.78
|
|
|
|
82.2
|
|
|
|
2,513
|
|
Utah
|
|
|
207,297
|
|
|
|
261.43
|
|
|
|
190,319
|
|
|
|
240.02
|
|
|
|
91.8
|
|
|
|
|
|
Washington
|
|
|
726,137
|
|
|
|
188.77
|
|
|
|
613,876
|
|
|
|
159.58
|
|
|
|
84.5
|
|
|
|
14,175
|
|
Other(3),(4)
|
|
|
12,774
|
|
|
|
|
|
|
|
37,957
|
|
|
|
|
|
|
|
|
|
|
|
57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,660,207
|
|
|
$
|
222.24
|
|
|
$
|
3,176,236
|
|
|
$
|
192.85
|
|
|
|
86.8
|
%
|
|
$
|
123,122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
417,027
|
|
|
$
|
112.06
|
|
|
$
|
363,776
|
|
|
$
|
97.75
|
|
|
|
87.2
|
%
|
|
$
|
12,503
|
|
Florida(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michigan
|
|
|
509,782
|
|
|
|
201.86
|
|
|
|
405,683
|
|
|
|
160.64
|
|
|
|
79.6
|
|
|
|
26,710
|
|
Missouri
|
|
|
225,280
|
|
|
|
247.62
|
|
|
|
184,298
|
|
|
|
202.58
|
|
|
|
81.8
|
|
|
|
|
|
New Mexico(2)
|
|
|
348,576
|
|
|
|
359.45
|
|
|
|
286,004
|
|
|
|
294.92
|
|
|
|
82.1
|
|
|
|
11,713
|
|
Ohio
|
|
|
602,826
|
|
|
|
301.76
|
|
|
|
549,182
|
|
|
|
274.91
|
|
|
|
91.1
|
|
|
|
30,505
|
|
Texas
|
|
|
110,178
|
|
|
|
316.32
|
|
|
|
84,324
|
|
|
|
242.09
|
|
|
|
76.5
|
|
|
|
1,995
|
|
Utah
|
|
|
155,991
|
|
|
|
236.75
|
|
|
|
139,011
|
|
|
|
210.98
|
|
|
|
89.1
|
|
|
|
|
|
Washington
|
|
|
709,943
|
|
|
|
202.02
|
|
|
|
575,085
|
|
|
|
163.64
|
|
|
|
81.0
|
|
|
|
11,668
|
|
Other(3),(4)
|
|
|
11,637
|
|
|
|
|
|
|
|
33,949
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,091,240
|
|
|
$
|
210.97
|
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
84.8
|
%
|
|
$
|
95,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Florida health plan began enrolling members in December 2008. |
|
(2) |
|
The medical care ratio of the New Mexico health plan was 85.7%
for the year ended December 31, 2009, up from 82.1% for the
same period in 2008. During 2008, the New Mexico health plan had
recognized $12.9 million of premium revenue due to the
reversal of amounts previously recorded as payable to the state
of New Mexico. Absent this revenue adjustment, the New Mexico
health plans medical care ratio would have been 85.2% for
the year ended December 31, 2008. |
|
(3) |
|
As of December 31, 2009, our Nevada health plan no longer
served members. Premium revenue and medical care costs for the
Nevada health plan have been included in Other. |
|
(4) |
|
Other medical care costs also include medically
related administrative costs at the parent company. |
Note: Estimates of utilization and unit costs may not
match changes in reported costs due to the impact of shifts in
case mix between the periods presented, prior period
development, the existence of pass-through contracts in which
third parties assume medical risk, and other factors.
Additionally, estimates of utilization for the year ended
December 31, 2009, exclude the month of December 2009 due
to the substantial incompleteness of claims payment data for
that month.
Operating results for the year ended December 31, 2009,
were most significantly impacted by the following:
|
|
|
|
|
Higher utilization due to widespread influenza-related illness
across the Companys health plans.
|
|
|
|
Margin compression related to state budget shortfalls.
|
|
|
|
Enrollment growth and the higher costs associated with new
members.
|
|
|
|
Higher emergency room costs.
|
Net
Income
For the year ended December 31, 2009, net income decreased
to $30.9 million, or $1.19 per diluted share, from
$59.6 million, or $2.15 per diluted share, for the year
ended December 31, 2008.
Premium
Revenue
Premium revenue grew approximately 18% in the year ended
December 31, 2009 compared with the same period in 2008.
During 2009, membership grew 16% overall, with Florida,
California, Washington, and Ohio gaining the most members.
Consolidated premium revenue increased 5.3% on a PMPM basis.
Increased membership contributed 71% of the growth in premium
revenue, and increases in PMPM revenue, as a result of both rate
changes and shifts in member mix, contributed the remaining 29%.
We received PMPM premium reductions in 2009 that were in many
cases correlated with reductions in the Medicaid fee schedule
that also reduced our medical costs. However, PMPM premium
reductions in Washington and Missouri in 2009 were not fully
commensurate with changes in the Medicaid fee schedule in those
states, and
42
thus decreases in premiums were not matched by lower medical
costs. In Washington, premium reductions not linked to decreases
in the Medicaid fee schedule lowered our medical margin by
approximately $13 million in 2009. In Missouri, the
retention of the pharmacy benefit by the state effective
October 1, 2009 reduced our medical margin by approximately
$1.2 million in 2009.
Investment
income
Investment income for 2009 decreased $12.0 million to
$9.1 million, from $21.1 million earned in 2008. This
decline was due to lower interest rates in 2009.
Medical
care costs
Medical care costs, in the aggregate, increased 8% on a PMPM
basis for the year ended December 31, 2009 compared with
the same period in 2008. The medical care ratio was 86.8% for
the year ended December 31, 2009, compared with 84.8% for
the same period in 2008. Increased expenses were generally the
result of higher utilization rather than higher unit costs
(except in the case of outpatient costs, where both utilization
and unit costs increased) and were most pronounced in connection
with physician and outpatient emergency room facility services.
Influenza-related illnesses and the costs associated with more
recently enrolled members were key factors in the higher
utilization. We estimate that the incremental costs associated
with influenza-related illnesses were approximately
$35 million, or $0.83 per diluted share, in the year ended
December 31, 2009 compared with the year ended
December 31, 2008.
Physician and outpatient costs exhibited the most significant
unfavorable cost trend in the year ended December 31, 2009.
Together, these costs increased approximately 13% on a PMPM
basis compared with the same period in 2008. Consistent with our
experience throughout 2009, emergency room utilization (up
approximately 9%) and cost per visit (up approximately 8%) were
the primary drivers of increased cost in the year ended
December 31, 2009.
Hospitals have billed us for more intensive levels of care than
in the same period in 2008 for outpatient emergency room
facility services. The billing codes for emergency room level of
care with Level 1 reflecting the least
intensive care and Level 5 reflecting the most intensive
care changed significantly in the year ended
December 31, 2009, compared with the same period in 2008.
Level 1 and Level 2 visits decreased by 9% and 6%,
respectively, while Level 3, Level 4, and Level 5
visits increased by 20%, 18%, and 20%, respectively.
Inpatient costs were flat on a PMPM basis
year-over-year
despite increased utilization.
Pharmacy costs (including the benefit of rebates) increased 6%
on a PMPM basis
year-over-year,
excluding the Missouri health plan, where the pharmacy benefit
was retained by the state of Missouri effective October 1,
2009. Pharmacy utilization increased approximately 6%
year-over-year,
while unit costs (excluding rebates) were flat.
Capitated costs increased approximately 10% PMPM
year-over-year,
primarily as a result of rate increases received for members
capitated on a percentage of premium basis at the New Mexico
health plan, and the transition of members into capitated
arrangements in California.
General
and administrative expenses
General and administrative expenses were $399.1 million, or
10.9% of total revenue, for 2009 compared with
$344.8 million, or 11.1% of total revenue, for 2008.
Included in G&A expenses were premium taxes totaling
$123.1 million in 2009 and $95.1 million in 2008.
Premium taxes increased in 2009 due to increased revenues in the
states where premium taxes are assessed.
43
Core G&A expenses, which we define as G&A expenses
less premium taxes, were 7.5% of revenue in the year ended
December 31, 2009, compared with 8.0% in the same period in
2008.
Year-over-year,
premium revenue grew faster than administrative costs, causing
administrative costs, as a percentage of revenue, to decrease.
On a PMPM basis, core G&A decreased to $16.76 for the year
ended December 31, 2009, from $17.04 for the same period in
2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
% of Total
|
|
|
|
Amount
|
|
|
Revenue
|
|
|
Amount
|
|
|
Revenue
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Medicare-related administrative costs
|
|
$
|
18,857
|
|
|
|
0.5
|
%
|
|
$
|
18,451
|
|
|
|
0.6
|
%
|
Non Medicare-related administrative costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative payroll, including employee incentive compensation
|
|
|
205,396
|
|
|
|
5.6
|
|
|
|
190,932
|
|
|
|
6.1
|
|
Florida health plan start up expenses
|
|
|
|
|
|
|
|
|
|
|
2,495
|
|
|
|
0.1
|
|
All other administrative expense
|
|
|
51,774
|
|
|
|
1.4
|
|
|
|
37,768
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core G&A expenses
|
|
$
|
276,027
|
|
|
|
7.5
|
%
|
|
$
|
249,646
|
|
|
|
8.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and Amortization
Depreciation and amortization expense increased
$4.4 million for the year ended December 31, 2009
compared with 2008, primarily due to depreciation expense
associated with investments in infrastructure. The following
table presents the components of depreciation and amortization
expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Depreciation expense
|
|
$
|
25,172
|
|
|
$
|
20,718
|
|
Amortization expense on intangible assets
|
|
|
12,938
|
|
|
|
12,970
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization expense
|
|
$
|
38,110
|
|
|
$
|
33,688
|
|
|
|
|
|
|
|
|
|
|
Interest
Expense
Interest expense for 2009 and 2008 includes non-cash interest
expense relating to our convertible senior notes, as a result of
the adoption of ASC Subtopic
470-20. The
amounts recorded for this non-cash interest expense totaled
$4.8 million for the year ended December 31, 2009, and
$4.7 million for the same period in 2008.
Income
Taxes
Income taxes were recorded at an effective rate of 29.2% for the
year ended December 31, 2009 compared with 40.0% for the
same period in 2008. The decrease in the effective tax rate was
primarily due to discrete tax benefits recognized during the
year relating to settling tax examinations, and higher than
previously estimated California enterprise zone tax credits.
44
Year
Ended December 31, 2008 Compared with the Year Ended
December 31, 2007
The following table summarizes premium revenue, medical care
costs, medical care ratio, and premium taxes by health plan for
the periods indicated (PMPM amounts are in whole dollars; other
dollar amounts are in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
417,027
|
|
|
$
|
112.06
|
|
|
$
|
363,776
|
|
|
$
|
97.75
|
|
|
|
87.2
|
%
|
|
$
|
12,503
|
|
Michigan
|
|
|
509,782
|
|
|
|
201.86
|
|
|
|
405,683
|
|
|
|
160.64
|
|
|
|
79.6
|
|
|
|
26,710
|
|
Missouri
|
|
|
225,280
|
|
|
|
247.62
|
|
|
|
184,298
|
|
|
|
202.58
|
|
|
|
81.8
|
|
|
|
|
|
Nevada
|
|
|
8,037
|
|
|
|
1,106.45
|
|
|
|
9,099
|
|
|
|
1,252.61
|
|
|
|
113.2
|
|
|
|
|
|
New Mexico
|
|
|
348,576
|
|
|
|
359.45
|
|
|
|
286,004
|
|
|
|
294.92
|
|
|
|
82.1
|
|
|
|
11,713
|
|
Ohio
|
|
|
602,826
|
|
|
|
301.76
|
|
|
|
549,182
|
|
|
|
274.91
|
|
|
|
91.1
|
|
|
|
30,505
|
|
Texas
|
|
|
110,178
|
|
|
|
316.32
|
|
|
|
84,324
|
|
|
|
242.09
|
|
|
|
76.5
|
|
|
|
1,995
|
|
Utah
|
|
|
155,991
|
|
|
|
236.75
|
|
|
|
139,011
|
|
|
|
210.98
|
|
|
|
89.1
|
|
|
|
|
|
Washington
|
|
|
709,943
|
|
|
|
202.02
|
|
|
|
575,085
|
|
|
|
163.64
|
|
|
|
81.0
|
|
|
|
11,668
|
|
Other
|
|
|
3,600
|
|
|
|
|
|
|
|
24,850
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,091,240
|
|
|
$
|
210.97
|
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
84.8
|
%
|
|
$
|
95,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
378,934
|
|
|
$
|
108.29
|
|
|
$
|
310,226
|
|
|
$
|
88.66
|
|
|
|
81.9
|
%
|
|
$
|
11,338
|
|
Michigan
|
|
|
487,032
|
|
|
|
187.55
|
|
|
|
409,230
|
|
|
|
157.59
|
|
|
|
84.0
|
|
|
|
28,493
|
|
Missouri
|
|
|
30,730
|
|
|
|
226.65
|
|
|
|
26,396
|
|
|
|
194.69
|
|
|
|
85.9
|
|
|
|
|
|
Nevada
|
|
|
2,438
|
|
|
|
1,440.73
|
|
|
|
2,069
|
|
|
|
1,222.76
|
|
|
|
84.9
|
|
|
|
|
|
New Mexico
|
|
|
268,115
|
|
|
|
333.94
|
|
|
|
221,567
|
|
|
|
275.97
|
|
|
|
82.6
|
|
|
|
9,088
|
|
Ohio
|
|
|
436,238
|
|
|
|
278.39
|
|
|
|
394,451
|
|
|
|
251.72
|
|
|
|
90.4
|
|
|
|
19,631
|
|
Texas
|
|
|
88,453
|
|
|
|
263.90
|
|
|
|
68,173
|
|
|
|
203.40
|
|
|
|
77.1
|
|
|
|
1,598
|
|
Utah
|
|
|
116,907
|
|
|
|
197.19
|
|
|
|
109,895
|
|
|
|
185.36
|
|
|
|
94.0
|
|
|
|
|
|
Washington
|
|
|
652,970
|
|
|
|
190.96
|
|
|
|
519,763
|
|
|
|
152.00
|
|
|
|
79.6
|
|
|
|
10,844
|
|
Other
|
|
|
552
|
|
|
|
|
|
|
|
18,313
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,462,369
|
|
|
$
|
190.13
|
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
84.5
|
%
|
|
$
|
81,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income
For the year ended December 31, 2008, net income increased
to $59.6 million, or $2.15 per diluted share, from
$57.7 million, or $2.03 per diluted share, for the year
ended December 31, 2007.
Premium
Revenue
Premium revenue for the year ended December 31, 2008 was
$3,091.2 million, an increase of $628.8 million, or
26%, over the $2,462.4 million of premium revenue for the
year ended December 31, 2007. Medicare premium revenue for
2008 was $95.1 million, compared with $49.3 million
for 2007.
Investment
income
Investment income for 2008 decreased $9.0 million to
$21.1 million, from $30.1 million earned in 2007. This
30% decline was due to declining interest rates in 2008.
45
Medical
care costs
Medical care costs as a percentage of premium revenue, or the
medical care ratio, increased to 84.8% in 2008 from 84.5% in
2007. Excluding Medicare, our medical care ratio was 84.8% in
2008, compared with 84.7% in 2007.
|
|
|
|
|
The medical care ratio of the California health plan was 87.2%
for 2008, up from 81.9% in 2007. The increase in the plans
medical care ratio was caused primarily by increased
fee-for-service
and pharmacy costs that proportionally exceeded the increased
revenue from premium rate increases.
|
|
|
|
The medical care ratio of the Michigan health plan was 79.6% for
2008, down from 84.0% in 2007. This decrease was caused
primarily by premium rate increases that proportionally exceeded
the plans increased medical costs.
|
|
|
|
The medical care ratio of the Missouri health plan was 81.8% for
2008, down from 85.9% in 2007. Premium increases were
proportionally greater than PMPM medical costs due to revised
provider contracts and a fee schedule increase effective
July 1, 2008.
|
|
|
|
The medical care ratio of the New Mexico health plan was 82.1%
in 2008, down from 82.6% in 2007. Between July 1, 2008 and
December 31, 2008, the New Mexico health plan received a
blended rate decrease of approximately 3% under the plans
Medicaid Salud! contract and two separate contracts serving
membership under the states coverage initiative for the
uninsured. The impact of this blended rate decrease was exceeded
by the reversal of a $12.9 million accrual established as
of December 31, 2007, pursuant to a minimum medical care
ratio contract provision. In 2007, the New Mexico health plan
had recorded a charge of $6.0 million related to this
contract provision. Absent the impact of the minimum medical
care ratio contract provision, the New Mexico health plans
MCR would have been 85.2% in 2008, compared with 80.8% in 2007,
due to higher
fee-for-service
and capitation costs and lower PMPM premium revenue.
|
|
|
|
The medical care ratio of the Ohio health plan increased to
91.1% in the 2008 from 90.4% in the 2007, primarily due to
higher pharmacy cost as a percentage of premium revenue. The
medical care ratio of the Ohio health plan, by line of business,
was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Covered Families and Children (CFC)
|
|
|
89.7
|
%
|
|
|
88.6
|
%
|
Aged, Blind or Disabled (ABD)
|
|
|
93.7
|
|
|
|
94.7
|
|
|
|
|
|
|
|
|
|
|
Aggregate
|
|
|
91.1
|
%
|
|
|
90.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The medical care ratio of the Texas health plan was 76.5% in
2008, down from 77.1% in 2007. Increased premiums more than
offset higher medical costs.
|
|
|
|
The medical care ratio of the Utah health plan was 89.1% in
2008, down from 94.0% in 2007. In 2007, the Utah health plan had
recorded a $4.2 million reduction of revenue as a result of
a reconciliation of amounts due the state of Utah under a
savings sharing arrangement. Absent the savings sharing
adjustment, the medical care ratio in 2007 would have been 90.7%.
|
|
|
|
The medical care ratio of the Washington health plan was 81.0%
in 2008, up from 79.6% in 2007, primarily due to higher
fee-for-service
specialist and hospital costs.
|
General
and administrative expenses
General and administrative expenses were $344.8 million, or
11.1% of total revenue, for 2008, compared with
$285.3 million, or 11.5% of total revenue, for 2007.
Included in G&A expenses were premium taxes totaling
$95.1 million in 2008 and $81.0 million in 2007.
Premium taxes increased in 2008 due to increased revenues in the
states where premium taxes are assessed.
Core G&A expenses were 8.0% of revenue in 2008, compared
with 8.2% in 2007. The decrease in core G&A compared with
2007 was primarily due to lower administrative payroll as a
percentage of revenue, as indicated in the table below.
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
% of Total
|
|
|
|
Amount
|
|
|
Revenue
|
|
|
Amount
|
|
|
Revenue
|
|
|
|
(In thousands)
|
|
|
Medicare-related administrative costs
|
|
$
|
18,451
|
|
|
|
0.6
|
%
|
|
$
|
9,778
|
|
|
|
0.4
|
%
|
Non Medicare-related administrative costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative payroll, including employee incentive compensation
|
|
|
190,932
|
|
|
|
6.1
|
|
|
|
163,420
|
|
|
|
6.6
|
|
Florida health plan start up expenses
|
|
|
2,495
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
All other administrative expense
|
|
|
37,768
|
|
|
|
1.2
|
|
|
|
31,077
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core G&A expenses
|
|
$
|
249,646
|
|
|
|
8.0
|
%
|
|
$
|
204,275
|
|
|
|
8.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and Amortization
Depreciation and amortization expense increased
$5.7 million for the year ended December 31, 2008
compared to 2007, primarily due to depreciation expense
associated with investments in infrastructure. Of the total
increase, amortization expense contributed $2.1 million,
primarily due to the Mercy CarePlus acquisition in Missouri in
2007. The following table presents the components of
depreciation and amortization expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Depreciation expense
|
|
$
|
20,718
|
|
|
$
|
17,118
|
|
Amortization expense on intangible assets
|
|
|
12,970
|
|
|
|
10,849
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization expense
|
|
$
|
33,688
|
|
|
$
|
27,967
|
|
|
|
|
|
|
|
|
|
|
Impairment
Charge on Purchased Software
During the second quarter of 2007, we recorded an impairment
charge of $782,000, related to purchased software no longer used
for operations. No such charge was recorded in 2008.
Interest
Expense
Interest expense increased to $13.2 million in 2008 from
$5.6 million in 2007 primarily due to the issuance of our
convertible senior notes in the fourth quarter of 2007. Interest
expense for 2008 and 2007 includes non-cash interest expense
relating to the convertible senior notes, as a result of the
adoption of ASC Subtopic
470-20. The
amounts recorded for this non-cash interest expense totaled
$4.7 million and $1.0 million for the years ended
December 31, 2008, and 2007, respectively.
Income
Taxes
Income taxes were recorded at an effective rate of 40.0% for the
year ended December 31, 2008, compared with 37.7% in the
prior year. The increase in our effective tax rate was primarily
the result of an increase in Michigan state taxes attributable
to tax law changes that took effect on January 1, 2008. The
increase in Michigan taxes was partially offset by prior
years tax benefits recorded during 2008 relating to
California enterprise zone credits. Absent the enterprise zone
credit tax benefits, our effective tax rate for the year ended
December 31, 2008 would have been approximately 41%.
Acquisitions
HIM Business of Unisys. On January 19,
2010, we entered into a definitive agreement to acquire the
Health Information Management business of Unisys Corporation.
The purchase price is expected to be approximately
$135 million, subject to a standard working capital
adjustment, to be paid in cash at closing using our credit
facility. The acquisition, which is expected to close in the
first half of 2010, is subject to customary regulatory approvals
and closing conditions, including receipt of customer consents.
47
The HIM business provides design, development, implementation,
and business process outsourcing solutions to state governments
for their Medicaid Management Information Systems. MMIS is a
core tool used to support the administration of state Medicaid
and other health care entitlement programs. The HIM business
currently holds MMIS contracts with the states of Idaho,
Louisiana, Maine, New Jersey, and West Virginia, as well as a
contract to provide drug rebate administration services for the
Florida Medicaid program. Annual revenues of the HIM business
are currently approximately $110 million. We expect the
approximately 900 employees of the HIM business to become
our employees upon closing of the transaction, and following the
closing Unisys has agreed to provide us certain transitional and
technology support services for up to one year.
Florida Health Plan. On December 31, 2009
(the acquisition date), we acquired 100% of the voting equity
interests in Florida NetPASS, LLC, or NetPASS. This acquisition
included the purchase of the NetPASS limited liability company
and its membership interests. We initially announced our
intention to purchase NetPASS in August 2008. NetPASS was a
provider of care management and administrative services at that
time to approximately 58,000 Florida MediPass members in South
and Central Florida (Florida MediPASS is the state of
Floridas Medicaid program).
Our wholly owned subsidiary, Molina Healthcare of Florida, Inc.,
was awarded a Medicaid managed care contract by the state of
Florida in October 2008. Subsequently, NetPASS members have been
notified of our intention to acquire NetPASS and, beginning in
December 2008, offered membership with our Florida health plan
on a
county-by-county
basis. Once transitioned, these members become full-risk members
of the Florida health plan. The Florida health plan receives
fixed PMPM payments from the state of Florida for the care of
these members, and the Florida health plan is at risk for the
cost of the members medical care.
As of December 31, 2009, we have transitioned approximately
48,000 NetPASS members to our Florida health plan, and have
recorded $28.7 million of goodwill and intangible assets
relating to these members. Of this amount, we have paid the
sellers $23.4 million, with the balance accrued to accounts
payable and accrued liabilities. The $5.3 million current
liability includes a 10% indemnification hold back totaling
$2.9 million, as provided in the purchase agreement, and a
$2.4 million payable to the sellers for membership
transitioned to date as of December 31, 2009. Because the
final membership reconciliation will take place early in the
second quarter of 2010, the provisional measurements of goodwill
and intangible assets are subject to change.
Liquidity
and Capital Resources
We manage our cash, investments, and capital structure to meet
the short- and long-term obligations of our business while
maintaining liquidity and financial flexibility. We forecast,
analyze, and monitor our cash flows to enable prudent investment
management and financing within the confines of our financial
strategy.
Our regulated subsidiaries generate significant cash flows from
premium revenue and investment income. Such cash flows are our
primary source of liquidity. Thus, any future decline in our
profitability may have a negative impact on our liquidity. We
generally receive premium revenue in advance of the payment of
claims for the related health care services. A majority of the
assets held by our regulated subsidiaries are in the form of
cash, cash equivalents and investments. After considering
expected cash flows from operating activities, we generally
invest cash of regulated subsidiaries that exceeds our expected
short-term obligations in longer term, investment-grade,
marketable debt securities to improve our overall investment
return. These investments are made pursuant to board approved
investment policies which conform to applicable state laws and
regulations. Our investment policies are designed to provide
liquidity, preserve capital, and maximize total return on
invested assets, all in a manner consistent with state
requirements that prescribe the types of instruments in which
our subsidiaries may invest. These investment policies require
that our investments have final maturities of ten years or less
(excluding auction rate securities and variable rate securities,
for which interest rates are periodically reset) and that the
average maturity be four years or less. Professional portfolio
managers operating under documented guidelines manage our
investments. As of December 31, 2009, a substantial portion
of our cash was invested in a portfolio of highly liquid money
market securities, and our investments consisted solely of
investment-grade debt securities. Our restricted investments are
invested principally in certificates of deposit and
U.S. treasury securities.
All of our investments are classified as current assets, except
for our investments in auction rate securities, which are
classified as non-current assets. The average annualized
portfolio yields for the years ended December 31, 2009,
2008, and 2007 were approximately 1.2%, 3.0%, and 5.2%,
respectively.
48
Investments and restricted investments are subject to interest
rate risk and will decrease in value if market rates increase.
We have the ability to hold our restricted investments until
maturity and, as a result, we would not expect the value of
these investments to decline significantly due to a sudden
change in market interest rates. Declines in interest rates over
time will reduce our investment income.
Cash in excess of the capital needs of our regulated health
plans is generally paid to our non-regulated parent company in
the form of dividends, when and as permitted by applicable
regulations, for general corporate use.
Cash provided by operating activities for the year ended
December 31, 2009, was $155 million compared with
$40 million for 2008, an increase of $115 million.
Significant components of cash provided by operating activities
during 2009 included the following items:
|
|
|
|
|
Net income, which decreased $29 million between 2008 and
2009.
|
|
|
|
Deferred revenue, which contributed $114 million to the
increase in cash provided by operating activities between 2008
and 2009. Deferred revenue increased substantially at the Ohio
health plan between the years ended 2008 and 2009.
|
|
|
|
Medical claims and benefits payable, which contributed
$43 million to the increase in cash provided by operating
activities between 2008 and 2009.
|
Cash used in investing activities was $37.7 million for the
year ended December 31, 2009, compared with
$64.5 million for 2008.
Cash used in financing activities totaled $35.3 million for
the year ended December 31, 2009, compared with
$47.8 million for 2008. The primary use of cash in both
2009 and 2008 was under our securities purchase programs, where
we purchased $27.7 million and $49.9 million of our
common stock in 2009, and 2008, respectively. In 2009, we
additionally purchased, as described further below, convertible
senior notes totaling $9.7 million ($9.8 million with
accrued interest).
EBITDA(1)
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Operating income
|
|
$
|
57,393
|
|
|
$
|
112,605
|
|
Add back:
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
38,110
|
|
|
|
33,688
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
95,503
|
|
|
$
|
146,293
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
We calculate EBITDA by adding back depreciation and amortization
expense to operating income. Operating income included interest
income of $8.0 million and $21.1 million for the years
ended December 31, 2009, and 2008, respectively. EBITDA is
not prepared in conformity with GAAP since it excludes
depreciation and amortization expense, as well as interest
expense, and the provision for income taxes. This non-GAAP
financial measure should not be considered as an alternative to
net income, operating income, operating margin, or cash provided
by operating activities. Management uses EBITDA as a
supplemental metric in evaluating our financial performance, in
evaluating financing and business development decisions, and in
forecasting and analyzing future periods. For these reasons,
management believes that EBITDA is a useful supplemental measure
to investors in evaluating our performance and the performance
of other companies in our industry. |
Securities Purchase Program. Under the
$25 million securities purchase program announced in
January 2009, we purchased and retired $13.0 million face
amount of our convertible senior notes during the first quarter
of 2009. We purchased the notes at an average price of $74.25
per $100 principal amount, for a total of $9.8 million,
including accrued interest. The gain recognized during the
quarter on the purchase of the notes was $1.5 million, or
approximately $0.04 per diluted share. Also during the first
quarter of 2009, we purchased approximately 808,000 shares
of our common stock for $15 million (average cost of
approximately $18.53 per share).
In March 2009, our board of directors authorized the purchase of
up to an additional $25 million in aggregate of either our
common stock or our convertible senior notes. The purchase
program was funded with working capital.
49
Under the purchase program, we purchased approximately
544,000 shares of common stock for $12.7 million
(average cost of approximately $23.41 per share) in the second
quarter of 2009. We did not purchase any shares in the third or
fourth quarters of 2009. This purchase program terminated
December 31, 2009.
Capital
Resources
At December 31, 2009, the parent company Molina
Healthcare, Inc. held cash and investments of
approximately $45.6 million, including $16.5 million
in non-current auction rate securities, compared with
$68.9 million of cash and investments at December 31,
2008. On a consolidated basis, at December 31, 2009, we had
working capital of $321.2 million compared with
$345.2 million at December 31, 2008. At
December 31, 2009 and December 31, 2008, cash and cash
equivalents were $469.5 million and $387.2 million,
respectively. At December 31, 2009, investments were
$234.5 million, including $59.7 million in non-current
auction rate securities, and at December 31, 2008,
investments were $248.0 million, including
$58.2 million in non-current auction rate securities.
We intend to use a draw on our credit facility, which currently
has no outstanding balance, to fund all or a substantial portion
of the $135 million purchase price of the HIM business.
Subject to the following discussion regarding our Credit
Facility and its use to acquire the HIM business of Unisys
Corporation, we believe that our cash resources and internally
generated funds will be sufficient to support our operations,
regulatory requirements, and capital expenditures for at least
the next 12 months.
Credit
Facility
In 2005, we entered into an Amended and Restated Credit
Agreement, dated as of March 9, 2005, among Molina
Healthcare Inc., certain lenders, and Bank of America N.A., as
Administrative Agent (the Credit Facility).
Effective May 2008, we entered into a third amendment of the
Credit Facility that increased the size of the revolving line of
credit from $180.0 million to $200.0 million, maturing
in May 2012. The Credit Facility is intended to be used for
general corporate purposes.
Pending the closing of the acquisition of the HIM business
as discussed below, interest rates on borrowings under the
Credit Facility are based, at our election, on the London
Interbank Offered Rate, or LIBOR, or the base rate plus an
applicable margin. The base rate equals the higher of Bank of
Americas prime rate or 0.500% above the federal funds
rate. We also pay a commitment fee on the total unused
commitments of the lenders under the Credit Facility. The
applicable margins and commitment fee are based on our ratio of
consolidated funded debt to consolidated earnings before
interest expense, taxes, depreciation and amortization, or
EBITDA. The applicable margins range between 0.750% and 1.750%
for LIBOR loans and between 0.000% and 0.750% for base rate
loans. The commitment fee ranges between 0.150% and 0.275%. In
addition, we are required to pay a fee for each letter of credit
issued under the Credit Facility equal to the applicable margin
for LIBOR loans and a customary fronting fee. As of
December 31, 2009, there were no borrowings outstanding
under the Credit Facility.
Our obligations under the Credit Facility are secured by a lien
on substantially all of our assets and by a pledge of the
capital stock of our health plan subsidiaries (with the
exception of the California health plan). The Credit Facility
includes usual and customary covenants for credit facilities of
this type, including covenants limiting liens, mergers, asset
sales, other fundamental changes, debt, acquisitions, dividends
and other distributions, capital expenditures, investments, and
a fixed charge coverage ratio. The Credit Facility also requires
us to maintain a ratio of total consolidated debt to total
consolidated EBITDA of not more than 2.75 to 1.00 at any time.
At December 31, 2009, we were in compliance with all
financial covenants in the Credit Facility.
Subject to the closing of the HIM acquisition as described above
under the heading, Acquisitions, in November 2009 we
agreed to enter into a fourth amendment to the Credit Facility.
The fourth amendment will become effective upon the closing of
the acquisition of the HIM business. The fourth amendment is
required because the $135 million purchase price for the
HIM business exceeds the currently applicable deal size
threshold under the terms of the Credit Facility. Pursuant to
the fourth amendment, the lenders have consented to our
acquisition of the HIM business.
Upon its effectiveness at the closing, the fourth amendment
would increase the commitment fee on the total unused
commitments of the lenders under the facility to 50 basis
points on all levels of the pricing grid, with the pricing grid
referring to our ratio of consolidated funded debt to
consolidated EBITDA. The pricing for LIBOR
50
loans and base rate loans would be raised by 200 basis
points at every level of the pricing grid. The applicable
margins would thus range between 2.75% and 3.75% for LIBOR
loans, and between 1.75% and 2.75% for base rate loans. Until
the delivery of a compliance certificate with respect to our
financial statements for the quarter ending after the HIM
business acquisition closes, the applicable margin shall be
fixed at 3.5% for LIBOR loans and 2.5% for base rate loans. In
connection with the lenders approval of the fourth
amendment, a consent fee of 10 basis points was paid on the
amount of each consenting lenders commitment. In addition,
the fourth amendment would carve out from our indebtedness and
restricted payment covenants under the Credit Facility the
$187.0 million current principal amount of the Notes
(although the $187.0 million indebtedness would still be
included in the calculation of our consolidated leverage ratio);
increase the amount of surety bond obligations we may incur;
increase our allowable capital expenditures; and reduce the
fixed charge coverage ratio from 3.50x to 2.75x (on a pro forma
basis) at December 31, 2009, and 3.00x thereafter.
On March 15, 2010, we agreed to enter into a fifth
amendment to the Credit Facility. The fifth amendment will also
become effective upon the closing of the acquisition of the HIM
business. The fifth amendment is required because, after giving
effect to the acquisition of the HIM business on a pro forma
basis, and inclusive of the Companys fourth quarter 2009
EBITDA of only $5.9 million, the Companys
consolidated leverage ratio for the preceding four fiscal
quarters would exceed the currently applicable ratio of 2.75 to
1.0. The fifth amendment will increase the maximum consolidated
leverage ratio under the Credit Facility to 3.25 to 1.0 for the
fourth quarter of 2009 (on a pro forma basis), and to 3.50 to
1.0 for the first, second, and third quarters of 2010, excluding
the single date of September 30, 2010. On
September 30, 2010, the maximum consolidated leverage ratio
shall revert back to 2.75 to 1.0. However, if the Company has
actually reduced its consolidated leverage ratio to no more than
2.75 to 1.0 on or before August 15, 2010, the consolidated
leverage ratio under the Credit Facility will revert back to
2.75 to 1.0 on August 15, 2010. On the date that the
consolidated leverage ratio reverts to 2.75 to 1.0
whether August 15, 2010 or September 30,
2010 the aggregate commitments of the lenders under
the Credit Facility shall be reduced on a pro rata basis from
$200 million to $150 million. In connection with the
lenders approval of the fifth amendment, we will pay an
amendment fee of 25 basis points on the amount of each
consenting lenders commitment. We will also pay an
incremental commitment fee of 12.5 basis points based on
each lenders unfunded commitment during the period from
the effective date of the fifth amendment through the date that
the maximum consolidated leverage ratio is reduced to 2.75 to
1.0, plus a potential duration fee of 50 basis points
payable on August 15, 2010 in the event that the
consolidated leverage ratio has not been reduced to 2.75 to 1.0
by August 15, 2010.
Shelf
Registration Statement
In December 2008, we filed a shelf registration statement on
Form S-3
with the SEC covering the issuance of up to $300 million of
our securities, including common stock, warrants, or debt
securities, and up to 250,000 shares of outstanding common
stock that may be sold from time to time by the Molina Siblings
Trust as a selling stockholder. We may publicly offer securities
from time to time at prices and terms to be determined at the
time of the offering.
Long-Term
Debt
Convertible
Senior Notes
In October 2007, we sold $200.0 million aggregate principal
amount of 3.75% Convertible Senior Notes due 2014 (the
Notes). The sale of the Notes resulted in net
proceeds totaling $193.4 million. During 2009, we purchased
and retired $13.0 million face amount of the Notes, for a
remaining aggregate principal amount of $187.0 million as
of December 31, 2009. The Notes rank equally in right of
payment with our existing and future senior indebtedness.
The Notes are convertible into cash and, under certain
circumstances, shares of our common stock. The initial
conversion rate is 21.3067 shares of our common stock per
$1,000 principal amount of the Notes. This represents an initial
conversion price of approximately $46.93 per share of our common
stock. In addition, if certain corporate transactions that
constitute a change of control occur prior to maturity, we will
increase the conversion rate in certain circumstances. Prior to
July 2014, holders may convert their Notes only under the
following circumstances:
|
|
|
|
|
During any fiscal quarter after our fiscal quarter ending
December 31, 2007, if the closing sale price per share of
our common stock, for each of at least 20 trading days during
the period of 30 consecutive trading
|
51
|
|
|
|
|
days ending on the last trading day of the previous fiscal
quarter, is greater than or equal to 120% of the conversion
price per share of our common stock;
|
|
|
|
|
|
During the five business day period immediately following any
five consecutive trading day period in which the trading price
per $1,000 principal amount of the Notes for each trading day of
such period was less than 98% of the product of the closing
price per share of our common stock on such day and the
conversion rate in effect on such day; or
|
|
|
|
Upon the occurrence of specified corporate transactions or other
specified events.
|
On or after July 1, 2014, holders may convert their Notes
at any time prior to the close of business on the scheduled
trading day immediately preceding the stated maturity date
regardless of whether any of the foregoing conditions is
satisfied.
We will deliver cash and shares of our common stock, if any,
upon conversion of each $1,000 principal amount of Notes, as
follows:
|
|
|
|
|
An amount in cash (the principal return) equal to
the sum of, for each of the 20 Volume-Weighted Average Price, or
VWAP, trading days during the conversion period, the lesser of
the daily conversion value for such VWAP trading day and $50
(representing 1/20th of $1,000); and
|
|
|
|
A number of shares based upon, for each of the 20 VWAP trading
days during the conversion period, any excess of the daily
conversion value above $50.
|
Regulatory
Capital and Dividend Restrictions
Our principal operations are conducted through our health plan
subsidiaries operating in California, Florida, Michigan,
Missouri, New Mexico, Ohio, Texas, Utah, and Washington. The
health plans are subject to state laws that, among other things,
require the maintenance of minimum levels of statutory capital,
as defined by each state, and may restrict the timing, payment,
and amount of dividends and other distributions that may be paid
to Molina Healthcare, Inc. as the sole stockholder of each of
our health plans. To the extent the subsidiaries must comply
with these regulations, they may not have the financial
flexibility to transfer funds to us. The net assets in these
subsidiaries, after intercompany eliminations, which may not be
transferable to us in the form of loans, advances, or cash
dividends totaled $368.7 million at December 31, 2009,
and $355.0 million at December 31, 2008.
The National Association of Insurance Commissioners, or NAIC,
adopted rules effective December 31, 1998, which, if
adopted by a particular state, set minimum capitalization
requirements for health plans and other insurance entities
bearing risk for health care coverage. The requirements take the
form of risk-based capital, or RBC, rules. These rules, which
vary slightly from state to state, have been adopted in
Michigan, Missouri, New Mexico, Ohio, Texas, Utah, and
Washington. California and Florida have not adopted RBC rules
and have not given notice of any intention to do so. The RBC
rules, if adopted by California and Florida, may increase the
minimum capital required by those states.
At December 31, 2009, our health plans had aggregate
statutory capital and surplus of approximately
$377.7 million, compared to the required minimum aggregate
statutory capital and surplus of approximately
$257.1 million. All of our health plans were in compliance
with the minimum capital requirements at December 31, 2009.
We have the ability and commitment to provide additional working
capital to each of our health plans when necessary to ensure
that capital and surplus continue to meet regulatory
requirements. Barring any change in regulatory requirements, we
believe that we will continue to be in compliance with these
requirements through 2010.
Critical
Accounting Policies
When we prepare our consolidated financial statements, we use
estimates and assumptions that may affect reported amounts and
disclosures. Actual results could differ from these estimates.
Principal areas requiring the use of estimates include those
areas listed below. The most significant of these estimates is
the determination of medical claims and benefits payable, which
is discussed in further detail below:
|
|
|
|
|
The determination of medical claims and benefits payable;
|
52
|
|
|
|
|
The determination of the amount of revenue to be recognized
under certain contracts that place revenue at risk dependent
upon either the achievement of certain quality or administrative
measurements, or the expenditure of certain percentages of
revenue on defined expenses;
|
|
|
|
The determination of allowances for uncollectible accounts;
|
|
|
|
The valuation of certain investments;
|
|
|
|
Settlements under risk or savings sharing programs;
|
|
|
|
The impairment of long-lived and intangible assets;
|
|
|
|
The determination of professional and general liability claims,
and reserves for potential absorption of claims unpaid by
insolvent providers;
|
|
|
|
The determination of reserves for the outcome of litigation;
|
|
|
|
The determination of valuation allowances for deferred tax
assets; and
|
|
|
|
The determination of unrecognized tax benefits.
|
Medical
Claims and Benefits Payable
The determination of our liability for claims and medical
benefits payable is particularly important to the determination
of our financial position and results of operations in any given
period. Such determination of our liability requires the
application of a significant degree of judgment by our
management. As a result, the determination of our liability for
claims and medical benefits is subject to an inherent degree of
uncertainty. Our medical care costs include amounts that have
been paid by us through the reporting date, as well as estimated
liabilities for medical care costs incurred but not paid by us
as of the reporting date. Such medical care cost liabilities
include, among other items, unpaid
fee-for-service
claims, capitation payments owed to providers, unpaid pharmacy
invoices, and various medically related administrative costs
that have been incurred but not paid. We use judgment to
determine the appropriate assumptions for determining the
required estimates.
The most important element in estimating our medical care costs
is our estimate for
fee-for-service
claims which have been incurred but not paid by us. These
fee-for-service
costs that have been incurred but have not been paid at the
reporting date are collectively referred to as medical costs
that are Incurred But Not Paid, or IBNP. Our IBNP
claims reserve, as reported in our balance sheet, represents our
best estimate of the total amount of claims we will ultimately
pay with respect to claims that we have incurred as of the
balance sheet date. We estimate our IBNP monthly using actuarial
methods based on a number of factors. Our estimated IBNP
liability represented $246.5 million of our total medical
claims and benefits payable of $316.5 million as of
December 31, 2009. Excluding amounts related to the run out
of our cost-plus Medicaid contract in Utah (which contract was
replaced with a prepaid capitation contract effective
September 1, 2009) and amounts that we anticipate
paying on behalf of a capitated provider in Ohio (which we will
subsequently withhold from that providers monthly
capitation payment), our IBNP liability at December 31,
2009 was $235.0 million.
The factors we consider when estimating our IBNP include,
without limitation, claims receipt and payment experience (and
variations in that experience), changes in membership, provider
billing practices, health care service utilization trends, cost
trends, product mix, seasonality, prior authorization of medical
services, benefit changes, known outbreaks of disease or
increased incidence of illness such as influenza, provider
contract changes, changes to Medicaid fee schedules, and the
incidence of high dollar or catastrophic claims. Our assessment
of these factors is then translated into an estimate of our IBNP
liability at the relevant measuring point through the
calculation of a base estimate of IBNP, a further reserve for
adverse claims development, and an estimate of the
administrative costs of settling all claims incurred through the
reporting date. The base estimate of IBNP is derived through
application of claims payment completion factors and trended
PMPM cost estimates.
For the fifth month of service prior to the reporting date and
earlier, we estimate our outstanding claims liability based on
actual claims paid, adjusted for estimated completion factors.
Completion factors seek to measure the cumulative percentage of
claims expense that will have been paid for a given month of
service as of the reporting date, based on historical payment
patterns.
The following table reflects the change in our estimate of
claims liability as of December 31, 2009 that would have
resulted had we changed our completion factors for the fifth
through the twelfth months preceding
53
December 31, 2009, by the percentages indicated. A
reduction in the completion factor results in an increase in
medical claims liabilities. Dollar amounts are in thousands.
|
|
|
|
|
(Decrease) Increase in
|
|
Increase (Decrease) in
|
Estimated
|
|
Medical Claims and
|
Completion Factors
|
|
Benefits Payable
|
|
(6)%
|
|
$
|
72,782
|
|
(4)%
|
|
|
48,521
|
|
(2)%
|
|
|
24,261
|
|
2%
|
|
|
(24,261
|
)
|
4%
|
|
|
(48,521
|
)
|
6%
|
|
|
(72,782
|
)
|
For the four months of service immediately prior to the
reporting date, actual claims paid are not a reliable measure of
our ultimate liability, given the delay between the
patient/physician encounter and the actual submission of a claim
for payment. For these months of service, we estimate our claims
liability based on trended PMPM cost estimates. These estimates
are designed to reflect recent trends in payments and expense,
utilization patterns, authorized services, and other relevant
factors. The following table reflects the change in our estimate
of claims liability as of December 31, 2009 that would have
resulted had we altered our trend factors by the percentages
indicated. An increase in the PMPM costs results in an increase
in medical claims liabilities. Dollar amounts are in thousands.
|
|
|
|
|
(Decrease) Increase in
|
|
(Decrease) Increase in
|
Trended Per Member Per Month
|
|
Medical Claims and
|
Cost Estimates
|
|
Benefits Payable
|
|
(6)%
|
|
$
|
(41,722
|
)
|
(4)%
|
|
|
(27,815
|
)
|
(2)%
|
|
|
(13,907
|
)
|
2%
|
|
|
13,907
|
|
4%
|
|
|
27,815
|
|
6%
|
|
|
41,722
|
|
The following per-share amounts are based on a combined federal
and state statutory tax rate of 38%, and 26 million diluted
shares outstanding for the year ended December 31, 2009.
Assuming a hypothetical 1% change in completion factors from
those used in our calculation of IBNP at December 31, 2009,
net income for the year ended December 31, 2009 would
increase or decrease by approximately $7.5 million, or
$0.29 per diluted share. Assuming a hypothetical 1% change in
PMPM cost estimates from those used in our calculation of IBNP
at December 31, 2009, net income for the year ended
December 31, 2009 would increase or decrease by
approximately $4.3 million, or $0.17 per diluted share. The
corresponding figures for a 5% change in completion factors and
PMPM cost estimates would be $37.6 million, or $1.45 per
diluted share, net of tax, and $21.6 million, or $0.83 per
diluted share, respectively.
It is important to note that any change in the estimate of
either completion factors or trended PMPM costs would usually be
accompanied by a change in the estimate of the other component,
and that a change in one component would almost always compound
rather than offset the resulting distortion to net income. When
completion factors are overestimated, trended PMPM costs
tend to be underestimated. Both circumstances will create
an overstatement of net income. Likewise, when completion
factors are underestimated, trended PMPM costs tend to be
overestimated, creating an understatement of net income.
In other words, errors in estimates involving both completion
factors and trended PMPM costs will usually act to drive
estimates of claims liabilities and medical care costs in the
same direction. For example, if completion factors were
overestimated by 1%, resulting in an overstatement of net income
by approximately $7.5 million, it is likely that trended
PMPM costs would be underestimated, resulting in an additional
overstatement of net income.
After we have established our base IBNP reserve through the
application of completion factors and trended PMPM cost
estimates, we then compute an additional liability, also using
actuarial techniques, to account for adverse developments in our
claims payments which the base actuarial model is not intended
to and does not account for. We refer to this additional
liability as the provision for adverse claims development. The
provision for adverse claims
54
development is a component of our overall determination of the
adequacy of our IBNP. It is intended to capture the potential
inadequacy of our IBNP estimate as a result of our inability to
adequately assess the impact of factors such as changes in the
speed of claims receipt and payment, the relative magnitude or
severity of claims, known outbreaks of disease such as
influenza, our entry into new geographical markets, our
provision of services to new populations such as the aged, blind
or disabled (ABD), changes to state-controlled fee schedules
upon which much of our provider payments are based,
modifications and upgrades to our claims processing systems and
practices, and increasing medical costs. Because of the
complexity of our business, the number of states in which we
operate, and the need to account for different health care
benefit packages among those states, we make an overall
assessment of IBNP after considering the base actuarial model
reserves and the provision for adverse claims development. We
also include in our IBNP liability an estimate of the
administrative costs of settling all claims incurred through the
reporting date. The development of IBNP is a continuous process
which we monitor and refine on a monthly basis as additional
claims payment information becomes available. As additional
information becomes known to us, we adjust our actuarial model
accordingly to establish IBNP.
On a monthly basis, we review and update our estimated IBNP
liability and the methods used to determine that liability. Any
adjustments are reflected in the period known. While we believe
our current estimates are adequate, we have in the past been
required to increase significantly our claims reserves for
periods previously reported, and may be required to do so again
in the future. Any significant increases to prior period claims
reserves would materially decrease reported earnings for the
period in which the adjustment is made.
In our judgment, the estimates for completion factors will
likely prove to be more accurate than trended PMPM cost
estimates because estimated completion factors are subject to
fewer variables in their determination. Completion factors are
developed over long periods of time, and are most likely to be
affected by changes in claims receipt and payment experience and
by provider billing practices. Trended PMPM cost estimates,
while affected by the same factors, will also be influenced by
health care service utilization trends, cost trends, product
mix, seasonality, prior authorization of medical services,
benefit changes, outbreaks of disease or increased incidence of
illness, provider contract changes, changes to Medicaid fee
schedules, and the incidence of high dollar or catastrophic
claims. As discussed above, however, errors in estimates
involving trended PMPM costs will almost always be accompanied
by errors in estimates involving completion factors, and vice
versa. In such circumstances, errors in estimation involving
both completion factors and trended PMPM costs will act to drive
estimates of claims liabilities (and therefore medical care
costs) in the same direction.
Assuming that base reserves have been accurately estimated, we
would expect that amounts ultimately paid would be between 8%
and 10% less than the liability recorded at the end of the
period as a result of the inclusion in that liability of the
allowance for adverse claims development and the accrued cost of
settling those claims. However, there can be no assurance that
amounts ultimately paid out will not be higher or lower than
this 8% to 10% range, as shown by our results in 2009 and 2008
when the amounts ultimately paid out were less than the amount
of the reserves we had established as of the beginning of those
years by approximately 18% and 20%, respectively.
As shown in greater detail in the table below, the amounts
ultimately paid out on our liabilities in fiscal years 2009 and
2008 were less than what we had expected when we had established
our reserves. While the specific reasons for the overestimation
of our liabilities were different in each of the two years, in
general the overestimations were tied to our assessment of
specific circumstances at our individual health plans which were
unique to those reporting periods.
For the year ended December 31, 2009, we recognized a
benefit from prior period claims development in the amount of
$51.6 million (see table below). This was primarily caused
by the overestimation of our liability for claims and medical
benefits payable at December 31, 2008. The overestimation
of claims liability at December 31, 2008 was the result of
the following factors:
|
|
|
|
|
In Michigan, we underestimated the impact of a steep drop in
claims inventory during December 2008, thereby overestimating
our liability at December 31, 2008.
|
|
|
|
In New Mexico, we overestimated the ultimate amounts we would
need to pay to resolve certain high dollar provider claims,
thereby overestimating our liability at December 31, 2008.
|
|
|
|
In Ohio, we underestimated the degree to which certain
operational initiatives had reduced our medical costs in the
last few months of 2008, thereby overestimating our liability at
December 31, 2008.
|
55
|
|
|
|
|
In Washington, we overestimated the impact that certain adverse
utilization trends would have on our liability at
December 31, 2008, thereby overestimating our liability at
December 31, 2008.
|
|
|
|
In California, we underestimated utilization trends at the end
of 2008, leading to an underestimation of our liability at
December 31, 2008. Additionally, we underestimated the
impact that certain delays in the receipt of paper claims (as
opposed to electronically submitted claims) would have on our
liability, leading to a further underestimation of our liability
at December 31, 2008.
|
For the year ended December 31, 2008, we recognized a
benefit from prior period claims development in the amount of
$62.1 million (see table below). This was primarily caused
by the overestimation of our liability for claims and medical
benefits payable at December 31, 2007. The overestimation
of claims liability at December 31, 2007 was the result of
the following factors:
|
|
|
|
|
In Michigan, we had overestimated the extent to which both
catastrophic claims and state-mandated changes to the
methodology used to pay outpatient claims had increased our
liability at December 31, 2007.
|
|
|
|
In Washington, we had overestimated the extent to which
state-mandated changes to hospital fee schedules implemented in
August 2007 had increased our liability at December 31,
2007.
|
In estimating our claims liability at December 31, 2009, we
adjusted our base calculation to take account of the following
factors which we believe are reasonably likely to change our
final claims liability amount:
|
|
|
|
|
The rapid growth of membership across nearly all of our health
plans in fiscal year 2009, particularly the growth in membership
at our Florida health plan and the growth in ABD membership
during the fourth quarter of 2009 at our Ohio health plan.
|
|
|
|
A decrease in claims inventory at our California, Ohio, and Utah
health plans through the fourth quarter of 2009.
|
|
|
|
The impact of the 2009 H1N1 flu through the fourth quarter of
2009.
|
|
|
|
The degree of change in the utilization of medical services and
the cost per unit of those services during 2009.
|
|
|
|
The impact of reductions to the state Medicaid fee schedules in
Washington and Michigan effective July 1, 2009, and in New
Mexico effective December 1, 2009.
|
|
|
|
Potential provider settlements across all states, particularly
in Missouri, New Mexico, Ohio, and Washington.
|
The use of a consistent methodology in estimating our liability
for claims and medical benefits payable minimizes the degree to
which the under- or overestimation of that liability at the
close of one period may affect consolidated results of
operations in subsequent periods. Facts and circumstances unique
to the estimation process at any single date, however, may still
lead to a material impact on consolidated results of operations
in subsequent periods. Any absence of adverse claims development
(as well as the expensing through general and administrative
expense of the costs to settle claims held at the start of the
period) will lead to the recognition of a benefit from prior
period claims development in the period subsequent to the date
of the original estimate. However, that benefit will affect
current period earnings only to the extent that the
replenishment of the reserve for adverse claims development (and
the re-accrual of administrative costs for the settlement of
those claims) is less than the benefit recognized from the prior
period liability. In 2009 and 2008 the absence of adverse
development of the liability for claims and medical benefits
payable at the close of the previous period resulted in the
recognition of substantial favorable prior period development.
In both years, however, the recognition of a benefit from prior
period claims development did not have a material impact on our
consolidated results of operations because the amount of benefit
recognized in each year was roughly consistent with that
recognized in the previous year.
We seek to maintain a consistent claims reserving methodology
across all periods. Accordingly, any prior period benefit from
an un-utilized reserve for adverse claims development may be
offset by the establishment of a new reserve in an approximately
equal amount (relative to premium revenue, medical care costs,
and medical claims and benefits payable) in the current period,
and thus the impact on earnings for the current period may be
minimal.
56
The following table presents the components of the change in our
medical claims and benefits payable for the years ended
December 31, 2009 and 2008. The negative amounts displayed
for components of medical care costs related to prior
years represent the amount by which our original
estimate of claims and benefits payable at the beginning of the
period exceeded the actual amount of the liability based on
information (principally the payment of claims) developed since
that liability was first reported.
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(Dollars in thousands, except
|
|
|
|
per-member amounts)
|
|
|
Balances at beginning of period
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
Components of medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
3,227,794
|
|
|
|
2,683,399
|
|
Prior years
|
|
|
(51,558
|
)
|
|
|
(62,087
|
)
|
|
|
|
|
|
|
|
|
|
Total medical care costs
|
|
|
3,176,236
|
|
|
|
2,621,312
|
|
|
|
|
|
|
|
|
|
|
Payments for medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
2,919,240
|
|
|
|
2,413,128
|
|
Prior years
|
|
|
232,922
|
|
|
|
227,348
|
|
|
|
|
|
|
|
|
|
|
Total paid
|
|
|
3,152,162
|
|
|
|
2,640,476
|
|
|
|
|
|
|
|
|
|
|
Balances at end of period
|
|
$
|
316,516
|
|
|
$
|
292,442
|
|
|
|
|
|
|
|
|
|
|
Benefit from prior period as a percentage of:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
|
17.6
|
%
|
|
|
19.9
|
%
|
Premium revenue
|
|
|
1.4
|
%
|
|
|
2.0
|
%
|
Total medical care costs
|
|
|
1.6
|
%
|
|
|
2.4
|
%
|
Days in claims payable
|
|
|
37
|
|
|
|
41
|
|
Number of members at end of period
|
|
|
1,455,000
|
|
|
|
1,256,000
|
|
Fee-for-service
claims processing and inventory information:
|
|
|
|
|
|
|
|
|
Number of claims in inventory at end of period
|
|
|
93,100
|
|
|
|
87,300
|
|
Billed charges of claims in inventory at end of period
|
|
$
|
131,400
|
|
|
$
|
115,400
|
|
Claims in inventory per member at end of period
|
|
|
0.06
|
|
|
|
0.07
|
|
Billed charges of claims in inventory per member at end of period
|
|
$
|
90.31
|
|
|
$
|
91.88
|
|
Number of claims received during the period
|
|
|
12,930,100
|
|
|
|
11,095,100
|
|
Billed charges of claims received during the period
|
|
$
|
9,769,000
|
|
|
$
|
7,794,900
|
|
Commitments
and Contingencies
We lease office space and equipment under various operating
leases. As of December 31, 2009, our lease obligations for
the next five years and thereafter were as follows:
$21.3 million in 2010, $20.8 million in 2011,
$18.6 million in 2012, $15.2 million in 2013,
$13.5 million in 2014, and an aggregate of
$39.6 million thereafter.
We are not an obligor to or guarantor of any indebtedness of any
other party. We are not a party to off-balance sheet financing
arrangements except for operating leases which are disclosed in
Note 18 to the accompanying audited consolidated financial
statements for the year ended December 31, 2009.
Contractual
Obligations
In the table below, we present our contractual obligations as of
December 31, 2009. Some of the amounts we have included in
this table are based on managements estimates and
assumptions about these obligations, including their duration,
the possibility of renewal, anticipated actions by third
parties, and other factors. Because these estimates and
assumptions are necessarily subjective, the contractual
obligations we will actually pay in future periods may vary from
those reflected in the table. Amounts are in thousands.
57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2010
|
|
|
2011-2012
|
|
|
2013-2014
|
|
|
2015 and Beyond
|
|
|
Medical claims and benefits payable
|
|
$
|
316,516
|
|
|
$
|
316,516
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Long-term debt(1)
|
|
|
187,000
|
|
|
|
|
|
|
|
|
|
|
|
187,000
|
|
|
|
|
|
Operating leases
|
|
|
128,980
|
|
|
|
21,334
|
|
|
|
39,365
|
|
|
|
28,705
|
|
|
|
39,576
|
|
Interest on long-term debt(1)
|
|
|
33,309
|
|
|
|
7,012
|
|
|
|
14,025
|
|
|
|
12,272
|
|
|
|
|
|
Purchase commitments
|
|
|
23,472
|
|
|
|
8,201
|
|
|
|
11,955
|
|
|
|
3,316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual obligations
|
|
$
|
689,277
|
|
|
$
|
353,063
|
|
|
$
|
65,345
|
|
|
$
|
231,293
|
|
|
$
|
39,576
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts relate to our 3.75% Convertible Senior Notes due
2014. |
As of December 31, 2009, we have recorded approximately
$4.1 million of unrecognized tax benefits. The above table
does not contain this amount because we cannot reasonably
estimate when or if such amount may be settled. See Note 13
to the accompanying audited consolidated financial statements
for the year ended December 31, 2009 for further
information.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
Quantitative
and Qualitative Disclosures About Market Risk
Financial instruments that potentially subject us to
concentrations of credit risk consist primarily of cash and cash
equivalents, investments, receivables, and restricted
investments. We invest a substantial portion of our cash in the
PFM Fund Prime Series Institutional Class, and
the PFM Fund Government Series. These funds represent a
portfolio of highly liquid money market securities that are
managed by PFM Asset Management LLC (PFM), a Virginia business
trust registered as an open-end management investment fund. Our
investments and a portion of our cash equivalents are managed by
professional portfolio managers operating under documented
investment guidelines. No investment that is in a loss position
can be sold by our managers without our prior approval. Our
investments consist solely of investment grade debt securities
with a maximum maturity of ten years and an average duration of
four years. Restricted investments are invested principally in
certificates of deposit and U.S. treasury securities.
Concentration of credit risk with respect to accounts receivable
is limited due to payors consisting principally of the
governments of each state in which our health plan subsidiaries
operate.
Inflation
Although the general rate of inflation has remained relatively
stable and health care cost inflation has stabilized in recent
years, the national health care cost inflation rate still
exceeds the general inflation rate. We use various strategies to
mitigate the negative effects of health care cost inflation.
Specifically, our health plans try to control medical and
hospital costs through contracts with independent providers of
health care services. Through these contracted providers, our
health plans emphasize preventive health care and appropriate
use of specialty and hospital services. While we currently
believe our strategies will mitigate health care cost inflation,
competitive pressures, new health care and pharmaceutical
product introductions, demands from health care providers and
customers, applicable regulations, or other factors may affect
our ability to control health care costs.
58
MOLINA
HEALTHCARE, INC.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
INDEX TO
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
MOLINA HEALTHCARE INC.
|
|
|
|
|
|
|
|
60
|
|
|
|
|
61
|
|
|
|
|
62
|
|
|
|
|
63
|
|
|
|
|
64
|
|
|
|
|
66
|
|
59
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
of Molina Healthcare, Inc.
We have audited the accompanying consolidated balance sheets of
Molina Healthcare, Inc. (the Company) as of December 31,
2009 and 2008, and the related consolidated statements of
income, stockholders equity and cash flows for each of the
three years in the period ended December 31, 2009. These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of Molina Healthcare, Inc. at
December 31, 2009 and 2008, and the consolidated results of
its operations and its cash flows for each of the three years in
the period ended December 31, 2009, in conformity with
U.S. generally accepted accounting principles.
As discussed in Note 1 to the consolidated financial
statements, during 2009 the Company changed its method of
accounting for convertible debt instruments.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States),
Molina Healthcare, Inc.s internal control over financial
reporting as of December 31, 2009, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated
March 16, 2010 expressed an unqualified opinion thereon.
Los Angeles, California
March 16, 2010
60
MOLINA
HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
|
(Amounts in thousands,
|
|
|
|
except per-share data)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
469,501
|
|
|
$
|
387,162
|
|
Investments
|
|
|
174,844
|
|
|
|
189,870
|
|
Receivables
|
|
|
136,654
|
|
|
|
128,562
|
|
Income tax refundable
|
|
|
6,067
|
|
|
|
4,019
|
|
Deferred income taxes
|
|
|
8,757
|
|
|
|
9,071
|
|
Prepaid expenses and other current assets
|
|
|
15,583
|
|
|
|
14,766
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
811,406
|
|
|
|
733,450
|
|
Property and equipment, net
|
|
|
78,171
|
|
|
|
65,058
|
|
Intangible assets, net
|
|
|
80,846
|
|
|
|
79,133
|
|
Goodwill and indefinite-lived intangible assets
|
|
|
133,408
|
|
|
|
113,466
|
|
Investments
|
|
|
59,687
|
|
|
|
58,169
|
|
Restricted investments
|
|
|
36,274
|
|
|
|
38,202
|
|
Receivable for ceded life and annuity contracts
|
|
|
25,455
|
|
|
|
27,367
|
|
Other assets
|
|
|
19,988
|
|
|
|
33,223
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,245,235
|
|
|
$
|
1,148,068
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Medical claims and benefits payable
|
|
$
|
316,516
|
|
|
$
|
292,442
|
|
Accounts payable and accrued liabilities
|
|
|
71,732
|
|
|
|
81,981
|
|
Deferred revenue
|
|
|
101,985
|
|
|
|
13,804
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
490,233
|
|
|
|
388,227
|
|
Long-term debt
|
|
|
158,900
|
|
|
|
164,873
|
|
Liability for ceded life and annuity contracts
|
|
|
25,455
|
|
|
|
27,367
|
|
Deferred income taxes
|
|
|
12,506
|
|
|
|
12,911
|
|
Other long-term liabilities
|
|
|
15,403
|
|
|
|
22,928
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
702,497
|
|
|
|
616,306
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; 80,000 shares
authorized; outstanding: 25,607 shares at December 31,
2009 and 26,725 shares at December 31, 2008
|
|
|
26
|
|
|
|
27
|
|
Preferred stock, $0.001 par value; 20,000 shares
authorized, no shares issued and outstanding
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
129,902
|
|
|
|
170,681
|
|
Accumulated other comprehensive loss
|
|
|
(1,812
|
)
|
|
|
(2,310
|
)
|
Retained earnings
|
|
|
414,622
|
|
|
|
383,754
|
|
Treasury stock, at cost; 1,201 shares at December 31,
2008
|
|
|
|
|
|
|
(20,390
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
542,738
|
|
|
|
531,762
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,245,235
|
|
|
$
|
1,148,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys consolidated financial position as of
December 31, 2008, has been recast to reflect the adoption
of FASB Accounting Standards Codification (ASC) Subtopic
470-20,
Debt with Conversion and Other Options (see Note 1). |
See accompanying notes.
61
MOLINA
HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1)
|
|
|
|
(In thousands, except per share data)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue
|
|
$
|
3,660,207
|
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
Investment income
|
|
|
9,149
|
|
|
|
21,126
|
|
|
|
30,085
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
3,669,356
|
|
|
|
3,112,366
|
|
|
|
2,492,454
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
3,176,236
|
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
General and administrative expenses
|
|
|
399,149
|
|
|
|
344,761
|
|
|
|
285,295
|
|
Depreciation and amortization
|
|
|
38,110
|
|
|
|
33,688
|
|
|
|
27,967
|
|
Impairment charge on purchased software
|
|
|
|
|
|
|
|
|
|
|
782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
3,613,495
|
|
|
|
2,999,761
|
|
|
|
2,394,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on purchase of convertible senior notes
|
|
|
1,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
57,393
|
|
|
|
112,605
|
|
|
|
98,327
|
|
Interest expense
|
|
|
(13,777
|
)
|
|
|
(13,231
|
)
|
|
|
(5,605
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
43,616
|
|
|
|
99,374
|
|
|
|
92,722
|
|
Provision for income taxes
|
|
|
12,748
|
|
|
|
39,776
|
|
|
|
34,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
30,868
|
|
|
$
|
59,598
|
|
|
$
|
57,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.19
|
|
|
$
|
2.15
|
|
|
$
|
2.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted(2)
|
|
$
|
1.19
|
|
|
$
|
2.15
|
|
|
$
|
2.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
25,843
|
|
|
|
27,676
|
|
|
|
28,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted(2)
|
|
|
25,984
|
|
|
|
27,772
|
|
|
|
28,419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys consolidated statements of income for the
years ended December 31, 2008 and 2007 have been recast to
reflect the adoption of FASB ASC Subtopic
470-20,
Debt with Conversion and Other Options
(see Note 1). |
|
(2) |
|
Potentially dilutive shares issuable pursuant to the
Companys 2007 offering of convertible senior notes were
not included in the computation of diluted net income per share
because to do so would have been anti-dilutive for the years
ended December 31, 2009, 2008, and 2007. |
See accompanying notes.
62
MOLINA
HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
Comprehensive
|
|
|
Retained
|
|
|
Treasury
|
|
|
|
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Capital
|
|
|
Income (Loss)
|
|
|
Earnings
|
|
|
Stock
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Balance at January 1, 2007
|
|
|
28,119
|
|
|
$
|
28
|
|
|
$
|
173,990
|
|
|
$
|
(337
|
)
|
|
$
|
266,875
|
|
|
$
|
(20,390
|
)
|
|
$
|
420,166
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57,726
|
|
|
|
|
|
|
|
57,726
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
57,726
|
|
|
|
|
|
|
|
58,335
|
|
Adjustment to adopt ASC Subtopic
470-20(1)
|
|
|
|
|
|
|
|
|
|
|
24,502
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,502
|
|
Adjustment to adopt ASC Subtopic
740-10
Accounting for Uncertainty in Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
(445
|
)
|
Stock options exercised, employee stock grants and employee
stock plan purchases
|
|
|
325
|
|
|
|
|
|
|
|
10,965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,965
|
|
Tax benefit from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
28,444
|
|
|
|
28
|
|
|
|
210,310
|
|
|
|
272
|
|
|
|
324,156
|
|
|
|
(20,390
|
)
|
|
|
514,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,598
|
|
|
|
|
|
|
|
59,598
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,025
|
)
|
|
|
|
|
|
|
|
|
|
|
(7,025
|
)
|
Other-than-temporary
impairment of
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,443
|
|
|
|
|
|
|
|
|
|
|
|
4,443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,582
|
)
|
|
|
59,598
|
|
|
|
|
|
|
|
57,016
|
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(49,940
|
)
|
|
|
(49,940
|
)
|
Retirement of treasury stock
|
|
|
(1,943
|
)
|
|
|
(1
|
)
|
|
|
(49,939
|
)
|
|
|
|
|
|
|
|
|
|
|
49,940
|
|
|
|
|
|
Stock issued in business purchase transaction
|
|
|
48
|
|
|
|
|
|
|
|
1,262
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,262
|
|
Stock options exercised, employee stock grants and employee
stock plan purchases
|
|
|
176
|
|
|
|
|
|
|
|
9,340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,340
|
|
Tax deficiency from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
(292
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(292
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
26,725
|
|
|
|
27
|
|
|
|
170,681
|
|
|
|
(2,310
|
)
|
|
|
383,754
|
|
|
|
(20,390
|
)
|
|
|
531,762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,868
|
|
|
|
|
|
|
|
30,868
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
498
|
|
|
|
|
|
|
|
|
|
|
|
498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
498
|
|
|
|
30,868
|
|
|
|
|
|
|
|
31,366
|
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27,712
|
)
|
|
|
(27,712
|
)
|
Retirement of treasury stock
|
|
|
(1,352
|
)
|
|
|
(1
|
)
|
|
|
(48,101
|
)
|
|
|
|
|
|
|
|
|
|
|
48,102
|
|
|
|
|
|
Retirement of convertible debt
|
|
|
|
|
|
|
|
|
|
|
(476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(476
|
)
|
Employee stock grants and employee stock plan purchases
|
|
|
234
|
|
|
|
|
|
|
|
8,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,516
|
|
Tax deficiency from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
(718
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(718
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
25,607
|
|
|
$
|
26
|
|
|
$
|
129,902
|
|
|
$
|
(1,812
|
)
|
|
$
|
414,622
|
|
|
$
|
|
|
|
$
|
542,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys consolidated statements of stockholders
equity for the years ended December 31, 2008 and 2007 have
been recast to reflect the adoption of FASB ASC Subtopic
470-20,
Debt with Conversion and Other Options (see Note 1). |
See accompanying notes.
63
MOLINA
HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1)
|
|
|
|
(In thousands)
|
|
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
30,868
|
|
|
$
|
59,598
|
|
|
$
|
57,726
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
38,110
|
|
|
|
33,688
|
|
|
|
27,967
|
|
Other-than-temporary
impairment on
available-for-sale
securities
|
|
|
|
|
|
|
7,166
|
|
|
|
|
|
Unrealized (gain) loss on trading securities
|
|
|
(3,394
|
)
|
|
|
399
|
|
|
|
|
|
Loss (gain) on rights agreement
|
|
|
3,100
|
|
|
|
(6,907
|
)
|
|
|
|
|
Deferred income taxes
|
|
|
(1
|
)
|
|
|
(3,404
|
)
|
|
|
(9,427
|
)
|
Stock-based compensation
|
|
|
7,485
|
|
|
|
7,811
|
|
|
|
7,188
|
|
Non-cash interest on convertible senior notes
|
|
|
4,782
|
|
|
|
4,707
|
|
|
|
1,012
|
|
Gain on purchase of convertible senior notes
|
|
|
(1,532
|
)
|
|
|
|
|
|
|
|
|
Amortization of deferred financing costs
|
|
|
1,872
|
|
|
|
1,435
|
|
|
|
1,004
|
|
Tax deficiency from employee stock compensation
|
|
|
(749
|
)
|
|
|
(335
|
)
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
|
|
|
|
142
|
|
|
|
|
|
Changes in operating assets and liabilities, net of effects of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(8,092
|
)
|
|
|
(17,025
|
)
|
|
|
15,007
|
|
Prepaid expenses and other current assets
|
|
|
(817
|
)
|
|
|
(2,245
|
)
|
|
|
(2,911
|
)
|
Medical claims and benefits payable
|
|
|
24,074
|
|
|
|
(19,164
|
)
|
|
|
6,683
|
|
Accounts payable and accrued liabilities
|
|
|
(26,467
|
)
|
|
|
10,830
|
|
|
|
18,700
|
|
Deferred revenue
|
|
|
88,181
|
|
|
|
(26,300
|
)
|
|
|
21,984
|
|
Income taxes
|
|
|
(2,049
|
)
|
|
|
(9,965
|
)
|
|
|
13,693
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
155,371
|
|
|
|
40,431
|
|
|
|
158,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of equipment
|
|
|
(35,870
|
)
|
|
|
(34,690
|
)
|
|
|
(22,299
|
)
|
Purchases of investments
|
|
|
(186,764
|
)
|
|
|
(263,229
|
)
|
|
|
(264,115
|
)
|
Sales and maturities of investments
|
|
|
204,365
|
|
|
|
246,524
|
|
|
|
103,718
|
|
Net cash paid in business purchase transactions
|
|
|
(11,294
|
)
|
|
|
(1,000
|
)
|
|
|
(70,172
|
)
|
Decrease (increase) in restricted investments
|
|
|
1,928
|
|
|
|
(9,183
|
)
|
|
|
(8,365
|
)
|
Increase in other assets
|
|
|
(2,553
|
)
|
|
|
(8,973
|
)
|
|
|
(4,330
|
)
|
(Decrease) increase in other long-term liabilities
|
|
|
(7,525
|
)
|
|
|
6,031
|
|
|
|
9,290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(37,713
|
)
|
|
|
(64,520
|
)
|
|
|
(256,273
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock purchases
|
|
|
(27,712
|
)
|
|
|
(49,940
|
)
|
|
|
|
|
Purchase and retirement of convertible senior notes
|
|
|
(9,653
|
)
|
|
|
|
|
|
|
|
|
Proceeds from issuance of convertible senior notes
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
Repayment of amounts borrowed under credit facility
|
|
|
|
|
|
|
|
|
|
|
(45,000
|
)
|
Payment of credit facility fees
|
|
|
|
|
|
|
|
|
|
|
(551
|
)
|
Payment of convertible senior notes fees
|
|
|
|
|
|
|
|
|
|
|
(6,498
|
)
|
Tax benefit from employee stock compensation
|
|
|
31
|
|
|
|
43
|
|
|
|
853
|
|
Proceeds from exercise of stock options and employee stock plan
purchases
|
|
|
2,015
|
|
|
|
2,084
|
|
|
|
4,257
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities
|
|
|
(35,319
|
)
|
|
|
(47,813
|
)
|
|
|
153,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
82,339
|
|
|
|
(71,902
|
)
|
|
|
55,414
|
|
Cash and cash equivalents at beginning of year
|
|
|
387,162
|
|
|
|
459,064
|
|
|
|
403,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
469,501
|
|
|
$
|
387,162
|
|
|
$
|
459,064
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64
MOLINA
HEALTHCARE, INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1)
|
|
|
|
(In thousands)
|
|
|
Supplemental cash flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
27,100
|
|
|
$
|
50,130
|
|
|
$
|
27,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
8,205
|
|
|
$
|
7,797
|
|
|
$
|
9,419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on investments
|
|
$
|
699
|
|
|
$
|
(3,956
|
)
|
|
$
|
977
|
|
Deferred income taxes
|
|
|
(201
|
)
|
|
|
1,374
|
|
|
|
(368
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gain (loss) on investments
|
|
$
|
498
|
|
|
$
|
(2,582
|
)
|
|
$
|
609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of common stock used for stock-based compensation
|
|
$
|
(984
|
)
|
|
$
|
(555
|
)
|
|
$
|
(480
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued purchases of equipment
|
|
$
|
935
|
|
|
$
|
65
|
|
|
$
|
672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of treasury stock
|
|
$
|
48,102
|
|
|
$
|
49,940
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of purchased software
|
|
$
|
|
|
|
$
|
|
|
|
$
|
782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative effect of adoption of FASB ASC Subtopic
740-10,
Accounting for Uncertainty in Income Taxes
|
|
$
|
|
|
|
$
|
|
|
|
$
|
445
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Details of business purchase transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of assets acquired
|
|
$
|
(34,594
|
)
|
|
$
|
(2,262
|
)
|
|
$
|
(106,233
|
)
|
Release of escrow and other deposits
|
|
|
18,000
|
|
|
|
|
|
|
|
|
|
Common stock issued to seller
|
|
|
|
|
|
|
1,262
|
|
|
|
|
|
Less cash acquired
|
|
|
|
|
|
|
|
|
|
|
10,843
|
|
Less payable to seller
|
|
|
5,300
|
|
|
|
|
|
|
|
|
|
Liabilities assumed
|
|
|
|
|
|
|
|
|
|
|
25,218
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash paid in business purchase transactions
|
|
$
|
(11,294
|
)
|
|
$
|
(1,000
|
)
|
|
$
|
(70,172
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business purchase transactions adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
|
|
|
$
|
1,265
|
|
|
$
|
|
|
Other long-term liabilities
|
|
|
|
|
|
|
2,368
|
|
|
|
|
|
Deferred taxes
|
|
|
|
|
|
|
(7,549
|
)
|
|
|
2,747
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill and intangible assets, net
|
|
$
|
|
|
|
$
|
(3,916
|
)
|
|
$
|
2,747
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Companys consolidated statements of cash flows for the
years ended December 31, 2008 and 2007 have been recast to
reflect the adoption of FASB ASC Subtopic
470-20,
Debt with Conversion and Other Options (see Note 1). |
See accompanying notes.
65
MOLINA
HEALTHCARE, INC.
Organization
and Operations
Molina Healthcare, Inc. is a multi-state managed care
organization that arranges for the delivery of health care
services to persons eligible for Medicaid, Medicare, and other
government-sponsored programs for low-income families and
individuals. We conduct our business primarily through licensed
health plans in the states of California, Florida, Michigan,
Missouri, New Mexico, Ohio, Texas, Utah, and Washington.
The health plans are locally operated by our respective wholly
owned subsidiaries in those states, each of which is licensed as
a health maintenance organization, or HMO. Effective
January 1, 2010 we terminated operations at our small
Medicare health plan in Nevada.
Our results of operations include the results of recent
acquisitions, including the acquisition of Florida NetPASS,
under which we began transitioning members in late December
2008. Additionally, we acquired Mercy CarePlus, a Medicaid
managed care organization based in St. Louis, Missouri,
effective November 1, 2007.
Consolidation
and Presentation
The consolidated financial statements include the accounts of
Molina Healthcare, Inc. and all majority-owned subsidiaries. All
significant intercompany transactions and balances have been
eliminated in consolidation. Financial information related to
subsidiaries acquired during any year is included only for the
period subsequent to their acquisition.
Evaluation
of Subsequent Events
We have evaluated subsequent events through the date of issuance
of our financial statements in this Annual Report on
Form 10-K.
Use of
Estimates
The preparation of consolidated financial statements in
conformity with accounting principles generally accepted in the
United States requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements. Estimates
also affect the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from these
estimates. Principal areas requiring the use of estimates
include:
|
|
|
|
|
The determination of medical claims and benefits payable;
|
|
|
|
The determination of the amount of revenue to be recognized
under certain contracts that place revenue at risk dependent
upon either the achievement of certain quality or administrative
measurements, or the expenditure of certain percentages of
revenue on defined expenses;
|
|
|
|
The determination of allowances for uncollectible accounts;
|
|
|
|
The valuation of certain investments;
|
|
|
|
Settlements under risk or savings sharing programs;
|
|
|
|
The impairment of long-lived and intangible assets;
|
|
|
|
The determination of professional and general liability claims,
and reserves for potential absorption of claims unpaid by
insolvent providers;
|
|
|
|
The determination of reserves for the outcome of litigation;
|
|
|
|
The determination of valuation allowances for deferred tax
assets; and
|
|
|
|
The determination of unrecognized tax benefits.
|
Reclassification
We have reclassified certain prior year balance sheet amounts to
conform to the 2009 presentation.
66
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Recast
of Prior Periods
In May 2008, the FASB issued a new standard relating to
convertible debt instruments. This standard requires the
proceeds from the issuance of applicable convertible debt
instruments to be allocated between a liability component and an
equity component. The resulting debt discount is amortized over
the period the convertible debt is expected to be outstanding,
as additional non-cash interest expense. We adopted this new
standard effective as of January 1, 2009. For further
information regarding our convertible senior notes, see
Note 12, Long-Term Debt.
The following tables illustrate the impact of adopting this
accounting standard on our consolidated statements of income.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2009
|
|
|
|
Excluding the
|
|
|
|
|
|
Including the
|
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
|
Accounting
|
|
|
Accounting
|
|
|
Accounting
|
|
|
|
Standard
|
|
|
Standard
|
|
|
Standard
|
|
|
|
(In thousands)
|
|
|
Operating income
|
|
$
|
58,786
|
|
|
$
|
(1,393
|
)
|
|
$
|
57,393
|
|
Interest expense
|
|
|
(9,344
|
)
|
|
|
(4,433
|
)
|
|
|
(13,777
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
49,442
|
|
|
|
(5,826
|
)
|
|
|
43,616
|
|
Provision for income taxes
|
|
|
14,961
|
|
|
|
(2,213
|
)
|
|
|
12,748
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
34,481
|
|
|
$
|
(3,613
|
)
|
|
$
|
30,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.33
|
|
|
$
|
(0.14
|
)
|
|
$
|
1.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
1.33
|
|
|
$
|
(0.14
|
)
|
|
$
|
1.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008
|
|
|
|
Excluding the
|
|
|
|
|
|
Including the
|
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
|
Accounting
|
|
|
Accounting
|
|
|
Accounting
|
|
|
|
Standard
|
|
|
Standard
|
|
|
Standard
|
|
|
|
(In thousands)
|
|
|
Operating income
|
|
$
|
112,605
|
|
|
$
|
|
|
|
$
|
112,605
|
|
Interest expense
|
|
|
(8,714
|
)
|
|
|
(4,517
|
)
|
|
|
(13,231
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
103,891
|
|
|
|
(4,517
|
)
|
|
|
99,374
|
|
Provision for income taxes
|
|
|
41,493
|
|
|
|
(1,717
|
)
|
|
|
39,776
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
(2,800
|
)
|
|
$
|
59,598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.25
|
|
|
$
|
(0.10
|
)
|
|
$
|
2.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.25
|
|
|
$
|
(0.10
|
)
|
|
$
|
2.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Excluding the
|
|
|
|
|
|
Including the
|
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
|
Accounting
|
|
|
Accounting
|
|
|
Accounting
|
|
|
|
Standard
|
|
|
Standard
|
|
|
Standard
|
|
|
|
(In thousands)
|
|
|
Operating income
|
|
$
|
98,327
|
|
|
$
|
|
|
|
$
|
98,327
|
|
Interest expense
|
|
|
(4,631
|
)
|
|
|
(974
|
)
|
|
|
(5,605
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
93,696
|
|
|
|
(974
|
)
|
|
|
92,722
|
|
Provision for income taxes
|
|
|
35,366
|
|
|
|
(370
|
)
|
|
|
34,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
58,330
|
|
|
$
|
(604
|
)
|
|
$
|
57,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.06
|
|
|
$
|
(0.02
|
)
|
|
$
|
2.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.05
|
|
|
$
|
(0.02
|
)
|
|
$
|
2.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following tables illustrate the impact of adopting this
standard on our consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Excluding the
|
|
|
|
|
|
Including the
|
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
|
Accounting
|
|
|
Accounting
|
|
|
Accounting
|
|
|
|
Standard
|
|
|
Standard
|
|
|
Standard
|
|
|
|
(In thousands)
|
|
|
Noncurrent assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
20,651
|
|
|
$
|
(663
|
)
|
|
$
|
19,988
|
|
Noncurrent liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
187,000
|
|
|
|
(28,100
|
)
|
|
|
158,900
|
|
Deferred income taxes
|
|
|
3,352
|
|
|
|
9,154
|
|
|
|
12,506
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
104,603
|
|
|
|
25,299
|
|
|
|
129,902
|
|
Retained earnings
|
|
|
421,639
|
|
|
|
(7,017
|
)
|
|
|
414,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Excluding the
|
|
|
|
|
|
Including the
|
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
Effect of the
|
|
|
|
Accounting
|
|
|
Accounting
|
|
|
Accounting
|
|
|
|
Standard
|
|
|
Standard
|
|
|
Standard
|
|
|
|
(In thousands)
|
|
|
Noncurrent assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
$
|
34,321
|
|
|
$
|
(1,098
|
)
|
|
$
|
33,223
|
|
Deferred income taxes
|
|
|
20
|
|
|
|
(20
|
)
|
|
|
|
|
Noncurrent liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
200,000
|
|
|
|
(35,127
|
)
|
|
|
164,873
|
|
Deferred income taxes
|
|
|
|
|
|
|
12,911
|
|
|
|
12,911
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
146,179
|
|
|
|
24,502
|
|
|
|
170,681
|
|
Retained earnings
|
|
|
387,158
|
|
|
|
(3,404
|
)
|
|
|
383,754
|
|
There was no impact resulting from this accounting change on our
cash flows from operating activities, investing activities, or
financing activities as reflected in the consolidated statements
of cash flows.
68
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
2.
|
Significant
Accounting Policies
|
Premium
Revenue
Premium revenue is fixed in advance of the periods covered and,
except as described below, is not generally subject to
significant accounting estimates. For the year ended
December 31, 2009, we received approximately 92% of our
premium revenue as a fixed amount per member per month, or PMPM,
pursuant to our contracts with state Medicaid agencies, Medicare
and other managed care organizations for which we operate as a
subcontractor. These premium revenues are recognized in the
month that members are entitled to receive health care services.
The state Medicaid programs and the federal Medicare program
periodically adjust premium rates.
The following table summarizes premium revenue by health plan
for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
California
|
|
$
|
481,717
|
|
|
$
|
417,027
|
|
|
$
|
378,934
|
|
Florida(1)
|
|
|
102,232
|
|
|
|
|
|
|
|
|
|
Michigan
|
|
|
557,421
|
|
|
|
509,782
|
|
|
|
487,032
|
|
Missouri(2)
|
|
|
230,222
|
|
|
|
225,280
|
|
|
|
30,730
|
|
New Mexico
|
|
|
404,026
|
|
|
|
348,576
|
|
|
|
268,115
|
|
Ohio
|
|
|
803,521
|
|
|
|
602,826
|
|
|
|
436,238
|
|
Texas
|
|
|
134,860
|
|
|
|
110,178
|
|
|
|
88,453
|
|
Utah
|
|
|
207,297
|
|
|
|
155,991
|
|
|
|
116,907
|
|
Washington
|
|
|
726,137
|
|
|
|
709,943
|
|
|
|
652,970
|
|
Other
|
|
|
12,774
|
|
|
|
11,637
|
|
|
|
2,990
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,660,207
|
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Florida health plan began enrolling members in December 2008. |
|
(2) |
|
We acquired the Missouri health plan in late 2007. |
For the year ended December 31, 2009, we received
approximately 5% of our premium revenue in the form of
birth income a one-time payment for the
delivery of a child from the Medicaid programs in
California (effective October 1, 2009), Michigan, Missouri,
Ohio, Texas, Utah ( effective September 1, 2009) and
Washington. Such payments are recognized as revenue in the month
the birth occurs. Approximately 2.5% of our premium revenue for
the year ended December 31, 2009 was realized under a
Medicaid cost-plus reimbursement agreement that our Utah health
plan had with that state until August 31, 2009. Effective
September 1, 2009, the Utah health plans contract
with the state of Utah became a prepaid capitation contract,
under which the plan is paid a fixed PMPM amount.
Certain components of premium revenue are subject to accounting
estimates. Chief among these are:
|
|
|
|
|
Florida Health Plan Medical Cost Floor (Minimum) for
Behavioral Health. A portion of premium revenue
paid to our Florida health plan by the state of Florida may be
refunded to the state if certain minimum amounts are not
expended on defined behavioral health care costs. At
December 31, 2009, we had not recorded any liability under
the terms of this contract provision. If the state of Florida
disagrees with our interpretation of the existing contract
terms, an adjustment to the amounts owed may be required. Any
changes to the terms of this provision, including revisions to
the definitions of premium revenue or behavioral health care
costs, the period of time over which performance is measured or
the manner of its measurement, or the percentages used in the
calculations, may affect the profitability of our Florida health
plan.
|
69
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
New Mexico Health Plan Medical Cost Floors (Minimums) and
Administrative Cost and Profit Ceilings
(Maximums): A portion of premium revenue paid to
our New Mexico health plan by the state of New Mexico may
be refunded to the state if certain minimum amounts are not
expended on defined medical care costs, or if administrative
costs or profit (as defined) exceed certain amounts. Our
contract with the state of New Mexico requires that we spend a
minimum percentage of premium revenue on certain explicitly
defined medical care costs (the medical cost floor). Our
contract is for a three-year period, and the medical cost floor
is based on premiums and medical care costs over the entire
contract period. Effective July 1, 2008, our New Mexico
health plan entered into a new three year contract that, in
addition to retaining the medical cost floor, added certain
limits on the amount our New Mexico health plan can:
(a) expend on administrative costs; and (b) retain as
profit. At December 31, 2009, we had not recorded any
liability under the terms of these contract provisions. If the
state of New Mexico disagrees with our interpretation of the
existing contract terms, an adjustment to the amounts owed may
be required. Any changes to the terms of these provisions,
including revisions to the definitions of premium revenue,
medical care costs, administrative costs or profit, the period
of time over which performance is measured or the manner of its
measurement, or the percentages used in the calculations, may
affect the profitability of our New Mexico health plan.
|
|
|
|
New Mexico Health Plan At-Risk Premium
Revenue: Under our contract with the state of New
Mexico, up to 1% of our New Mexico health plans revenue
may be refundable to the state if certain performance measures
are not met. These performance measures are generally linked to
various quality of care and administrative measures dictated by
the state. Through December 31, 2009, our New Mexico health
plan had received $3.6 million in at-risk revenue for state
fiscal year 2009 and the first half of state fiscal year 2010
combined. We have recognized $2.2 million of that amount as
revenue through December 31, 2009, and recorded a liability
of approximately $1.4 million for the remainder.
|
|
|
|
Ohio Health Plan At-Risk Premium
Revenue: Under our contract with the state of
Ohio, up to 1% of our Ohio health plans revenue may be
refundable to the state if certain performance measures are not
met. These performance measures are generally linked to various
quality of care measures dictated by the state. Through
December 31, 2009 our Ohio health plan had received
$8.8 million in at-risk revenue for state fiscal year 2009
and the first half of state fiscal year 2010 combined. We have
recognized $7.5 million of that amount as revenue through
December 31, 2009 and recorded a liability of approximately
$1.3 million for the remainder.
|
|
|
|
Utah Health Plan Premium Revenue: Our Utah
health plan may be entitled to receive additional premium
revenue from the state of Utah as an incentive payment for
saving the state of Utah money in relation to
fee-for-service
Medicaid. In prior years, we estimated amounts we believed were
recoverable under our savings sharing agreement with the state
of Utah based on available information and our interpretation of
our contract with the state. The state may not agree with our
interpretation or our application of the contract language, and
it may also not agree with the manner in which we have processed
and analyzed our member claims and encounter records. Thus, the
ultimate amount of savings sharing revenue that we realize from
prior years may be subject to negotiation with the state. During
2007, as a result of an ongoing disagreement with the state of
Utah, we wrote off the entire receivable, totaling
$4.7 million. Our Utah health plan continues to assert its
claim to the amounts believed to be due under the savings share
agreement. When additional information is known, or resolution
is reached with the state regarding the appropriate savings
sharing payment amount for prior years, we will adjust the
amount of savings sharing revenue recorded in our financial
statements as appropriate in light of such new information or
agreement. No receivables for saving sharing revenue have been
established at December 31, 2009 and 2008.
|
|
|
|
Texas Health Plan Premium Revenue: The
contract entered into between our Texas health plan and the
state of Texas includes a profit-sharing agreement, where we pay
a rebate to the state of Texas if our Texas health plan
generates pretax income above a certain specified percentage, as
determined in accordance with a tiered rebate schedule. We are
limited in the amount of administrative costs that we may deduct
in
|
70
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
calculating the rebate, if any. As of December 31, 2009, we
had an aggregate liability of approximately $2.0 million
accrued pursuant to our profit-sharing agreement with the state
of Texas for the 2009 and 2010 contract years (ending August 31
of each year). During 2009, we paid the state of Texas
$4.9 million relating to the 2008 and 2009 contract years,
and the 2008 contract year is now closed. Because the final
settlement calculations include a claims run-out period of
nearly one year, the amounts recorded, based on our estimates,
may be adjusted. We believe that the ultimate settlement will
not differ materially from our estimates.
|
|
|
|
|
|
Texas Health Plan At-Risk Premium
Revenue: Under our contract with the state of
Texas, up to 1% of our Texas health plans revenue may be
refundable to the state if certain performance measures are not
met. These performance measures are generally linked to various
quality of care measures dictated by the state. Through
December 31, 2009, our Texas health plan had received
$1.7 million in at-risk revenue for state fiscal year 2009
and the first half of state fiscal year 2010 combined. We have
recognized $1.2 million of that amount as revenue through
December 31, 2009, and recorded a liability of
approximately $0.5 million for the remainder.
|
|
|
|
Medicare Premium Revenue: Based on member
encounter data that we submit to CMS, our Medicare revenue is
subject to retroactive adjustment for both member risk scores
and member pharmacy cost experience for up to two years after
the original year of service. This adjustment takes into account
the acuity of each members medical needs relative to what
was anticipated when premiums were originally set for that
member. In the event that a member requires less acute medical
care than was anticipated by the original premium amount, CMS
may recover premium from us. In the event that a member requires
more acute medical care than was anticipated by the original
premium amount, CMS may pay us additional retroactive premium. A
similar retroactive reconciliation is undertaken by CMS for our
Medicare members pharmacy utilization. That analysis is
similar to the process for the adjustment of member risk scores,
but is further complicated by member pharmacy cost sharing
provisions attached to the Medicare pharmacy benefit that do not
apply to the services measured by the member risk adjustment
process. We estimate the amount of Medicare revenue that will
ultimately be realized for the periods presented based on our
knowledge of our members heath care utilization patterns
and CMS practices. To the extent that the premium revenue
ultimately received from CMS differs from recorded amounts, we
will adjust reported Medicare revenue. Based upon our knowledge
of member health care utilization patterns we have recorded a
liability of approximately $0.6 million related to the
potential recoupment of Medicare premium revenue at
December 31, 2009.
|
Medical
Care Costs
Expenses related to medical care services are captured in the
following four categories:
|
|
|
|
|
Fee-for-service: Physician
providers paid on a
fee-for-service
basis are paid according to a fee schedule set by the state or
by our contracts with these providers. We pay hospitals on a
fee-for-service
basis in a variety of ways, including per diem amounts,
diagnostic-related groups or DRGs, percent of billed charges,
and case rates. We also pay a small portion of hospitals on a
capitated basis. We also have stop-loss agreements with the
hospitals with which we contract. Under all
fee-for-service
arrangements, we retain the financial responsibility for medical
care provided. Expenses related to
fee-for-service
contracts are recorded in the period in which the related
services are dispensed. The costs of drugs administered in a
physician or hospital setting that are not billed through our
pharmacy benefit managers are included in
fee-for-service
costs.
|
|
|
|
Capitation: Many of our primary care
physicians and a small portion of our specialists and hospitals
are paid on a capitated basis. Under capitation contracts, we
typically pay a fixed PMPM payment to the provider without
regard to the frequency, extent, or nature of the medical
services actually furnished. Under capitated contracts, we
remain liable for the provision of certain health care services.
Certain of our capitated contracts also contain incentive
programs based on service delivery, quality of care, utilization
management, and other criteria. Capitation payments are fixed in
advance of the periods covered and are not subject to
|
71
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
significant accounting estimates. These payments are expensed in
the period the providers are obligated to provide services. The
financial risk for pharmacy services for a small portion of our
membership is delegated to capitated providers.
|
|
|
|
|
|
Pharmacy: Pharmacy costs include all drug,
injectibles, and immunization costs paid through our pharmacy
benefit managers. As noted above, drugs and injectibles not paid
through our pharmacy benefit managers are included in
fee-for-service
costs, except in those limited instances where we capitate drug
and injectible costs.
|
|
|
|
Other: Other medical care costs include
medically related administrative costs, certain provider
incentive costs, reinsurance cost, and other health care
expense. Medically related administrative costs include, for
example, expenses relating to health education, quality
assurance, case management, disease management,
24-hour
on-call nurses, and a portion of our information technology
costs. Salary and benefit costs are a substantial portion of
these expenses. For the years ended December 31, 2009,
2008, and 2007, medically related administrative costs were
approximately $74.6 million, $75.9 million, and
$65.4 million, respectively.
|
The following table provides the details of our consolidated
medical care costs for the periods indicated (dollars in
thousands, except PMPM amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Fee-for- service
|
|
$
|
2,077,489
|
|
|
$
|
126.14
|
|
|
|
65.4
|
%
|
|
$
|
1,709,806
|
|
|
$
|
116.69
|
|
|
|
65.2
|
%
|
|
$
|
1,343,911
|
|
|
$
|
103.77
|
|
|
|
64.6
|
%
|
Capitation
|
|
|
558,538
|
|
|
|
33.91
|
|
|
|
17.6
|
|
|
|
450,440
|
|
|
|
30.74
|
|
|
|
17.2
|
|
|
|
375,206
|
|
|
|
28.97
|
|
|
|
18.0
|
|
Pharmacy
|
|
|
414,785
|
|
|
|
25.18
|
|
|
|
13.1
|
|
|
|
356,184
|
|
|
|
24.31
|
|
|
|
13.6
|
|
|
|
270,363
|
|
|
|
20.88
|
|
|
|
13.0
|
|
Other
|
|
|
125,424
|
|
|
|
7.62
|
|
|
|
3.9
|
|
|
|
104,882
|
|
|
|
7.16
|
|
|
|
4.0
|
|
|
|
90,603
|
|
|
|
7.00
|
|
|
|
4.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,176,236
|
|
|
$
|
192.85
|
|
|
|
100.0
|
%
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
100.0
|
%
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our medical care costs include amounts that have been paid by us
through the reporting date, as well as estimated liabilities for
medical care costs incurred but not paid by us as of the
reporting date. Such medical care cost liabilities include,
among other items, unpaid
fee-for-service
claims, capitation payments owed providers, unpaid pharmacy
invoices, and various medically related administrative costs
that have been incurred but not paid. We use judgment to
determine the appropriate assumptions for determining the
required estimates.
The most important element in estimating our medical care costs
is our estimate for
fee-for-service
claims which have been incurred but not paid by us. These
fee-for-service
costs that have been incurred but have not been paid at the
reporting date are collectively referred to as medical costs
that are Incurred But Not Paid, or IBNP. Our IBNP
claims reserve, as reported in our balance sheet, represents our
best estimate of the total amount of claims we will ultimately
pay with respect to claims that we have incurred as of the
balance sheet date. We estimate our IBNP monthly using actuarial
methods based on a number of factors.
The factors we consider when estimating our IBNP include,
without limitation, claims receipt and payment experience (and
variations in that experience), changes in membership, provider
billing practices, health care service utilization trends, cost
trends, product mix, seasonality, prior authorization of medical
services, benefit changes, known outbreaks of disease or
increased incidence of illness such as influenza, provider
contract changes, changes to Medicaid fee schedules, and the
incidence of high dollar or catastrophic claims. Our assessment
of these factors is then translated into an estimate of our IBNP
liability at the relevant measuring point through the
calculation of a base estimate of IBNP, a further reserve for
adverse claims development, and an estimate of the
administrative costs of settling all claims incurred through the
reporting date. The base estimate of IBNP is derived through
application of claims payment completion factors and trended
PMPM cost estimates. See Note 11, Medical Claims and
Benefits Payable.
72
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We report reinsurance premiums as medical care costs, while
related reinsurance recoveries are reported as deductions from
medical care costs. We limit our risk of catastrophic losses by
maintaining high deductible reinsurance coverage. We do not
consider this coverage to be material because the cost is not
significant and the likelihood that coverage will apply is low.
Taxes
Based on Premiums
Our California, Florida, Michigan, New Mexico, Ohio, Texas and
Washington health plans are assessed a tax based on premium
revenue collected. We report these taxes on a gross basis,
included in general and administrative expenses. Premium tax
expense totaled $123.1 million, $95.1 million, and
$81.0 million in 2009, 2008, and 2007, respectively.
Delegated
Provider Insolvency
Circumstances may arise where providers to whom we have
delegated risk, due to insolvency or other circumstances, are
unable to pay claims they have incurred with third parties in
connection with referral services provided to our members. The
inability of delegated providers to pay referral claims presents
us with both immediate financial risk and potential disruption
to member care. Depending on states laws, we may be held
liable for such unpaid referral claims even though the delegated
provider has contractually assumed such risk. Additionally,
competitive pressures may force us to pay such claims even when
we have no legal obligation to do so. To reduce the risk that
delegated providers are unable to pay referral claims, we
monitor the operational and financial performance of such
providers. We also maintain contingency plans that include
transferring members to other providers in response to potential
network instability.
In certain instances, we have required providers to place funds
on deposit with us as protection against their potential
insolvency. These reserves are frequently in the form of
segregated funds received from the provider and held by us or
placed in a third-party financial institution. These funds may
be used to pay claims that are the financial responsibility of
the provider in the event the provider is unable to meet these
obligations. Additionally, we have recorded liabilities for
estimated losses arising from provider instability or insolvency
in excess of provider funds on deposit with us. Such liabilities
were not material at December 31, 2009, or 2008.
Premium
Deficiency Reserves on Loss Contracts
We assess the profitability of our contracts for providing
medical care services to our members and identify those
contracts where current operating results or forecasts indicate
probable future losses. Anticipated future premiums are compared
to anticipated medical care costs, including the cost of
processing claims. If the anticipated future costs exceed the
premiums, a loss contract accrual is recognized. No such accrual
was recorded as of December 31, 2009, or 2008.
Cash
and Cash Equivalents
Cash and cash equivalents consist of cash and short-term, highly
liquid investments that are both readily convertible into known
amounts of cash and have a maturity of three months or less on
the date of purchase.
Investments
Our investments are principally held in debt securities, which
are grouped into three separate categories for accounting and
reporting purposes:
available-for-sale
securities,
held-to-maturity
securities, and trading securities.
Available-for-sale
securities are recorded at fair value and unrealized gains and
losses, if any, are recorded in stockholders equity as
other comprehensive income, net of applicable income taxes.
Held-to-maturity
securities are recorded at amortized cost, which approximates
fair value, and unrealized holding gains or losses are not
generally recognized. Realized gains and losses and unrealized
losses judged to be other than temporary with respect to
available-for-sale
and
held-to-maturity
securities are included in the determination of net income.
Trading securities are recorded at fair value, and holding gains
and losses are recognized in net income.
73
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Except for restricted investments and certain student loan
portfolios (the auction rate securities), our debt
securities are designated as
available-for-sale
and are carried at fair value. The cost of securities sold is
determined using the specific-identification method, on an
amortized cost basis. Fair values of securities are generally
based on quoted prices in active markets.
Our investment policy requires that all of our investments have
final maturities of ten years or less (excluding auction rate
and variable rate securities where interest rates may be
periodically reset), and that the average maturity be four years
or less. Investments and restricted investments are subject to
interest rate risk and will decrease in value if market rates
increase. Declines in interest rates over time will reduce our
investment income.
In general, our
available-for-sale
securities are classified as current assets without regard to
the securities contractual maturity dates because they may
be readily liquidated. During 2008, our auction rate securities
were classified as non-current assets. During the fourth quarter
of 2008, certain auction rate securities were designated as
trading securities. For comprehensive discussions of the fair
value and classification of our current and non-current
investments, including auction rate securities, see Note 5,
Fair Value Measurements, and Note 6,
Investments.
Receivables
Receivables consist primarily of amounts due from the various
states in which we operate. All receivables are subject to
potential retroactive adjustment. Because the amounts of nearly
all receivables are readily determinable and our creditors are
primarily state governments, our allowance for doubtful accounts
is immaterial. Any amounts determined to be uncollectible are
charged to expense when such determination is made. See
Note 7, Receivables.
Property
and Equipment
Property and equipment are stated at historical cost.
Replacements and major improvements are capitalized, and repairs
and maintenance are charged to expense as incurred. Software
developed for internal use is capitalized. Furniture and
equipment are depreciated using the straight-line method over
estimated useful lives ranging from three to seven years.
Software is amortized over its estimated useful life of three
years. Leasehold improvements are amortized over the term of the
lease or five to 10 years, whichever is shorter. Buildings
are depreciated over their estimated useful lives of
31.5 years. See Note 8, Property and
Equipment.
Goodwill
and Intangible Assets
Goodwill represents the excess of the purchase price over the
fair value of net assets acquired. Identifiable intangible
assets (consisting principally of purchased contract rights and
provider contracts) are amortized on a straight-line basis over
the expected period to be benefited (between one and
15 years). See Note 9, Goodwill and Intangible
Assets.
Goodwill and indefinite lived assets are not amortized, but are
subject to impairment tests on an annual basis or more
frequently if indicators of impairment exist. We used a
discounted cash flow methodology to assess the fair values of
our reporting units at December 31, 2009 and 2008. If the
carrying values of our reporting units exceed the fair values,
we perform a hypothetical purchase price allocation. Impairment
is measured by comparing the goodwill derived from the
hypothetical purchase price allocation to the carrying value of
the goodwill and indefinite lived asset balance. Based on the
results of our impairment testing, no adjustments were required
for the years ended December 31, 2009, 2008, and 2007.
Long-Lived
Asset Impairment
Situations may arise where the carrying value of a long-lived
asset may exceed the undiscounted expected cash flows associated
with that asset. In such circumstances, the asset is deemed to
be impaired. We review material long-lived assets for impairment
on an annual basis, as well as when events or changes in
business conditions suggest potential impairment. Impaired
assets are written down to fair value. In the second quarter of
2007, we recorded an impairment charge totaling $782,000 related
to commercial software no longer used in operations.
74
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Other than this 2007 charge, we have determined that no
long-lived assets were impaired in the years ended
December 31, 2009, 2008, and 2007.
Restricted
Investments
Restricted investments, which consist of certificates of deposit
and treasury securities, are designated as
held-to-maturity
and are carried at amortized cost, which approximates market
value. The use of these funds is limited to specific purposes as
required by each state, or as protection against the insolvency
of capitated providers. We have the ability to hold our
restricted investments until maturity and, as a result, we would
not expect the value of these investments to decline
significantly due to a sudden change in market interest rates.
See Note 10, Restricted Investments.
Receivable/Liability
for Ceded Life and Annuity Contracts
We report a 100% ceded reinsurance arrangement for life
insurance policies written and held by our wholly owned
insurance subsidiary, Molina Healthcare Insurance Company, by
recording a non-current receivable from the reinsurer with a
corresponding non-current liability for ceded life and annuity
contracts.
Other
Assets
Significant items included in other assets include deferred
financing costs associated with our convertible senior notes and
with our credit facility, certain investments held in connection
with our employee deferred compensation program, and an
investment in a vision services provider (see Note 17,
Related Party Transactions). The deferred financing
costs are being amortized on a straight-line basis over the
seven year term of the convertible senior notes and the five
year term of the credit facility. As of December 31, 2009,
other assets decreased compared with December 31, 2008
primarily due to the reclassification, to goodwill and
intangible assets, of the $9.0 million initial purchase
deposit of the Florida NetPASS acquisition (see Note 4,
Business Purchase Transactions). Additionally, as of
December 31, 2009, the fair value of the non-current asset
relating to a rights agreement decreased $3.1 million (see
Note 5, Fair Value Measurements) compared with
the balance as of December 31, 2008.
Income
Taxes
Deferred tax assets and liabilities are recorded based on
temporary differences between the financial statement basis and
the tax basis of assets and liabilities using presently enacted
tax rates. We record accruals for uncertain tax positions by
applying a two-step process. First, we determine whether it is
more likely than not that a tax position will be sustained upon
examination. In the second step, a tax position that meets the
more-likely-than-not recognition threshold is measured to
determine the amount of benefit to recognize in the financial
statements. For further discussion and disclosure, see
Note 13, Income Taxes.
Concentrations
of Credit Risk
Financial instruments that potentially subject us to
concentrations of credit risk consist primarily of cash and cash
equivalents, investments, receivables, and restricted
investments. We invest a substantial portion of our cash in the
PFM Fund Prime Series Institutional Class, and
the PFM Fund Government Series. These funds represent a
portfolio of highly liquid money market securities that are
managed by PFM Asset Management LLC (PFM), a Virginia business
trust registered as an open-end management investment fund. As
of December 31, 2009, and 2008, our investments with PFM
totaled $296.0 million and $253.8 million,
respectively. Our investments and a portion of our cash
equivalents are managed by professional portfolio managers
operating under documented investment guidelines. No investment
that is in a loss position can be sold by our managers without
our prior approval. Our investments consist solely of investment
grade debt securities with a maximum maturity of ten years and
an average duration of four years. Restricted investments are
invested principally in certificates of deposit and treasury
securities. Concentration of credit risk with respect to
accounts receivable is limited due to payors consisting
principally of the governments of each state in which our health
plan subsidiaries operate.
75
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Risks
and Uncertainties
Our profitability depends in large part on our ability to
accurately predict and effectively manage medical care costs. We
continually review our medical costs in light of our underlying
claims experience and revised actuarial data. However, several
factors could adversely affect medical care costs. These
factors, which include changes in health care practices,
inflation, new technologies, major epidemics, natural disasters,
and malpractice litigation, are beyond our control and may have
an adverse effect on our ability to accurately predict and
effectively control medical care costs. Costs in excess of those
anticipated could have a material adverse effect on our
financial condition, results of operations, or cash flows.
At December 31, 2009, we operated in nine states (not
including Nevada, where we no longer served members effective
January 1, 2010), in some instances as a direct contractor
with the state, and in others as a subcontractor to another
health plan holding a direct contract with the state. We are
therefore dependent upon a small number of contracts to support
our revenue. The loss of any one of those contracts could have a
material adverse effect on our financial position, results of
operations, or cash flows. Our ability to arrange for the
provision of medical services to our members is dependent upon
our ability to develop and maintain adequate provider networks.
Our inability to develop or maintain such networks might, in
certain circumstances, have a material adverse effect on our
financial position, results of operations, or cash flows.
Segment
Information
We present segment information externally in the same manner
used by management to make operating decisions and assess
performance. Each of our subsidiaries arranges for the provision
of health care services to Medicaid, CHIP and Medicare members
in return for compensation from state and Federal agencies. They
share similar characteristics in the membership they serve, the
nature of services provided and the method by which medical care
is rendered. The subsidiaries are also subject to similar
regulatory environments and long-term economic prospects. As
such, we have one reportable segment.
Recent
Accounting Pronouncements
In 2009, the FASB issued the FASB Accounting Standards
Codification (the Codification) for financial
statements issued for interim and annual periods ending after
September 15, 2009. The Codification became the single
authoritative source for GAAP. Accordingly, previous references
to GAAP accounting standards are no longer used in our
disclosures, including these Notes to the Consolidated Financial
Statements. The Codification does not impact our consolidated
financial position, results of operations or cash flows.
In October 2009, the Financial Accounting Standards Board
(FASB) issued new revenue recognition standards for
arrangements with multiple deliverables, where certain of those
deliverables are non-software related. The new standards permit
entities to initially use managements best estimate of
selling price to value individual deliverables when those
deliverables do not have vendor specific objective evidence, or
VSOE, of fair value or when third-party evidence is not
available. Additionally, these new standards modify the manner
in which the transaction consideration is allocated across the
separately identified deliverables by no longer permitting the
residual method of allocating arrangement consideration. These
new standards are effective for annual periods ending after
June 15, 2010, however early adoption is permitted. We are
currently evaluating the impact of adopting these new standards
on our consolidated financial position, results of operations
and cash flows.
In October 2009, the FASB issued an update that offers guidance
on how to use a net asset value per share to estimate the fair
value of investments in various types of funds including hedge
funds, private equity funds, real estate funds, venture capital
funds, and offshore fund vehicles. We adopted the update in the
fourth quarter of 2009, and because we do not invest in such
funds, it did not impact our consolidated financial position,
results of operations or cash flows.
In August 2009, the FASB issued an update that provides
additional guidance clarifying the measurement of liabilities at
fair value. Because we do not measure any of our liabilities at
fair value, the adoption of the new standards did not impact our
consolidated financial position, results of operations or cash
flows.
76
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In June 2009, the FASB issued an amended standard for
determining whether to consolidate a variable interest entity.
This new standard amends the evaluation criteria to identify the
primary beneficiary of a variable interest entity and requires
ongoing reassessment of whether an enterprise is the primary
beneficiary of the variable interest entity. We adopted the
standards in the fourth quarter of 2009, and the standard did
not impact our consolidated financial position, results of
operations or cash flows.
In May 2009, the FASB issued a new standard for subsequent
events, which establishes general standards of accounting for
and disclosure of events that occur after the balance sheet date
but before financial statements are issued or are available to
be issued. We adopted the new standard during the second quarter
of 2009 and, because the pronouncement only requires additional
disclosure, the adoption did not impact our consolidated
financial position, results of operations or cash flows. The
required disclosure is included in Note 1, Basis of
Presentation.
In April 2009, the FASB issued a new standard for the
recognition and measurement of
other-than-temporary
impairments for debt securities which replaced the pre-existing
intent and ability indicator. This new standard
specifies that if the fair value of a debt security is less than
its amortized cost basis, an
other-than-temporary
impairment is triggered in circumstances where (1) an
entity has an intent to sell the security, (2) it is more
likely than not that the entity will be required to sell the
security before recovery of its amortized cost basis, or
(3) the entity does not expect to recover the entire
amortized cost basis of the security (that is, a credit loss
exists).
Other-than-temporary
impairments are separated into amounts representing credit
losses which are recognized in earnings and amounts related to
all other factors which are recognized in other comprehensive
income (loss). We adopted this standard in the second quarter of
2009 and it did not have a material effect on our consolidated
financial position, results of operations or cash flows.
In April 2009, the FASB issued a new standard that provides
guidance on how to determine the fair value of assets and
liabilities when the volume and level of activity for the asset
or liability has significantly decreased. This new standard also
provides guidance on identifying circumstances that indicate a
transaction is not orderly. In addition, we are required to
disclose in interim as well as annual reporting periods the
inputs and valuation techniques used to measure fair value and
discussion of changes in valuation techniques. We adopted this
standard in the second quarter of 2009 and it did not have a
material effect on our consolidated financial position, results
of operations or cash flows.
Other recent accounting pronouncements issued by the FASB
(including its Emerging Issues Task Force), the AICPA, and the
SEC did not, or are not believed by management to, have a
material impact on our present or future consolidated financial
statements.
The denominators for the computation of basic and diluted
earnings per share were calculated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Shares outstanding at the beginning of the year
|
|
|
26,725
|
|
|
|
28,444
|
|
|
|
28,119
|
|
Weighted-average number of shares repurchased
|
|
|
(988
|
)
|
|
|
(871
|
)
|
|
|
|
|
Weighted-average number of shares issued
|
|
|
106
|
|
|
|
103
|
|
|
|
156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings per share
|
|
|
25,843
|
|
|
|
27,676
|
|
|
|
28,275
|
|
Dilutive effect of employee stock options and stock grants(1)
|
|
|
141
|
|
|
|
96
|
|
|
|
144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted earnings per share(2)
|
|
|
25,984
|
|
|
|
27,772
|
|
|
|
28,419
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Options to purchase common shares are included in the
calculation of diluted earnings per share when their exercise
prices are below the average fair value of the common shares for
each of the periods presented. For the years ended
December 31, 2009, 2008 and 2007, there were approximately
620,000, 532,000, and 136,000 anti-dilutive weighted options,
respectively. Restricted shares are included in the calculation
of diluted earnings per |
77
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
share when their grant date fair values are below the average
fair value of the common shares for each of the periods
presented. For the years ended December 31, 2009, 2008 and
2007, there were approximately 21,000, 39,000, and 4,000
anti-dilutive weighted restricted shares, respectively. |
|
(2) |
|
Potentially dilutive shares issuable pursuant to our 2007
offering of convertible senior notes were not included in the
computation of diluted net income per share because to do so
would have been anti-dilutive for the years ended
December 31, 2009, 2008 and 2007. |
|
|
4.
|
Business
Purchase Transactions
|
On January 1, 2009, we adopted the FASBs revised
standard for accounting for business combinations. The
transaction described below under Florida health
plan, was accounted for under the new standard. The
adoption of the standard did not have a material effect on our
consolidated financial position, results of operations or cash
flows.
Florida health plan. On December 31, 2009
(the acquisition date), we acquired 100% of the voting equity
interests in Florida NetPASS, LLC (NetPASS). This
acquisition included the purchase of the NetPASS limited
liability company and its membership interests. We initially
announced our intention to purchase NetPASS in August 2008.
NetPASS was a provider of care management and administrative
services at that time to approximately 58,000 Florida MediPass
members in South and Central Florida (Florida MediPASS is the
state of Floridas Medicaid program). As a result of the
acquisition, we have expanded our health plan operations to the
southeastern United States.
Our wholly owned subsidiary, Molina Healthcare of Florida, Inc.,
was awarded a Medicaid managed care contract by the state of
Florida in October 2008. Subsequently, NetPASS members have been
notified of our intention to acquire NetPASS and, beginning in
December 2008, offered membership with our Florida health plan
on a
county-by-county
basis. Once transitioned, these members become full-risk members
of the Florida health plan. That is, the Florida health plan
receives fixed per member per month payments from the state of
Florida for the care of these members, and the Florida health
plan is at risk for the cost of the members medical care.
As of December 31, 2008, we had transitioned fewer than 50
NetPASS members to our Florida health plan.
As of December 31, 2009, we have transitioned approximately
48,000 NetPASS members to our Florida health plan, and have
recorded $28.7 million to goodwill and intangible assets
relating to these members. Of this amount, we have paid the
sellers $23.4 million, with the balance accrued to accounts
payable and accrued liabilities. The $5.3 million current
liability includes a 10% indemnification hold back totaling
$2.9 million, as provided in the purchase agreement, and a
$2.4 million payable to the sellers for membership
transitioned to date as of December 31, 2009. Because the
final membership reconciliation will take place in the second
quarter of 2010, the provisional measurements of goodwill and
intangible assets recorded as of December 31, 2009, are
subject to change. The final purchase price of the acquisition
will be based on the final membership transitioned to our
Florida health plan under the terms of the purchase agreement.
As of December 31, 2009, we do not expect adjustments
relating to the final membership reconciliation to be
significant. The following table summarizes the estimated fair
values of the assets acquired as of December 31, 2009:
|
|
|
|
|
|
|
(In thousands)
|
|
|
Goodwill (indefinite life)
|
|
$
|
17,048
|
|
Contract rights and licenses (five-year useful life)
|
|
|
8,576
|
|
Provider networks
(10-year
useful life)
|
|
|
3,076
|
|
|
|
|
|
|
|
|
$
|
28,700
|
|
|
|
|
|
|
The entire amount recorded for goodwill is deductible for income
tax purposes. The amount recorded for goodwill as of
December 31, 2009, represents intangible assets that do not
qualify for separate recognition as identifiable intangible
assets.
78
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We have received a series of demand letters from the sellers of
NetPASS related to the enrollment of members and the applicable
purchase price. We believe the sellers demands are without
merit, and in the event arbitration or litigation is commenced
by the sellers, we intend to vigorously contest the
sellers claims.
Missouri health plan. Effective
November 1, 2007, we acquired Mercy CarePlus, a licensed
Medicaid managed care plan based in St. Louis, Missouri, to
expand our market share within our core Medicaid managed care
business. The results of operations for Mercy CarePlus are
included in the consolidated financial statements from periods
following November 1, 2007. The purchase price for the
acquisition was $80.0 million, and was funded with
available cash and proceeds from our issuance of convertible
senior notes in October 2007. The purchase price was subject to
certain post-closing adjustments. During the third quarter of
2009, we paid the sellers $2.5 million to settle all
outstanding issues relating to the post-closing adjustments. We
recorded this amount to goodwill in the accompanying
consolidated balance sheets. Additionally during the
post-acquisition period in 2008, we reduced goodwill by
approximately $6.2 million, primarily due to the
establishment of a deferred tax asset relating to the carryover
tax basis in certain identifiable intangibles.
Other. In June 2008, we paid $1.0 million
and issued a total of 48,186 shares of our common stock in
connection with our acquisition of the assets of The Game of
Work, LLC. The purchase price consideration totaled
$2.3 million. The Game of Work, LLC is a company
specializing in productivity measurement and improvement, and is
used internally to improve operational efficiency.
See Note 21, Subsequent Events, for further
information regarding a business purchase transaction we
announced in January 2010.
|
|
5.
|
Fair
Value Measurements
|
Our consolidated balance sheets include the following financial
instruments: cash and cash equivalents, investments,
receivables, trade accounts payable, medical claims and benefits
payable, long-term debt and other liabilities. We consider the
carrying amounts of cash and cash equivalents, receivables,
other current assets and current liabilities to approximate
their fair value because of the relatively short period of time
between the origination of these instruments and their expected
realization or payment. For a comprehensive discussion of fair
value measurements with regard to our current and non-current
investments, see below.
Based on quoted market prices, the fair value of our convertible
senior notes issued in October 2007 was approximately
$160.8 million, and $115.5 million as of
December 31, 2009, and 2008, respectively. The carrying
amount of the convertible senior notes was $158.9 million,
and $164.9 million as of December 31, 2009, and 2008,
respectively.
To prioritize the inputs we use in measuring fair value, we
apply a three-tier fair value hierarchy. These tiers include:
Level 1, defined as observable inputs such as quoted prices
in active markets; Level 2, defined as inputs other than
quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable
inputs in which little or no market data exists, therefore
requiring an entity to develop its own assumptions.
79
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
As of December 31, 2009, we held certain assets that are
required to be measured at fair value on a recurring basis.
These included investments and restricted investments as follows:
|
|
|
Balance Sheet Classification
|
|
Description
|
|
Current assets:
|
|
|
Investments
|
|
Investment grade debt securities; designated as
available-for-sale; reported at fair value based on market
prices that are readily available (Level 1). See Note 6,
Investments, for further information regarding fair
value.
|
Non-current assets:
|
|
|
Investments
|
|
Auction rate securities; designated as available-for-sale;
reported at fair value based on discounted cash flow analysis or
other type of valuation model (Level 3).
|
|
|
Auction rate securities; designated as trading; reported at fair
value based on discounted cash flow analysis or other type of
valuation model (Level 3).
|
Restricted investments
|
|
Interest-bearing deposits and U.S. treasury securities required
by the respective states in which we operate, or required by
contractual arrangement with a third party such as a provider
group; designated as held-to-maturity; reported at amortized
cost which approximates market value and based on market prices
that are readily available (Level 1). See Note 10,
Restricted Investments, for further information
regarding fair value.
|
Other assets
|
|
Other assets include auction rate securities rights; reported at
fair value based on discounted cash flow analysis or other type
of valuation model (Level 3).
|
As of December 31, 2009, $67.8 million par value (fair
value of $59.7 million) of our investments consisted of
auction rate securities, all of which were collateralized by
student loan portfolios guaranteed by the U.S. government.
We continued to earn interest on substantially all of these
auction rate securities as of December 31, 2009. Due to
events in the credit markets, the auction rate securities held
by us experienced failed auctions beginning in the first quarter
of 2008. As such, quoted prices in active markets were not
readily available during the majority of 2008, and continued to
be unavailable as of December 31, 2009. To estimate the
fair value of these securities, we used pricing models that
included factors such as the collateral underlying the
securities, the creditworthiness of the counterparty, the timing
of expected future cash flows, and the expectation of the next
time the security would have a successful auction. The estimated
values of these securities were also compared, when possible, to
valuation data with respect to similar securities held by other
parties. We concluded that these estimates, given the lack of
market available pricing, provided a reasonable basis for
determining fair value of the auction rate securities as of
December 31, 2009. For our investments in auction rate
securities, we do not intend to sell, nor is it more likely than
not that we will be required to sell, these investments before
recovery of their cost.
As of December 31, 2009, we held $40.9 million par
value (fair value of $36.7 million) auction rate securities
(designated as trading securities) with a certain investment
securities firm. In the fourth quarter of 2008, we entered into
a rights agreement with this firm that (1) allows us to
exercise rights (the Rights) to sell the eligible
auction rate securities at par value to this firm between
June 30, 2010 and July 2, 2012, and (2) gives the
investment securities firm the right to purchase the auction
rate securities from us any time after the agreement date as
long as we receive the par value.
We account for the Rights as a freestanding financial
instrument, and record the value of the Rights at fair value,
which totaled $3.8 million, and $6.9 million at
December 31, 2009, and 2008, respectively. To determine the
fair value estimate of the Rights, we use a discounted cash-flow
model based on the expectation that the auction rate securities
will be put back to the investment securities firm at par on
June 30, 2010, as permitted by the rights agreement.
For the year ended December 31, 2009, we recorded a pretax
gain on the change in the fair value of the auction rate
securities underlying the Rights totaling $3.4 million,
which was offset by a pretax loss on the Rights totaling
$3.1 million. In 2008, simultaneous to the recognition of
the $6.9 million rights agreement described above, we
80
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
recorded an
other-than-temporary
impairment of the underlying auction rate securities, and prior
unrealized losses on the auction rate securities that had been
recorded to other comprehensive loss through November 2008 were
charged to income, totaling $7.2 million. We expect that
the future changes in the fair value of the Rights will continue
to be substantially offset by the fair value movements in the
underlying auction rate securities.
As of December 31, 2009, the remainder of our auction rate
securities (designated as
available-for-sale
securities) amounted to $26.9 million par value (fair value
of $23.0 million). As a result of the increase in fair
value of auction rate securities designated as
available-for-sale,
we recorded unrealized gains of $0.8 million
($0.5 million, net of tax) to accumulated other
comprehensive income for the year ended December 31, 2009.
We recorded unrealized losses of $7.6 million
($4.7 million, net of tax) to other comprehensive loss for
the year ended December 31, 2008. We have deemed these
unrealized gains and losses to be temporary and attribute the
decline in value to liquidity issues, as a result of the failed
auction market, rather than to credit issues. Any future
fluctuation in fair value related to these instruments that we
deem to be temporary, including any recoveries of previous
write-downs, would be recorded to accumulated other
comprehensive loss. If we determine that any future valuation
adjustment was
other-than-temporary,
we would record a charge to earnings as appropriate.
Based on market conditions that resulted in the absence of
quoted prices in active markets for our auction rate securities,
we changed our valuation methodology for auction rate securities
to a discounted cash flow analysis during the first quarter of
2008. Our assets measured at fair value on a recurring basis at
December 31, 2009, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
(In thousands)
|
|
|
Investments (not including auction rate securities)
|
|
$
|
174,844
|
|
|
$
|
174,844
|
|
|
$
|
|
|
|
$
|
|
|
Auction rate securities
(available-for-sale)
|
|
|
22,957
|
|
|
|
|
|
|
|
|
|
|
|
22,957
|
|
Auction rate securities (trading)
|
|
|
36,730
|
|
|
|
|
|
|
|
|
|
|
|
36,730
|
|
Auction rate securities rights
|
|
|
3,807
|
|
|
|
|
|
|
|
|
|
|
|
3,807
|
|
Restricted investments
|
|
|
36,274
|
|
|
|
36,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets measured at fair value
|
|
$
|
274,612
|
|
|
$
|
211,118
|
|
|
$
|
|
|
|
$
|
63,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents our assets measured at fair value
on a recurring basis using significant unobservable inputs
(Level 3):
|
|
|
|
|
|
|
(Level 3)
|
|
|
|
(In thousands)
|
|
|
Balance at December 31, 2008
|
|
$
|
65,076
|
|
Total gains (realized or unrealized):
|
|
|
|
|
Included in earnings
|
|
|
294
|
|
Included in other comprehensive income
|
|
|
824
|
|
Settlements
|
|
|
(2,700
|
)
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
63,494
|
|
|
|
|
|
|
The amount of total gains for the period included in other
comprehensive income attributable to the change in unrealized
gains relating to assets still held at December 31, 2009
|
|
$
|
824
|
|
|
|
|
|
|
81
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following tables summarize our investments as of the dates
indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
|
Cost or
|
|
|
Gross
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Government-sponsored enterprise securities
|
|
$
|
89,451
|
|
|
$
|
504
|
|
|
$
|
281
|
|
|
$
|
89,674
|
|
Municipal securities (including auction rate securities)
|
|
|
82,009
|
|
|
|
3,120
|
|
|
|
4,154
|
|
|
|
80,975
|
|
U.S. treasury notes
|
|
|
28,052
|
|
|
|
92
|
|
|
|
84
|
|
|
|
28,060
|
|
Certificates of deposit
|
|
|
3,258
|
|
|
|
|
|
|
|
|
|
|
|
3,258
|
|
Corporate bonds
|
|
|
32,543
|
|
|
|
206
|
|
|
|
185
|
|
|
|
32,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
235,313
|
|
|
$
|
3,922
|
|
|
$
|
4,704
|
|
|
$
|
234,531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cost or
|
|
|
Gross
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Government-sponsored enterprise securities
|
|
$
|
93,994
|
|
|
$
|
1,309
|
|
|
$
|
79
|
|
|
$
|
95,224
|
|
Municipal securities (including auction rate securities)
|
|
|
85,973
|
|
|
|
23
|
|
|
|
5,313
|
|
|
|
80,683
|
|
U.S. treasury notes
|
|
|
8,604
|
|
|
|
295
|
|
|
|
|
|
|
|
8,899
|
|
Certificates of deposit
|
|
|
13,494
|
|
|
|
|
|
|
|
|
|
|
|
13,494
|
|
Corporate bonds
|
|
|
50,315
|
|
|
|
155
|
|
|
|
731
|
|
|
|
49,739
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
252,380
|
|
|
$
|
1,782
|
|
|
$
|
6,123
|
|
|
$
|
248,039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The contractual maturities of our investments as of
December 31, 2009 are summarized below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Due in one year or less
|
|
$
|
67,475
|
|
|
$
|
67,387
|
|
Due one year through five years
|
|
|
106,624
|
|
|
|
106,934
|
|
Due after five years through ten years
|
|
|
1,430
|
|
|
|
1,400
|
|
Due after ten years
|
|
|
59,784
|
|
|
|
58,810
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
235,313
|
|
|
$
|
234,531
|
|
|
|
|
|
|
|
|
|
|
Gross realized gains and gross realized losses from sales of
available-for-sale
securities are calculated under the specific identification
method and are included in investment income. Total proceeds
from sales of
available-for-sale
securities were $60.3 million, $55.3 million, and
$13.1 million for the years ended December 31, 2009,
2008 and 2007, respectively. Net realized investment gains
(losses) for the years ended December 31, 2009, 2008 and
2007 were $267,000, $342,000 and $(78,000) respectively.
We monitor our investments for
other-than-temporary
impairment. For investments other than our municipal securities,
we have determined that unrealized gains and losses at
December 31, 2009 and 2008 are temporary in nature, because
the change in market value for these securities has resulted
from fluctuating interest rates, rather than a deterioration of
the credit worthiness of the issuers. So long as we hold these
securities to maturity, we are unlikely to experience gains or
losses. In the event that we dispose of these securities before
maturity, we expect that realized gains or losses, if any, will
be immaterial.
82
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Our investment in municipal securities consists primarily of
auction rate securities. As described in Note 5, Fair
Value Measurements, the unrealized losses on these
investments were caused primarily by the illiquidity in the
auction markets. Because the decline in market value is not due
to the credit quality of the issuers, and because we do not
intend to sell, nor is it more likely than not that we will be
required to sell these investments before recovery of their
cost, we do not consider the auction rate securities that are
designated as
available-for-sale
to be
other-than-temporarily
impaired at December 31, 2009.
The following table segregates those
available-for-sale
investments that have been in a continuous loss position for
less than 12 months and those that have been in a loss
position for 12 months or more as of December 31, 2009
and 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In a Continuous Loss
|
|
|
In a Continuous Loss
|
|
|
|
|
|
|
Position
|
|
|
Position
|
|
|
|
|
|
|
for Less than 12 Months
|
|
|
for 12 Months or More
|
|
|
|
|
|
|
as of December 31, 2009
|
|
|
as of December 31, 2009
|
|
|
Total as of December 31, 2009
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
(In thousands)
|
|
|
Municipal securities
|
|
$
|
10,427
|
|
|
$
|
77
|
|
|
$
|
24,031
|
|
|
$
|
3,902
|
|
|
$
|
34,458
|
|
|
$
|
3,979
|
|
Government-sponsored enterprise securities
|
|
|
11,192
|
|
|
|
150
|
|
|
|
7,297
|
|
|
|
94
|
|
|
|
18,489
|
|
|
|
244
|
|
U.S. treasury notes
|
|
|
5,572
|
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
5,572
|
|
|
|
34
|
|
Corporate bonds
|
|
|
8,170
|
|
|
|
124
|
|
|
|
1,203
|
|
|
|
36
|
|
|
|
9,373
|
|
|
|
160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
35,361
|
|
|
$
|
385
|
|
|
$
|
32,531
|
|
|
$
|
4,032
|
|
|
$
|
67,892
|
|
|
$
|
4,417
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In a Continuous Loss
|
|
|
In a Continuous Loss
|
|
|
|
|
|
|
Position
|
|
|
Position
|
|
|
|
|
|
|
for Less than 12 Months
|
|
|
for 12 Months or More
|
|
|
|
|
|
|
as of December 31, 2008
|
|
|
as of December 31, 2008
|
|
|
Total as of December 31, 2008
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
(In thousands)
|
|
|
Municipal securities
|
|
$
|
41,901
|
|
|
$
|
4,914
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
41,901
|
|
|
$
|
4,914
|
|
Government-sponsored enterprise securities
|
|
|
7,237
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
7,237
|
|
|
|
79
|
|
Corporate bonds
|
|
|
30,276
|
|
|
|
731
|
|
|
|
|
|
|
|
|
|
|
|
30,276
|
|
|
|
731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
79,414
|
|
|
$
|
5,724
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
79,414
|
|
|
$
|
5,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Accounts receivable by health plan operating subsidiary were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
California
|
|
$
|
34,289
|
|
|
$
|
20,740
|
|
Michigan
|
|
|
14,977
|
|
|
|
6,637
|
|
Missouri
|
|
|
19,670
|
|
|
|
24,024
|
|
New Mexico
|
|
|
11,919
|
|
|
|
5,712
|
|
Ohio
|
|
|
37,004
|
|
|
|
34,562
|
|
Utah
|
|
|
6,107
|
|
|
|
20,614
|
|
Washington
|
|
|
9,910
|
|
|
|
14,184
|
|
Other
|
|
|
2,778
|
|
|
|
2,089
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
136,654
|
|
|
$
|
128,562
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable as of December 31, 2009, increased
compared with the prior year generally as a result of increased
membership across several of our health plans. These increases
were partially offset by the decrease at our Utah health plan,
due to the termination of the plans cost-plus
reimbursement contract with the state of Utah effective
September 1, 2009, as described further below.
Ohio. As of December 31, 2009, the
receivable due our Ohio health plan included two significant
components. The first is approximately $5.1 million of
accrued birth income, net, due from the state of Ohio. Birth
income is a one-time payment for the delivery of a child from
the Medicaid program in Ohio.
The second significant component of the Ohio receivable is
approximately $28.8 million due from a capitated provider
group. Although we have a capitation arrangement with this
provider group, our agreement with them calls for us to pay for
certain medical services incurred by the provider groups
members, and then to deduct the amount of such payments from
future monthly capitation amounts owed to the provider group. Of
the $28.8 million receivable, approximately
$19.3 million represents medical services we have paid on
behalf of the provider group, which we will deduct from
capitation payments in the months of January and February 2010.
The other component of the Ohio receivable includes an estimate
of our liability for claims incurred by members of this provider
group, not covered by capitation, for which we have not yet made
payment. This amount totaled $9.5 million as of
December 31, 2009. The offsetting liability for the amount
of this receivable established for claims incurred but not paid
is included in Medical claims and benefits payable
in our consolidated balance sheets. As part of the agreement
with this provider group, our Ohio health plan has withheld
approximately $8.2 million from capitation payments due the
group, and placed the funds in an escrow account. The Ohio
health plan is entitled to the escrow amount if the provider
group is unable to repay amounts owed to us for these incurred
but not reported claims. The escrow account is included in
Restricted investments in our consolidated balance
sheets. During the year ended December 31, 2009, our
average monthly capitation payment to this provider group was
approximately $14 million.
Utah. Prior to September 1, 2009, our
Utah health plans agreement with the state of Utah called
for the reimbursement of medical costs incurred in serving our
members plus an administrative fee for a specified percentage of
that medical cost amount (which was formerly 9% and most
recently 6.5%), plus a portion of any cost savings realized as
defined in the agreement. Our Utah health plan billed the state
of Utah monthly for actual paid health care claims plus
administrative fees. Prior to September 1, 2009, our
receivable balance from the state of Utah included:
(1) amounts billed to the state for actual paid health care
claims plus administrative fees; and (2) amounts estimated
for incurred but not paid claims, which, along with the related
administrative fees, are not billable to the state of Utah until
such claims are actually paid. Effective as of September 1,
2009, the Utah health plans agreement with the state of
Utah became a prepaid capitation contract, under which the plan
is paid a fixed per member per month amount.
84
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
California. Effective October 1, 2009,
the state of California implemented a delivery payment as part
of its Medicaid managed care payment methodology. Accordingly,
the California health plan only receives delivery payments upon
acceptance by the state of a delivery encounter. The
substitution of this methodology for a portion of the state
payment that was previously paid as part of monthly capitation
has, combined with the increase in enrollment at the California
health plan during 2009, increased that health plans
accounts receivable at December 31, 2009 when compared with
December 31, 2008.
Michigan. Accounts receivable at our Michigan
health plan increased at December 31, 2009 when compared
with December 31, 2008 as a result of: (1) the
states notice that we would be receiving additional
premium for the months of October and November 2009 in
connection with a rate increase we received effective
October 1, 2009; (2) the accrual of a performance
bonus from the state of Michigan that was accrued at
December 31, 2009 and received in January 2010; and
(3) state delays in processing new born premiums at
December 31, 2009.
Missouri. Effective October 1, 2009, the
state of Missouri carved out the Medicaid pharmacy benefit from
the payments made to Medicaid health plans contracted in that
state and retained responsibility for administering that
benefit. As a result, monthly revenue (and the related
receivable) recorded by the Missouri health plan have decreased
at December 31, 2009 when compared with December 31,
2008.
New Mexico Effective July 1, 2009, the New Mexico
health plan began performing certain administrative services for
that states Medicaid program under a separate contract.
Accounts receivable recorded in connection with that contract
represent the majority of the increase in accounts receivable at
the New Mexico health plan between December 31, 2008 and
December 31, 2009.
Washington. More rapid collection of delivery
payments due from the state has reduced the Washington health
plans accounts receivable at December 31, 2009 when
compared with December 31, 2008.
|
|
8.
|
Property
and Equipment
|
A summary of property and equipment is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Land
|
|
$
|
3,524
|
|
|
$
|
3,461
|
|
Building and improvements
|
|
|
41,476
|
|
|
|
25,047
|
|
Furniture, equipment and automobiles
|
|
|
54,898
|
|
|
|
47,074
|
|
Capitalized computer software costs
|
|
|
66,526
|
|
|
|
56,211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
166,424
|
|
|
|
131,793
|
|
|
|
|
|
|
|
|
|
|
Less: accumulated depreciation and amortization on building and
improvements, furniture, equipment and automobiles
|
|
|
(50,911
|
)
|
|
|
(42,056
|
)
|
Less: accumulated amortization on capitalized computer software
costs
|
|
|
(37,342
|
)
|
|
|
(24,679
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(88,253
|
)
|
|
|
(66,735
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
78,171
|
|
|
$
|
65,058
|
|
|
|
|
|
|
|
|
|
|
The increase in property and equipment for the year ended
December 31, 2009 was primarily due to the build out and
commencement of operations of our new information technology
data center in Albuquerque, New Mexico. Depreciation expense
recognized for building and improvements, furniture, equipment
and automobiles was $11.0 million, $9.0 million, and
$8.5 million for the years ended December 31, 2009,
2008, and 2007, respectively. Amortization expense recognized
for capitalized computer software costs was $14.2 million,
$11.7 million, and $8.6 million for the years ended
December 31, 2009, 2008, and 2007, respectively.
85
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
9.
|
Goodwill
and Intangible Assets
|
Other intangible assets are amortized over their useful lives
ranging from one to 15 years. The weighted average
amortization period for contract rights and licenses is
approximately 11 years, and for provider networks is
approximately 10 years. Amortization expense on intangible
assets recognized for the years ended December 31, 2009,
2008, and 2007 was $12.9 million, $13.0 million, and
$10.8 million, respectively. Based on the balances of our
identifiable intangible assets as of December 31, 2009, we
estimate that our intangible asset amortization expense will be
$14.6 million in 2010, $13.4 million in 2011,
$11.0 million in 2012, $7.8 million in 2013, and
$7.0 million in 2014. The following table provides the
details of identified intangible assets, by major class, for the
periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
Net
|
|
|
|
Cost
|
|
|
Amortization
|
|
|
Balance
|
|
|
|
(In thousands)
|
|
|
Intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract rights and licenses
|
|
$
|
119,101
|
|
|
$
|
51,246
|
|
|
$
|
67,855
|
|
Provider networks
|
|
|
17,146
|
|
|
|
4,155
|
|
|
|
12,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
136,247
|
|
|
$
|
55,401
|
|
|
$
|
80,846
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract rights and licenses
|
|
$
|
114,219
|
|
|
$
|
46,160
|
|
|
$
|
68,059
|
|
Provider networks
|
|
|
14,548
|
|
|
|
3,474
|
|
|
|
11,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
128,767
|
|
|
$
|
49,634
|
|
|
$
|
79,133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The changes in the carrying amount of goodwill and
indefinite-lived intangible assets were as follows (in
thousands):
|
|
|
|
|
Balance as of December 31, 2008
|
|
$
|
113,466
|
|
Goodwill recorded for acquisition of Florida NetPASS
|
|
|
17,048
|
|
Goodwill adjustment related to acquisition of the Missouri
health plan
|
|
|
2,894
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
133,408
|
|
|
|
|
|
|
Our health plan subsidiaries have generally been successful in
obtaining the renewal by amendment of their contracts in each
state prior to the actual expiration of their contracts.
However, there can be no assurance that these contracts will
continue to be renewed.
|
|
10.
|
Restricted
Investments
|
Pursuant to the regulations governing our subsidiaries, we
maintain statutory deposits and deposits required by state
Medicaid authorities. Additionally, we maintain restricted
investments as protection against the insolvency of
86
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
capitated providers. The following table presents the balances
of restricted investments by health plan, and by our insurance
company:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
California
|
|
$
|
368
|
|
|
$
|
367
|
|
Florida
|
|
|
2,052
|
|
|
|
9,828
|
|
Insurance Company
|
|
|
4,686
|
|
|
|
4,718
|
|
Michigan
|
|
|
1,000
|
|
|
|
1,000
|
|
Missouri
|
|
|
503
|
|
|
|
506
|
|
New Mexico
|
|
|
15,497
|
|
|
|
9,670
|
|
Ohio
|
|
|
9,036
|
|
|
|
8,459
|
|
Texas
|
|
|
1,515
|
|
|
|
1,521
|
|
Utah
|
|
|
578
|
|
|
|
577
|
|
Washington
|
|
|
151
|
|
|
|
151
|
|
Other
|
|
|
888
|
|
|
|
1,405
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
36,274
|
|
|
$
|
38,202
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2009, the Florida health plans
restricted investments decreased compared with the prior year
due to the release of escrow funds relating to a settlement
agreement with the state of Florida that was a component of the
purchase price of NetPASS (see Note 4, Business
Purchase Transactions). The increase in the New Mexico
health plans restricted investments over the same period
was due primarily to an increase in premium revenue at the plan,
a percentage of which is used to determine the restricted
investment balance required by the state of New Mexico.
Additionally, the state of New Mexicos calculation
methodology changed to use gross premium revenue, rather than
the net premiums after taxes and assessments, also resulting in
an increase to the required balance.
The contractual maturities of our
held-to-maturity
restricted investments as of December 31, 2009 are
summarized below.
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
Due in one year or less
|
|
$
|
35,408
|
|
|
$
|
35,425
|
|
Due one year through five years
|
|
|
724
|
|
|
|
721
|
|
Due after five years through ten years
|
|
|
142
|
|
|
|
155
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
36,274
|
|
|
$
|
36,301
|
|
|
|
|
|
|
|
|
|
|
|
|
11.
|
Medical
Claims and Benefits Payable
|
The following table presents the components of the change in our
medical claims and benefits payable for the years ended
December 31, 2009 and 2008. The negative amounts displayed
for Components of medical care costs related to: Prior
periods represent the amount by which our original
estimate of claims and benefits payable at the
87
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
beginning of the period exceeded the actual amount of the
liability based on information (principally the payment of
claims) developed since that liability was first reported.
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(Dollars in thousands)
|
|
|
Balances at beginning of period
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
Components of medical care costs related to:
|
|
|
|
|
|
|
|
|
Current period
|
|
|
3,227,794
|
|
|
|
2,683,399
|
|
Prior periods
|
|
|
(51,558
|
)
|
|
|
(62,087
|
)
|
|
|
|
|
|
|
|
|
|
Total medical care costs
|
|
|
3,176,236
|
|
|
|
2,621,312
|
|
|
|
|
|
|
|
|
|
|
Payments for medical care costs related to:
|
|
|
|
|
|
|
|
|
Current period
|
|
|
2,919,240
|
|
|
|
2,413,128
|
|
Prior periods
|
|
|
232,922
|
|
|
|
227,348
|
|
|
|
|
|
|
|
|
|
|
Total paid
|
|
|
3,152,162
|
|
|
|
2,640,476
|
|
|
|
|
|
|
|
|
|
|
Balances at end of period
|
|
$
|
316,516
|
|
|
$
|
292,442
|
|
|
|
|
|
|
|
|
|
|
Benefit from prior period as a percentage of:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
|
17.6
|
%
|
|
|
19.9
|
%
|
Premium revenue
|
|
|
1.4
|
%
|
|
|
2.0
|
%
|
Total medical care costs
|
|
|
1.6
|
%
|
|
|
2.4
|
%
|
The overestimation of our liability for claims and medical
benefits payable at December 31, 2008 led to the
recognition of a benefit from prior period claims development
for the year ended December 31, 2009 totaling
$51.6 million. The overestimation of the claims liability
at our Michigan, New Mexico, Ohio, and Washington health plans
was principally the cause of the recognition of a benefit from
prior period claims development. This was partially offset by
the underestimation of our claims liability at December 31,
2008 at our California health plan. The details were as follows:
|
|
|
|
|
In Michigan, we underestimated the impact of a steep drop in
claims inventory during December 2008, thereby overestimating
our liability at December 31, 2008.
|
|
|
|
In New Mexico, we overestimated at December 31, 2008 the
ultimate amounts we would need to pay to resolve certain high
dollar provider claims, thereby overestimating our liability at
December 31, 2008.
|
|
|
|
In Ohio, we underestimated the degree to which certain
operational initiatives had reduced our medical costs in the
last few months of 2008, thereby overestimating our liability at
December 31, 2008.
|
|
|
|
In Washington, we overestimated the impact that certain adverse
utilization trends would have on our liability at
December 31, 2008, thereby overestimating our liability at
December 31, 2008.
|
|
|
|
In California, we underestimated utilization trends at the end
of 2008, leading to an underestimation of our liability at
December 31, 2008. Additionally, we underestimated the
impact that certain delays in the receipt of paper claims (as
opposed to electronically submitted claims) would have on our
liability, leading to a further underestimation of our liability
at December 31, 2008.
|
In 2008, overestimation of our claims liability, particularly at
our Michigan and Washington health plans, at December 31,
2007 led to the recognition of a benefit from prior period
claims development totaling $62.1 million, as follows:
|
|
|
|
|
In Michigan, we overestimated the extent to which both
catastrophic claims and state-mandated changes to the
methodology used to pay outpatient claims had increased our
liability at December 31, 2007.
|
88
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
In Washington, we overestimated the extent to which
state-mandated changes to hospital fee schedules implemented in
August 2007 had increased our liability at December 31,
2007.
|
The use of a consistent methodology in estimating our liability
for claims and medical benefits payable minimizes the degree to
which the under- or overestimation of that liability at the
close of one period may affect consolidated results of
operations in subsequent periods. Facts and circumstances unique
to the estimation process at any single date, however, may still
lead to a material impact on consolidated results of operations
in subsequent periods Any absence of adverse claims development
(as well as the expensing through general and administrative
expense of the costs to settle claims held at the start of the
period) will lead to the recognition of a benefit from prior
period claims development in the period subsequent to the date
of the original estimate. However, that benefit will affect
current period earnings only to the extent that the
replenishment of the reserve for adverse claims development (and
the re-accrual of administrative costs for the settlement of
those claims) is less than the benefit recognized from the prior
period liability. In 2009 and 2008 the absence of adverse
development of the liability for claims and medical benefits
payable at the close of the previous period resulted in the
recognition of substantial favorable prior period development.
In both years, however, the recognition of a benefit from prior
period claims development did not have a material impact on our
consolidated results of operations as the amount of benefit
recognized in each your was roughly consistent with that
recognized in the previous year.
Convertible
Senior Notes
In October 2007, we sold $200.0 million aggregate principal
amount of 3.75% Convertible Senior Notes due 2014 (the
Notes). The sale of the Notes resulted in net
proceeds totaling $193.4 million. During 2009, we purchased
and retired $13.0 million face amount of the Notes, so the
remaining aggregate principal amount totaled $187.0 million
as of December 31, 2009 (see further discussion below
regarding the purchase program). The Notes rank equally in right
of payment with our existing and future senior indebtedness.
The Notes are convertible into cash and, under certain
circumstances, shares of our common stock. The initial
conversion rate is 21.3067 shares of our common stock per
one thousand dollar principal amount of the Notes. This
represents an initial conversion price of approximately $46.93
per share of our common stock. In addition, if certain corporate
transactions that constitute a change of control occur prior to
maturity, we will increase the conversion rate in certain
circumstances. Prior to July 2014, holders may convert their
Notes only under the following circumstances:
|
|
|
|
|
During any fiscal quarter after our fiscal quarter ending
December 31, 2007, if the closing sale price per share of
our common stock, for each of at least 20 trading days during
the period of 30 consecutive trading days ending on the last
trading day of the previous fiscal quarter, is greater than or
equal to 120% of the conversion price per share of our common
stock;
|
|
|
|
During the five business day period immediately following any
five consecutive trading day period in which the trading price
per one thousand dollar principal amount of the Notes for each
trading day of such period was less than 98% of the product of
the closing price per share of our common stock on such day and
the conversion rate in effect on such day; or
|
|
|
|
Upon the occurrence of specified corporate transactions or other
specified events.
|
On or after July 1, 2014, holders may convert their Notes
at any time prior to the close of business on the scheduled
trading day immediately preceding the stated maturity date
regardless of whether any of the foregoing conditions is
satisfied.
89
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We will deliver cash and shares of our common stock, if any,
upon conversion of each $1,000 principal amount of Notes, as
follows:
|
|
|
|
|
An amount in cash (the principal return) equal to
the sum of, for each of the 20 Volume-Weighted Average Price
(VWAP) trading days during the conversion period, the lesser of
the daily conversion value for such VWAP trading day and fifty
dollars (representing 1/20th of one thousand
dollars); and
|
|
|
|
A number of shares based upon, for each of the 20 VWAP trading
days during the conversion period, any excess of the daily
conversion value above fifty dollars.
|
In May 2008, the FASB issued new standards relating to certain
convertible debt instruments, which we adopted effective
January 1, 2009 (see Note 1, Basis of
Presentation). These standards require the proceeds from
the issuance of such convertible debt instruments to be
allocated between a liability component and an equity component,
which we have done with respect to the Notes. We have determined
that the effective interest rate of the Notes is 7.5%,
principally based on the seven-year U.S. treasury note rate
as of the October 2007 issuance date, plus an appropriate credit
spread. The resulting debt discount is being amortized over the
period the Notes are expected to be outstanding, as additional
non-cash interest expense. As of December 31, 2009, we
expect the Notes to be outstanding until their October 1,
2014 maturity date, for a remaining amortization period of
57 months. The Notes if-converted value did not
exceed their principal amount as of December 31, 2009. We
allocated $24.5 million, net of the impact of deferred
taxes, to the equity component of the Notes, which amount
continued to be the carrying amount of the equity component as
of December 31, 2008. At December 31, 2009, the equity
component of the Notes, net of the impact of deferred taxes, was
$24.0 million. The slight reduction in the amount of the
equity component was due to amounts recorded as a result of our
purchase of $13.0 million face amount of the Notes during
the first quarter of 2009 (described further below). The
following table provides the details of the liability amounts
recorded:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
As of
|
|
|
|
December 30,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Details of the liability component:
|
|
|
|
|
|
|
|
|
Principal amount
|
|
$
|
187,000
|
|
|
$
|
200,000
|
|
Unamortized discount
|
|
|
(28,100
|
)
|
|
|
(35,127
|
)
|
|
|
|
|
|
|
|
|
|
Net carrying amount
|
|
$
|
158,900
|
|
|
$
|
164,873
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Interest cost recognized for the period relating to the:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual interest coupon rate of 3.75%
|
|
$
|
7,076
|
|
|
$
|
7,500
|
|
|
$
|
1,688
|
|
Amortization of the discount on the liability component
|
|
|
4,782
|
|
|
|
4,707
|
|
|
|
1,012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest cost recognized
|
|
$
|
11,858
|
|
|
$
|
12,207
|
|
|
$
|
2,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Program. Under the
$25 million securities purchase program announced in
January 2009, we purchased and retired $13.0 million
face amount of the Notes during the first quarter of 2009. We
purchased the Notes at an average price of $74.25 per $100
principal amount, for a total of $9.8 million, including
accrued interest. The gain recognized during the quarter ended
March 31, 2009 on the purchase of the Notes was
$1.5 million, or approximately $0.04 per diluted share.
In March 2009, our board of directors authorized the purchase of
up to an additional $25 million in aggregate of either our
common stock or the Notes. The purchase program was funded with
working capital, and common stock purchases were made from time
to time on the open market or through privately negotiated
transactions during
90
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2009. The purchase program extended through December 31,
2009. See the details regarding the common stock purchases at
Note 14, Stockholders Equity.
Credit
Facility
In 2005, we entered into the Amended and Restated Credit
Agreement, dated as of March 9, 2005, among Molina
Healthcare Inc., certain lenders, and Bank of America N.A., as
Administrative Agent (the Credit Facility).
Effective May 2007, we entered into a third amendment of the
Credit Facility that increased the size of the revolving line of
credit from $180.0 million to $200.0 million, maturing
in May 2012. The Credit Facility is intended to be used for
general corporate purposes.
Pending the closing of the acquisition of the HIM business and
the effectiveness of the fourth amendment, interest rates on
borrowings under the Credit Facility are based, at our election,
on the London Interbank Offered Rate, or LIBOR, or the base rate
plus an applicable margin. The base rate equals the higher of
Bank of Americas prime rate or 0.500% above the federal
funds rate. We also pay a commitment fee on the total unused
commitments of the lenders under the Credit Facility. The
applicable margins and commitment fee are based on our ratio of
consolidated funded debt to consolidated earnings before
interest expense, taxes, depreciation and amortization, or
EBITDA. The applicable margins range between 0.750% and 1.750%
for LIBOR loans and between 0.000% and 0.750% for base rate
loans. The commitment fee ranges between 0.150% and 0.275%. In
addition, we are required to pay a fee for each letter of credit
issued under the Credit Facility equal to the applicable margin
for LIBOR loans and a customary fronting fee. As of
December 31, 2009 and 2008, there were no amounts
outstanding under the Credit Facility.
Our obligations under the Credit Facility are secured by a lien
on substantially all of our assets and by a pledge of the
capital stock of our health plan subsidiaries (with the
exception of our California health plan). The Credit Facility
includes usual and customary covenants for credit facilities of
this type, including covenants limiting liens, mergers, asset
sales, other fundamental changes, debt, acquisitions, dividends
and other distributions, capital expenditures, investments, and
a fixed charge coverage ratio. The Credit Facility also requires
us to maintain a ratio of total consolidated debt to total
consolidated EBITDA of not more than 2.75 to 1.00 at any time.
At December 31, 2009, we were in compliance with all
financial covenants in the Credit Facility. See Note 21,
Subsequent Events, for further discussion of our
fourth amendment and fifth amendment of the Credit Facility,
relating to a business purchase transaction announced in January
2010.
The provision for income taxes consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
9,421
|
|
|
$
|
32,972
|
|
|
$
|
36,171
|
|
State
|
|
|
3,901
|
|
|
|
6,916
|
|
|
|
3,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current
|
|
|
13,322
|
|
|
|
39,888
|
|
|
|
39,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
1,924
|
|
|
|
378
|
|
|
|
(3,955
|
)
|
State
|
|
|
(2,498
|
)
|
|
|
(490
|
)
|
|
|
(338
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred
|
|
|
(574
|
)
|
|
|
(112
|
)
|
|
|
(4,293
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in valuation allowance
|
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
12,748
|
|
|
$
|
39,776
|
|
|
$
|
34,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
91
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A reconciliation of the effective income tax rate to the
statutory federal income tax rate is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Taxes on income at statutory federal tax rate (35%)
|
|
$
|
15,266
|
|
|
$
|
34,782
|
|
|
$
|
32,453
|
|
State income taxes, net of federal benefit
|
|
|
912
|
|
|
|
4,176
|
|
|
|
1,925
|
|
(Benefit) liability for unrecognized tax benefits
|
|
|
(3,315
|
)
|
|
|
450
|
|
|
|
85
|
|
Other
|
|
|
(115
|
)
|
|
|
368
|
|
|
|
533
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income tax expense
|
|
$
|
12,748
|
|
|
$
|
39,776
|
|
|
$
|
34,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our effective tax rate is based on expected income, statutory
tax rates, and tax planning opportunities available to us in the
various jurisdictions in which we operate. Significant
management estimates and judgments are required in determining
our effective tax rate. We are routinely under audit by federal,
state, or local authorities regarding the timing and amount of
deductions, nexus of income among various tax jurisdictions, and
compliance with federal, state, and local tax laws. We have
pursued various strategies to reduce our federal, state and
local taxes. As a result, we have reduced our state income tax
expense due to California enterprise zone credits.
During 2009, 2008, and 2007, tax-related benefits (deficiencies)
on share-based compensation were $(718,000), $(292,000), and
$853,000, respectively. Such amounts were recorded as
adjustments to income taxes payable with a corresponding
increase (decrease) to additional paid-in capital.
92
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Deferred tax assets and liabilities are classified as current or
non-current according to the classification of the related asset
or liability. Significant components of our deferred tax assets
and liabilities as of December 31, 2009 and 2008 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Accrued expenses
|
|
$
|
2,494
|
|
|
$
|
6,785
|
|
Reserve liabilities
|
|
|
285
|
|
|
|
1,046
|
|
State taxes
|
|
|
1,151
|
|
|
|
172
|
|
Other accrued medical costs
|
|
|
1,628
|
|
|
|
1,724
|
|
Net operating losses
|
|
|
27
|
|
|
|
27
|
|
Unrealized (gains) losses
|
|
|
(408
|
)
|
|
|
1,274
|
|
Unearned premiums
|
|
|
6,554
|
|
|
|
2,063
|
|
Prepaid expenses
|
|
|
(2,894
|
)
|
|
|
(3,979
|
)
|
Other, net
|
|
|
(80
|
)
|
|
|
(41
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax asset, net of valuation allowance
current
|
|
|
8,757
|
|
|
|
9,071
|
|
|
|
|
|
|
|
|
|
|
Accrued expenses
|
|
|
(281
|
)
|
|
|
|
|
Reserve liabilities
|
|
|
2,501
|
|
|
|
1,684
|
|
State taxes
|
|
|
|
|
|
|
1,830
|
|
Other accrued medical costs
|
|
|
(866
|
)
|
|
|
108
|
|
Net operating losses
|
|
|
237
|
|
|
|
971
|
|
Unrealized losses
|
|
|
1,480
|
|
|
|
199
|
|
Unearned premiums
|
|
|
(264
|
)
|
|
|
|
|
Depreciation and amortization
|
|
|
(10,415
|
)
|
|
|
(10,698
|
)
|
Deferred compensation
|
|
|
6,817
|
|
|
|
5,876
|
|
Debt basis
|
|
|
(11,555
|
)
|
|
|
(12,931
|
)
|
Other, net
|
|
|
(160
|
)
|
|
|
745
|
|
Valuation allowance
|
|
|
|
|
|
|
(695
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liability, net of valuation allowance
long term
|
|
|
(12,506
|
)
|
|
|
(12,911
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred income tax liability
|
|
$
|
(3,749
|
)
|
|
$
|
(3,840
|
)
|
|
|
|
|
|
|
|
|
|
At December 31, 2009, we had federal and state net
operating loss carryforwards of $344,000 and $3.8 million,
respectively. The federal net operating loss begins expiring in
2011, and state net operating losses begin expiring in 2028. The
utilization of the net operating losses is subject to certain
limitations under federal and state law.
At December 31, 2009, we had California enterprise zone tax
credit carryovers of $2.1 million which do not expire.
We have determined that as of December 31, 2008, $695,000
of deferred tax assets did not satisfy the recognition criteria.
Accordingly, we recorded a valuation allowance of $695,000 as of
December 31, 2008. The valuation allowance primarily
related to the uncertainty of realizing certain Indiana state
net operating loss carryforwards. We determined in 2009 that we
would no longer file an Indiana state tax return, thus,
rendering the state net operating loss carryover worthless. As
such, we recorded a write-off of the deferred tax asset and
corresponding valuation allowance relating to the Indiana state
net operating loss carryover.
During 2008, $7.4 million of net deferred tax assets were
established with a corresponding reduction to goodwill for
certain acquired intangible assets in connection with the 2007
purchase of Mercy CarePlus.
93
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Additionally during 2008, $2.2 million of deferred tax
assets relating to the 2006 purchase of the Cape Health Plan
were derecognized which resulted in a corresponding increase to
goodwill under purchase accounting.
We recognize tax benefits only if the tax position is more
likely than not to be sustained. We are subject to income taxes
in the U.S. and numerous state jurisdictions. Significant
judgment is required in evaluating our tax positions and
determining our provision for income taxes. During the ordinary
course of business, there are many transactions and calculations
for which the ultimate tax determination is uncertain. We
establish reserves for tax-related uncertainties based on
estimates of whether, and the extent to which, additional taxes
will be due. These reserves are established when we believe that
certain positions might be challenged despite our belief that
our tax return positions are fully supportable. We adjust these
reserves in light of changing facts and circumstances, such as
the outcome of tax audit. The provision for income taxes
includes the impact of reserve provisions and changes to
reserves that are considered appropriate.
The roll forward of our unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Gross unrecognized tax benefits at beginning of period
|
|
$
|
(11,676
|
)
|
|
$
|
(10,278
|
)
|
|
$
|
(4,355
|
)
|
Increases in tax positions for prior years
|
|
|
(3,748
|
)
|
|
|
(3,310
|
)
|
|
|
(3,197
|
)
|
Decreases in tax positions for prior years
|
|
|
6,804
|
|
|
|
2,682
|
|
|
|
1,527
|
|
Increases in tax positions for current year
|
|
|
|
|
|
|
(2,061
|
)
|
|
|
(4,935
|
)
|
Decreases in tax positions for current year
|
|
|
|
|
|
|
892
|
|
|
|
|
|
Settlements
|
|
|
4,355
|
|
|
|
|
|
|
|
202
|
|
Lapse in statute of limitations
|
|
|
137
|
|
|
|
399
|
|
|
|
480
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross unrecognized tax benefits at end of period
|
|
$
|
(4,128
|
)
|
|
$
|
(11,676
|
)
|
|
$
|
(10,278
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2009, we had $4.1 million of
unrecognized tax benefits of which $3.4 million, if fully
recognized, would affect our effective tax rate. We anticipate a
decrease of $408,000 to our liability for unrecognized tax
benefits within the next twelve-month period due to normal
expiration of tax statutes.
Our continuing practice is to recognize interest
and/or
penalties related to unrecognized tax benefits in income tax
expense. As of December 31, 2009, December 31, 2008,
and December 31, 2007, we had accrued $75,000,
$1.4 million and $638,000, respectively, for the payment of
interest and penalties.
We may be subject to examination by the Internal Revenue Service
(IRS) for calendar years 2006 through 2009. We are
under examination, or may be subject to examination, in certain
state and local jurisdictions, with the major jurisdictions
being California, Missouri, and Michigan, for the years 2004
through 2009. Our subsidiary, HCLB, entered into a closing
agreement with the IRS in December 2009 that successfully
concluded with certainty the IRS examination of HCLB for the
year ended May 2006.
Under the purchase program described in Note 12,
Long-Term Debt, we have purchased approximately
1.4 million shares of our common stock for
$27.7 million (average cost of approximately $20.49 per
share) during 2009. These purchases have increased diluted
earnings per share for the year ended December 31, 2009 by
$0.04. We have retired the $27.7 million of treasury shares
purchased in 2009, and we have also retired $20.4 million
of treasury shares that were purchased prior to 2009
($48.1 million in aggregate). This resulted in the
reduction of additional paid-in capital as of December 31,
2009, compared with December 31, 2008. Also in 2009, the
treasury stock balance decreased as a result of the retirement
of the $20.4 million of treasury shares purchased prior to
2009.
In April 2008, our board of directors authorized the purchase of
up to $30 million of our common stock on the open market or
through privately negotiated transactions, and then subsequently
in July 2008, authorized the purchase of up to an additional one
million shares of our common stock. We used working capital to
fund the
94
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
purchases under these programs. The timing and amount of
purchases were primarily made pursuant to a
Rule 10b5-1
trading plans. Under these programs, we purchased approximately
1.9 million shares for an aggregate purchase price of
$49.9 million (average cost of approximately $25.70 per
share). These shares were subsequently retired in 2008.
In December 2008, we filed a shelf registration statement on
Form S-3
with the Securities and Exchange Commission covering the
issuance of up to $300 million of securities, including
common stock or debt securities, and up to 250,000 shares
of our common stock, offered by selling stockholders. We may
publicly offer securities from time to time at prices and terms
to be determined at the time of the offering.
We sponsor a defined contribution 401(k) plan that covers
substantially all full-time salaried and hourly employees of our
company and its subsidiaries. Eligible employees are permitted
to contribute up to the maximum amount allowed by law. We match
up to the first 4% of compensation contributed by employees.
Expense recognized in connection with our contributions to the
401(k) plan totaled $4.7 million, $3.9 million and
$3.6 million in the years ended December 31, 2009,
2008, and 2007, respectively.
We also have a nonqualified deferred compensation plan for
certain key employees. Under this plan, eligible participants
may defer up to 100% of their base salary and 100% of their
bonus to provide tax-deferred growth for retirement. The funds
deferred are invested in corporate-owned life insurance, under a
rabbi trust.
In 2002, we adopted the 2002 Equity Incentive Plan (the
2002 Plan), which provides for the award of stock
options, restricted stock, performance shares, and stock bonuses
to the companys officers, employees, directors,
consultants, advisors, and other service providers. The 2002
Plan initially allowed for the issuance of 1.6 million
shares of common stock. Beginning January 1, 2004, shares
eligible for issuance automatically increase by the lesser of
400,000 shares or 2% of total outstanding capital stock on
a fully diluted basis, unless the board of directors
affirmatively acts to nullify the automatic increase. There were
4.0 million shares reserved for issuance under the 2002
Plan as of January 1, 2009.
Restricted stock awards are granted with a fair value equal to
the market price of our common stock on the date of grant, and
generally vest in equal annual installments over periods up to
four years from the date of grant. Stock option awards have an
exercise price equal to the fair market value of our common
stock on the date of grant, generally vest in equal annual
installments over periods up to four years from the date of
grant, and have a maximum term of ten years from the date of
grant.
Under our 2002 Employee Stock Purchase Plan (the
ESPP), eligible employees may purchase common shares
at 85% of the lower of the fair market value of our common stock
on either the first or last trading day of each six-month
offering period. Each participant is limited to a maximum
purchase of $25,000 (as measured by the fair value of the stock
acquired) per year through payroll deductions. Under the ESPP,
we issued 120,300 and 86,400 shares of our common stock
during the years ended December 31, 2009 and 2008,
respectively. Beginning January 1, 2004, and each year
until the 2.2 million maximum aggregate number of shares
reserved for issuance was reached on December 31, 2008,
shares available for issuance under the ESPP automatically
increased by 1% of total outstanding capital stock. The
aggregate number of unissued common shares available for future
grants under the 2002 Plan and the ESPP combined was
3.8 million as of December 31, 2009, and
3.9 million as of December 31, 2008.
95
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table illustrates the components of our
stock-based compensation expense that are reported in general
and administrative expenses in the consolidated statements of
income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
|
Charges
|
|
|
Amount
|
|
|
Charges
|
|
|
Amount
|
|
|
Charges
|
|
|
Amount
|
|
|
Restricted stock awards
|
|
$
|
5,789
|
|
|
$
|
3,589
|
|
|
$
|
5,171
|
|
|
$
|
3,206
|
|
|
$
|
3,751
|
|
|
$
|
2,335
|
|
Stock options (including expense relating to our ESPP)
|
|
|
1,696
|
|
|
|
1,052
|
|
|
|
2,640
|
|
|
|
1,637
|
|
|
|
3,437
|
|
|
|
2,139
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
7,485
|
|
|
$
|
4,641
|
|
|
$
|
7,811
|
|
|
$
|
4,843
|
|
|
$
|
7,188
|
|
|
$
|
4,474
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For both restricted stock and stock option awards, the expense
is recognized over the vesting period, generally straight-line
over four years. As of December 31, 2009, there was
$12.2 million of unrecognized compensation cost related to
unvested restricted stock awards, which we expect to recognize
over a weighted-average period of 2.6 years. This
unrecognized compensation cost assumes an estimated forfeiture
rate of 6% as of December 31, 2009. Also as of
December 31, 2009, there was $0.9 million of
unrecognized compensation expense related to unvested stock
options, which we expect to recognize over a weighted-average
period of 1.3 years.
The total fair value of restricted shares vested during the
years ended December 31, 2009, 2008, and 2007 was
$3.2 million, $2.5 million, and $2.6 million,
respectively. Unvested restricted stock activity for the year
ended December 31, 2009 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
Average Grant Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Unvested balance as of December 31, 2008
|
|
|
470,955
|
|
|
$
|
31.95
|
|
Granted
|
|
|
425,000
|
|
|
$
|
18.93
|
|
Vested
|
|
|
(163,700
|
)
|
|
$
|
30.52
|
|
Forfeited
|
|
|
(44,625
|
)
|
|
$
|
25.82
|
|
|
|
|
|
|
|
|
|
|
Unvested balance as of December 31, 2009
|
|
|
687,630
|
|
|
$
|
24.64
|
|
|
|
|
|
|
|
|
|
|
No stock options were exercised during the year ended
December 31, 2009; the total intrinsic value of stock
options exercised during the year ended December 31, 2008
was nominal. The total intrinsic value of stock options
exercised during the year ended December 31, 2007 amounted
to $4.3 million. Stock option activity for the year ended
December 31, 2009 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Intrinsic
|
|
|
|
Number
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Value
|
|
|
|
of Options
|
|
|
Price
|
|
|
Term (Years)
|
|
|
(000s)
|
|
|
Outstanding at December 31, 2008
|
|
|
665,339
|
|
|
$
|
30.29
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(14,600
|
)
|
|
$
|
31.96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2009
|
|
|
650,739
|
|
|
$
|
30.25
|
|
|
|
5.8
|
|
|
$
|
288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable and expected to vest at December 31, 2009(a)
|
|
|
640,478
|
|
|
$
|
30.22
|
|
|
|
5.8
|
|
|
$
|
288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2009
|
|
|
542,905
|
|
|
$
|
29.92
|
|
|
|
5.5
|
|
|
$
|
288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Stock options exercisable and expected to vest at
December 31, 2009 information is based on an estimated
forfeiture rate of 13%. |
96
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following is a summary of information about stock options
outstanding and exercisable at December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
|
Number
|
|
|
Weighted-
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
Outstanding
|
|
|
Average
|
|
|
Weighted-
|
|
|
Exercisable
|
|
|
Weighted-
|
|
|
|
at
|
|
|
Remaining
|
|
|
Average
|
|
|
at
|
|
|
Average
|
|
|
|
December 31,
|
|
|
Contractual
|
|
|
Exercise
|
|
|
December 31,
|
|
|
Exercise
|
|
Range of Exercise Prices
|
|
2009
|
|
|
Life (Years)
|
|
|
Price
|
|
|
2009
|
|
|
Price
|
|
|
$4.50 - $27.49
|
|
|
164,170
|
|
|
|
4.0
|
|
|
$
|
23.11
|
|
|
|
162,670
|
|
|
$
|
23.10
|
|
$28.66 - $28.66
|
|
|
173,744
|
|
|
|
6.1
|
|
|
$
|
28.66
|
|
|
|
173,744
|
|
|
$
|
28.66
|
|
$29.17 - $30.05
|
|
|
9,350
|
|
|
|
5.9
|
|
|
$
|
29.86
|
|
|
|
9,350
|
|
|
$
|
29.86
|
|
$31.32 - $44.29
|
|
|
303,475
|
|
|
|
6.7
|
|
|
$
|
35.03
|
|
|
|
197,141
|
|
|
$
|
36.66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,739
|
|
|
|
5.8
|
|
|
$
|
30.25
|
|
|
|
542,905
|
|
|
$
|
29.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Black-Scholes valuation model was used to estimate the fair
value of stock options at grant date (for options awarded in
2008 and 2007; no options were awarded in 2009) based on
the assumptions noted in the following table. The risk-free
interest rate is based on the implied yield on
U.S. treasury zero coupon issues for the expected option
term. The expected volatility is based on historical volatility
levels of our common stock. Beginning in the first quarter of
2008, we used an expected term for each option award based on
historical experience of employee post-vesting exercise and
termination behavior. Prior to 2008, the expected option term of
each award granted was calculated using the simplified
method in accordance with Staff Accounting
Bulletin No. 107. This change did not produce
materially different valuation results for the stock options
awarded in 2008. The assumptions disclosed below represent a
weighted-average of the assumptions used for all of our stock
option grants throughout each of the years presented.
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2008
|
|
2007
|
|
Risk-free interest rate
|
|
|
2.5
|
%
|
|
|
4.5
|
%
|
Expected volatility
|
|
|
45.3
|
%
|
|
|
47.1
|
%
|
Expected option life (in years)
|
|
|
4
|
|
|
|
6
|
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Grant date weighted-average fair value
|
|
$
|
12.80
|
|
|
$
|
16.37
|
|
|
|
17.
|
Related
Party Transactions
|
We have an equity investment in a medical service provider that
provides certain vision services to our members. We account for
this investment under the equity method of accounting because we
have an ownership interest in the investee that confers
significant influence over operating and financial policies of
the investee. As of December 31, 2009 and 2008, our
carrying amount for this investment totaled $4.1 million
and $3.6 million, respectively. During 2008, we advanced
this provider $1.3 million, all of which was collected
during 2009. For the years ended December 31, 2009, 2008,
and 2007, we paid $21.8 million, $15.4 million, and
$10.9 million, respectively, for medical service fees to
this provider.
We are a party to a
fee-for-service
agreement with Pacific Hospital of Long Beach (Pacific
Hospital). Pacific Hospital is owned by Abrazos
Healthcare, Inc., the shares of which are held as community
property by the husband of Dr. Martha Bernadett, the sister
of Dr. J. Mario Molina, our Chief Executive Officer, and
John Molina, our Chief Financial Officer. Amounts paid to
Pacific Hospital under the terms of this
fee-for-service
agreement were $745,000, $242,000, and $157,000 for the years
ended December 31, 2009, 2008, and 2007, respectively. We
also had a capitation arrangement with Pacific Hospital, where
we paid Pacific Hospital a fixed monthly fee per member. This
contract was terminated by the parties effective August 31,
2009. Amounts paid to Pacific Hospital for capitated services
totaled approximately $1.1 million, $3.8 million, and
$4.8 million for the years ended
97
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
December 31, 2009, 2008, and 2007, respectively. We believe
that both arrangements with Pacific Hospital are based on
prevailing market rates for similar services.
|
|
18.
|
Commitments
and Contingencies
|
Leases
We lease office space, clinics, equipment, and automobiles under
agreements that expire at various dates through 2018. Future
minimum lease payments by year and in the aggregate under all
non-cancelable operating leases consist of the following
approximate amounts:
|
|
|
|
|
Year ending December 31,
|
|
|
|
|
|
(In thousands)
|
|
|
2010
|
|
$
|
21,334
|
|
2011
|
|
|
20,761
|
|
2012
|
|
|
18,604
|
|
2013
|
|
|
15,183
|
|
2014
|
|
|
13,522
|
|
Thereafter
|
|
|
39,576
|
|
|
|
|
|
|
Total minimum lease payments
|
|
$
|
128,980
|
|
|
|
|
|
|
Rental expense related to these leases totaled
$20.8 million, $17.5 million, and $18.1 million
for the years ended December 31, 2009, 2008, and 2007,
respectively.
Employment
Agreements
During 2001 and 2002, we entered into employment agreements with
three current executives with initial terms of one to three
years, subject to automatic one-year extensions thereafter. In
most cases, should the executive be terminated without cause or
resign for good reason before a change of control, as defined,
we will pay one years base salary and termination bonus,
as defined, in addition to full vesting of 401(k) employer
contributions and stock-based awards, and a cash sum equal in
value to health and welfare benefits provided for
18 months. If any of the executives are terminated for
cause, no further payments are due under the contracts.
In most cases, if termination occurs within two years following
a change of control, the employee will receive two times their
base salary and termination bonus, in addition to full vesting
of 401(k) employer contributions and stock-based awards, and a
cash sum equal in value to health and welfare benefits provided
for three years.
Executives who receive severance benefits, whether or not in
connection with a change of control, will also receive all
accrued benefits for prior service including a termination bonus.
Legal
Proceedings
The health care industry is subject to numerous laws and
regulations of federal, state, and local governments. Compliance
with these laws and regulations can be subject to government
review and interpretation, as well as regulatory actions unknown
and unasserted at this time. Penalties associated with
violations of these laws and regulations include significant
fines and penalties, exclusion from participating in publicly
funded programs, and the repayment of previously billed and
collected revenues.
We are involved in legal actions in the ordinary course of
business, some of which seek monetary damages, including claims
for punitive damages, which are not covered by insurance. The
outcome of such legal actions is inherently uncertain.
Nevertheless, we believe that these actions, when finally
concluded and determined, are not likely to have a material
adverse effect on our consolidated financial position, results
of operations, or cash flows.
98
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Professional
Liability Insurance
We carry medical malpractice insurance for health care services
rendered through our clinics in California. Claims-made coverage
under this policy is $1.0 million per occurrence with an
annual aggregate limit of $3.0 million for each of the
years ended December 31, 2009, 2008, and 2007. We also
carry claims-made managed care errors and omissions professional
liability insurance for our health plan operations. This
insurance is subject to a coverage limit of $15.0 million
per occurrence and $15.0 million in the aggregate for each
policy year.
Provider
Claims
Many of our medical contracts are complex in nature and may be
subject to differing interpretations regarding amounts due for
the provision of various services. Such differing
interpretations may lead medical providers to pursue us for
additional compensation. The claims made by providers in such
circumstances often involve issues of contract compliance,
interpretation, payment methodology, and intent. These claims
often extend to services provided by the providers over a number
of years.
Various providers have contacted us seeking additional
compensation for claims that we believe to have been settled.
These matters, when finally concluded and determined, will not,
in our opinion, have a material adverse effect on our
consolidated financial position, results of operations, or cash
flows.
Regulatory
Capital and Dividend Restrictions
Our principal operations are conducted through our health plan
subsidiaries operating in California, Florida, Michigan,
Missouri, New Mexico, Ohio, Texas, Utah, and Washington. Our
health plans are subject to state regulations that, among other
things, require the maintenance of minimum levels of statutory
capital, as defined by each state, and restrict the timing,
payment and amount of dividends and other distributions that may
be paid to us as the sole stockholder. To the extent the
subsidiaries must comply with these regulations, they may not
have the financial flexibility to transfer funds to us. The net
assets in these subsidiaries (after intercompany eliminations)
which may not be transferable to us in the form of loans,
advances or cash dividends was $368.7 million at
December 31, 2009, and $355.0 million at
December 31, 2008. The National Association of Insurance
Commissioners, or NAIC, adopted rules effective
December 31, 1998, which, if implemented by the states, set
new minimum capitalization requirements for insurance companies,
HMOs and other entities bearing risk for health care coverage.
The requirements take the form of risk-based capital (RBC)
rules. Michigan, Missouri, New Mexico, Ohio, Texas, Washington,
and Utah have adopted these rules, which may vary from state to
state. California and Florida have not yet adopted NAIC
risk-based capital requirements for HMOs and have not formally
given notice of their intention to do so. Such requirements, if
adopted by California and Florida, may increase the minimum
capital required for those states.
As of December 31, 2009, our health plans had aggregate
statutory capital and surplus of approximately
$377.7 million compared with the required minimum aggregate
statutory capital and surplus of approximately
$257.1 million. All of our HMOs were in compliance with the
minimum capital requirements at December 31, 2009. We have
the ability and commitment to provide additional capital to each
of our health plans when necessary to ensure that statutory
capital and surplus continue to meet regulatory requirements.
|
|
19.
|
Quarterly
Results of Operations (Unaudited)
|
The following is a summary of the quarterly results of
operations for the years ended December 31, 2009 and 2008.
99
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Quarter Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
2009
|
|
|
|
(In thousands)
|
|
|
Premium revenue
|
|
$
|
857,484
|
|
|
$
|
925,507
|
|
|
$
|
914,805
|
|
|
$
|
962,411
|
|
Operating income (loss)
|
|
|
24,115
|
|
|
|
20,726
|
|
|
|
16,274
|
|
|
|
(3,722
|
)
|
Income (loss) before income taxes
|
|
|
20,700
|
|
|
|
17,503
|
|
|
|
12,995
|
|
|
|
(7,582
|
)
|
Net income (loss)
|
|
|
12,211
|
|
|
|
14,565
|
|
|
|
8,564
|
|
|
|
(4,472
|
)
|
Net income (loss) per share(1),(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.46
|
|
|
$
|
0.56
|
|
|
$
|
0.34
|
|
|
$
|
(0.18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.46
|
|
|
$
|
0.56
|
|
|
$
|
0.33
|
|
|
$
|
(0.18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Quarter Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2008(1)
|
|
|
2008(1)
|
|
|
2008(1)
|
|
|
2008(1)
|
|
|
|
(In thousands)
|
|
|
Premium revenue
|
|
$
|
729,638
|
|
|
$
|
761,153
|
|
|
$
|
791,554
|
|
|
$
|
808,895
|
|
Operating income
|
|
|
24,451
|
|
|
|
30,258
|
|
|
|
30,429
|
|
|
|
27,467
|
|
Income before income taxes(3)
|
|
|
21,083
|
|
|
|
26,833
|
|
|
|
27,309
|
|
|
|
24,149
|
|
Net income(3)
|
|
|
12,475
|
|
|
|
15,823
|
|
|
|
16,480
|
|
|
|
14,820
|
|
Net income per share(1),(3):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.44
|
|
|
$
|
0.57
|
|
|
$
|
0.60
|
|
|
$
|
0.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.44
|
|
|
$
|
0.56
|
|
|
$
|
0.60
|
|
|
$
|
0.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Potentially dilutive shares issuable pursuant to our 2007
offering of convertible senior notes were not included in the
computation of diluted net income per share because to do so
would have been anti-dilutive for the years ended
December 31, 2009 and 2008. |
|
(2) |
|
For the quarter ended December 31, 2009, no potentially
dilutive options or nonvested stock were included in the
computation of our diluted loss per share because to do so would
have been anti-dilutive for that period. |
|
(3) |
|
The Companys consolidated statement of income for the year
ended December 31, 2008 has been recast to reflect the
adoption of ASC Subtopic
470-20,
Debt with Conversion and Other Options (see Note 1). |
100
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
20.
|
Condensed
Financial Information of Registrant
|
Following are our parent company only condensed balance sheets
as of December 31, 2009 and 2008, and our condensed
statements of income and condensed statements of cash flows for
each of the three years in the period ended December 31,
2009.
Condensed
Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
|
(In thousands except per- share data)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
26,040
|
|
|
$
|
42,776
|
|
Investments
|
|
|
3,002
|
|
|
|
9,745
|
|
Income tax receivable
|
|
|
|
|
|
|
3,119
|
|
Deferred income taxes
|
|
|
|
|
|
|
6,230
|
|
Due from affiliates
|
|
|
19,121
|
|
|
|
13,247
|
|
Prepaid and other current assets
|
|
|
11,435
|
|
|
|
10,228
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
59,598
|
|
|
|
85,345
|
|
Property and equipment, net
|
|
|
65,067
|
|
|
|
53,471
|
|
Goodwill
|
|
|
45,943
|
|
|
|
3,721
|
|
Investments
|
|
|
16,516
|
|
|
|
16,364
|
|
Investment in subsidiaries
|
|
|
545,731
|
|
|
|
568,224
|
|
Advances to related parties and other assets
|
|
|
16,742
|
|
|
|
19,379
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
749,597
|
|
|
$
|
746,504
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
24,577
|
|
|
$
|
24,595
|
|
Long-term debt
|
|
|
158,900
|
|
|
|
164,873
|
|
Deferred income taxes
|
|
|
10,769
|
|
|
|
12,530
|
|
Other long-term liabilities
|
|
|
12,613
|
|
|
|
12,744
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
206,859
|
|
|
|
214,742
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; 80,000 shares
authorized, outstanding 25,607 shares at December 31,
2009 and 26,725 shares at December 31, 2008
|
|
|
26
|
|
|
|
27
|
|
Preferred stock, $0.001 par value; 20,000 shares
authorized, no shares issued and outstanding
|
|
|
|
|
|
|
|
|
Paid-in capital
|
|
|
129,902
|
|
|
|
170,681
|
|
Accumulated other comprehensive loss, net of tax
|
|
|
(1,812
|
)
|
|
|
(2,310
|
)
|
Retained earnings
|
|
|
414,622
|
|
|
|
383,754
|
|
Treasury stock, at cost; 1,201 shares at December 31,
2008
|
|
|
|
|
|
|
(20,390
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
542,738
|
|
|
|
531,762
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
749,597
|
|
|
$
|
746,504
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Registrants condensed statement of financial position
as of December 31, 2008, has been recast to reflect the
adoption of FASB Accounting Standards Codification (ASC)
Subtopic
470-20,
Debt with Conversion and Other Options (see Note 1). |
101
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008(1)
|
|
|
2007(1)
|
|
|
|
(In thousands)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Management fees
|
|
$
|
218,571
|
|
|
$
|
190,361
|
|
|
$
|
154,071
|
|
Other operating revenue
|
|
|
340
|
|
|
|
177
|
|
|
|
186
|
|
Investment income
|
|
|
1,540
|
|
|
|
2,733
|
|
|
|
2,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
220,451
|
|
|
|
193,271
|
|
|
|
157,172
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
26,865
|
|
|
|
21,759
|
|
|
|
22,042
|
|
General and administrative expenses
|
|
|
160,792
|
|
|
|
143,709
|
|
|
|
114,616
|
|
Depreciation and amortization
|
|
|
25,223
|
|
|
|
18,980
|
|
|
|
15,101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
212,880
|
|
|
|
184,448
|
|
|
|
151,759
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on purchase of convertible senior notes
|
|
|
1,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
9,103
|
|
|
|
8,823
|
|
|
|
5,413
|
|
Interest expense
|
|
|
(13,770
|
)
|
|
|
(13,167
|
)
|
|
|
(5,459
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes and equity in net income of subsidiaries
|
|
|
(4,667
|
)
|
|
|
(4,344
|
)
|
|
|
(46
|
)
|
Income tax (benefit) expense
|
|
|
(3,755
|
)
|
|
|
(456
|
)
|
|
|
1,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss before equity in net income of subsidiaries
|
|
|
(912
|
)
|
|
|
(3,888
|
)
|
|
|
(2,009
|
)
|
Equity in net income of subsidiaries
|
|
|
31,780
|
|
|
|
63,486
|
|
|
|
59,735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
30,868
|
|
|
$
|
59,598
|
|
|
$
|
57,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Registrants condensed statements of income for the
years ended December 31, 2008 and 2007 have been recast to
reflect the adoption of FASB ASC Subtopic
470-20,
Debt with Conversion and Other Options
(see Note 1). |
102
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash provided by operating activities
|
|
$
|
40,551
|
|
|
$
|
17,532
|
|
|
$
|
23,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net dividends from and capital contributions to subsidiaries
|
|
|
21,960
|
|
|
|
42,872
|
|
|
|
(16,890
|
)
|
Purchases of investments
|
|
|
(3,844
|
)
|
|
|
(25,515
|
)
|
|
|
(74,604
|
)
|
Sales and maturities of investments
|
|
|
12,669
|
|
|
|
56,833
|
|
|
|
29,946
|
|
Cash paid in business purchase transactions
|
|
|
(2,894
|
)
|
|
|
(1,000
|
)
|
|
|
(80,045
|
)
|
Purchases of equipment
|
|
|
(32,245
|
)
|
|
|
(33,047
|
)
|
|
|
(20,159
|
)
|
Changes in amounts due to and due from affiliates
|
|
|
(17,074
|
)
|
|
|
(6,542
|
)
|
|
|
2,887
|
|
Change in other assets and liabilities
|
|
|
(540
|
)
|
|
|
3,170
|
|
|
|
1,192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
(21,968
|
)
|
|
|
36,771
|
|
|
|
(157,673
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock purchases
|
|
|
(27,712
|
)
|
|
|
(49,940
|
)
|
|
|
|
|
Purchase of convertible senior notes
|
|
|
(9,653
|
)
|
|
|
|
|
|
|
|
|
Proceeds from issuance of convertible senior notes
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
Repayments of amounts borrowed under credit facility
|
|
|
|
|
|
|
|
|
|
|
(45,000
|
)
|
Payment of credit facility fees
|
|
|
|
|
|
|
|
|
|
|
(551
|
)
|
Payment of convertible senior notes fees
|
|
|
|
|
|
|
|
|
|
|
(6,498
|
)
|
Excess tax benefits from employee stock compensation
|
|
|
31
|
|
|
|
43
|
|
|
|
853
|
|
Proceeds from exercise of stock options and employee stock plan
purchases
|
|
|
2,015
|
|
|
|
2,084
|
|
|
|
4,257
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities
|
|
|
(35,319
|
)
|
|
|
(47,813
|
)
|
|
|
153,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents
|
|
|
(16,736
|
)
|
|
|
6,490
|
|
|
|
18,888
|
|
Cash and cash equivalents at beginning of year
|
|
|
42,776
|
|
|
|
36,286
|
|
|
|
17,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
26,040
|
|
|
$
|
42,776
|
|
|
$
|
36,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
103
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Notes to
Condensed Financial Information of Registrant
Note A
Basis of Presentation
Molina Healthcare, Inc. (Registrant) was incorporated on
July 24, 2002. Prior to that date, Molina Healthcare of
California (formerly known as Molina Medical Centers) operated
as a California health plan and as the parent company for Molina
Healthcare of Utah, Inc. and Molina Healthcare of Michigan, Inc.
In June 2003, the employees and operations of the corporate
entity were transferred from Molina Healthcare of California to
the Registrant.
The Registrants investment in subsidiaries is stated at
cost plus equity in undistributed earnings of subsidiaries since
the date of acquisition. The parent company-only financial
statements should be read in conjunction with the consolidated
financial statements and accompanying notes.
Note B
Transactions with Subsidiaries
The Registrant provides certain centralized medical and
administrative services to its subsidiaries pursuant to
administrative services agreements, including medical affairs
and quality management, health education, credentialing,
management, financial, legal, information systems and human
resources services. Fees are based on the fair market value of
services rendered and are recorded as operating revenue. Payment
is subordinated to the subsidiaries ability to comply with
minimum capital and other restrictive financial requirements of
the states in which they operate. Charges in 2009, 2008, and
2007 for these services totaled $218.6 million,
$190.4 million, and $154.1 million, respectively,
which are included in operating revenue.
The Registrant and its subsidiaries are included in the
consolidated federal and state income tax returns filed by the
Registrant. Income taxes are allocated to each subsidiary in
accordance with an intercompany tax allocation agreement. The
agreement allocates income taxes in an amount generally
equivalent to the amount which would be expensed by the
subsidiary if it filed a separate tax return. Net operating loss
benefits are paid to the subsidiary by the Registrant to the
extent such losses are utilized in the consolidated tax returns.
Note C
Capital Contribution and Dividends
During 2009, 2008, and 2007, the Registrant received dividends
from its subsidiaries totaling $76.7 million,
$91.5 million, and $39.0 million, respectively. Such
amounts have been recorded as a reduction to the investments in
the respective subsidiaries.
During 2009, 2008, and 2007, the Registrant made capital
contributions to certain subsidiaries totaling
$54.7 million, $48.6 million, and $55.9 million,
respectively, primarily to comply with minimum net worth
requirements and to fund contract acquisitions. Such amounts
have been recorded as an increase in investment in the
respective subsidiaries.
Note D
Related Party Transactions
The Registrant has an equity investment in a medical service
provider that provides certain vision services to its members.
The Registrant accounts for this investment under the equity
method of accounting because the Registrant has an ownership
interest in the investee that confers significant influence over
operating and financial policies of the investee. As of
December 31, 2009 and 2008, the Registrants carrying
amount for this investment totaled $4.1 million and
$3.6 million, respectively. During 2008, the Registrant
advanced this provider $1.3 million, all of which was
collected during 2009. For the years ended December 31,
2009, 2008 and 2007, the Registrant paid $21.8 million,
$15.4 million, and $10.9 million, respectively, for
medical service fees to this provider.
The Registrant is a party to a
fee-for-service
agreement with Pacific Hospital of Long Beach (Pacific
Hospital). Pacific Hospital is owned by Abrazos
Healthcare, Inc., the shares of which are held as community
property by the husband of Dr. Martha Bernadett, the sister
of Dr. J. Mario Molina, our Chief Executive Officer, and
John Molina, our Chief Financial Officer. Amounts paid to
Pacific Hospital under the terms of this
fee-for-service
agreement were $745,000, $242,000, and $157,000 for the years
ended December 31, 2009, 2008, and 2007, respectively. The
Registrant also had a capitation arrangement with Pacific
Hospital, where the Registrant paid
104
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Pacific Hospital a fixed monthly fee per member. This contract
was terminated by the parties effective August 31, 2009.
Amounts paid to Pacific Hospital for capitated services totaled
approximately $1.1 million, $3.8 million, and
$4.8 million for the years ended December 31, 2009,
2008, and 2007, respectively. The Registrant believes that both
arrangements with Pacific Hospital are based on prevailing
market rates for similar services.
|
|
Note 21.
|
Subsequent
Events
|
Acquisition
of HIM
On January 18, 2010, we entered into a definitive agreement
to acquire the Health Information Management, or HIM, business
of Unisys Corporation. The purchase price is expected to be
approximately $135 million, subject to a standard working
capital adjustment, to be paid in cash at closing using our
credit facility. The acquisition, which is expected to close in
the first half of 2010, is subject to customary regulatory
approvals and closing conditions, including receipt of customer
consents.
The HIM business provides design, development, implementation,
and business process outsourcing solutions to state governments
for their Medicaid Management Information Systems, or MMIS. MMIS
is a core tool used to support the administration of state
Medicaid and other health care entitlement programs. The HIM
business currently holds MMIS contracts with the states of
Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well
as a contract to provide drug rebate administration services for
the Florida Medicaid program. Annual revenues of the HIM
business are currently approximately $110 million. We
expect the approximately 900 employees of the HIM business
to become our employees upon closing of the transaction, and
following the closing Unisys has agreed to provide certain
transitional and technology support services to us for up to one
year.
Subject to the closing of the HIM acquisition, in November 2009
we agreed to enter into a fourth amendment to the Credit
Facility. The fourth amendment will become effective upon the
closing of the acquisition of the HIM business. The fourth
amendment is required because the $135 million purchase
price for the HIM business exceeds the currently applicable deal
size threshold under the terms of the Credit Facility. Pursuant
to the fourth amendment, the lenders have consented to our
acquisition of the HIM business.
Upon its effectiveness at the closing, the fourth amendment
would increase the commitment fee on the total unused
commitments of the lenders under the Credit Facility to
50 basis points on all levels of the pricing grid, with the
pricing grid referring to our ratio of consolidated funded debt
to consolidated EBITDA. The pricing for LIBOR loans and base
rate loans would be raised by 200 basis points at every
level of the pricing grid. The applicable margins would thus
range between 2.75% and 3.75% for LIBOR loans, and between 1.75%
and 2.75% for base rate loans. Until the delivery of a
compliance certificate with respect to our financial statements
for the quarter ending after the HIM business acquisition
closes, the applicable margin shall be fixed at 3.5% for LIBOR
loans and 2.5% for base rate loans. In connection with the
lenders approval of the fourth amendment, a consent fee of
10 basis points was paid on the amount of each consenting
lenders commitment. In addition, the fourth amendment
would carve out from our indebtedness and restricted payment
covenants under the Credit Facility the $187.0 million
current principal amount of the Notes (although the
$187.0 million indebtedness would still be included in the
calculation of our Consolidated Leverage Ratio); increase the
amount of surety bond obligations we may incur; increase our
allowable capital expenditures; and reduce the fixed charge
coverage ratio from 3.50x to 2.75x (on a pro forma basis) at
December 31, 2009, and 3.00x thereafter.
On March 15, 2010, we agreed to enter into a fifth
amendment to the Credit Facility. The fifth amendment will also
become effective upon the closing of the acquisition of the HIM
business. The fifth amendment is required because, after giving
effect to the acquisition of the HIM business on a pro forma
basis, and inclusive of the Companys fourth quarter 2009
EBITDA of only $5.9 million, the Companys
consolidated leverage ratio for the preceding four fiscal
quarters would exceed the currently applicable ratio of 2.75 to
1.0. The fifth amendment will increase the maximum consolidated
leverage ratio under the Credit Facility to 3.25 to 1.0 for the
fourth quarter of 2009 (on a pro forma basis), and to 3.50 to
1.0 for the first, second, and third quarters of 2010, excluding
the single date of September 30, 2010. On
September 30, 2010, the maximum consolidated leverage ratio
shall revert back to 2.75 to 1.0. However, if the Company has
actually reduced its consolidated leverage ratio to no more than
2.75 to 1.0
105
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
on or before August 15, 2010, the consolidated leverage
ratio under the Credit Facility will revert back to 2.75 to 1.0
on August 15, 2010. On the date that the consolidated
leverage ratio reverts to 2.75 to 1.0 whether
August 15, 2010 or September 30, 2010 the
aggregate commitments of the lenders under the Credit Facility
shall be reduced on a pro rata basis from $200 million to
$150 million. In connection with the lenders approval
of the fifth amendment, we will pay an amendment fee of
25 basis points on the amount of each consenting
lenders commitment. We will also pay an incremental
commitment fee of 12.5 basis points based on each
lenders unfunded commitment during the period from the
effective date of the fifth amendment through the date that the
maximum consolidated leverage ratio is reduced to 2.75 to 1.0,
plus a potential duration fee of 50 basis points payable on
August 15, 2010 in the event that the consolidated leverage
ratio has not been reduced to 2.75 to 1.0 by August 15,
2010.
106
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosures
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Disclosure Controls and Procedures: Our
management is responsible for establishing and maintaining
effective internal control over financial reporting as defined
in
Rules 13a-15(f)
and
15d-15(f)
under the Securities Exchange Act of 1934 (the Exchange
Act). Our internal control over financial reporting is
designed to provide reasonable assurance to our management and
board of directors regarding the preparation and fair
presentation of published financial statements. We maintain
controls and procedures designed to ensure that we are able to
collect the information we are required to disclose in the
reports we file with the Securities and Exchange Commission, and
to process, summarize and disclose this information within the
time periods specified in the rules of the Securities and
Exchange Commission.
Evaluation of Disclosure Controls and
Procedures: Our management, with the
participation of our Chief Executive Officer and our Chief
Financial Officer, has conducted an evaluation of the design and
operation of our disclosure controls and procedures
(as defined in
Rules 13a-15(e)
and
15d-15(e))
under the Exchange Act. Based on this evaluation, our Chief
Executive Officer and our Chief Financial Officer have concluded
that our disclosure controls and procedures are effective as of
the end of the period covered by this report to ensure that
information required to be disclosed in the reports that we file
or submit under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the
Securities and Exchange Commissions rules and forms.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Therefore, even those systems determined to be effective can
provide only reasonable assurance with respect to financial
statement preparation and presentation.
Changes in Internal Controls: There were no
changes in our internal control over financial reporting during
the three months ended December 31, 2009 that have
materially affected, or are reasonably likely to materially
affect, our internal controls over financial reporting.
Managements Report on Internal Control over Financial
Reporting: Management of the Company is
responsible for establishing and maintaining adequate internal
control over financial reporting, as such term is defined in
Rule 13a-15(f)
under the Exchange Act. The Companys internal control over
financial reporting is designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles in the
United States. However, all internal control systems, no matter
how well designed, have inherent limitations. Therefore, even
those systems determined to be effective can provide only
reasonable assurance with respect to financial statement
preparation and reporting.
Management assessed the effectiveness of the Companys
internal control over financial reporting as of
December 31, 2009. In making this assessment, management
used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in
Internal Control-Integrated Framework. Based on our
assessment, management believes that the Company maintained
effective internal control over financial reporting as of
December 31, 2009, based on those criteria.
The effectiveness of the Companys internal control over
financial reporting has been audited by Ernst & Young
LLP, an independent registered public accounting firm, as stated
in their report appearing on page 109 of this Annual Report
on Form 10-K, which expresses an unqualified opinion on the
effectiveness of the Companys internal control over
financial reporting as of December 31, 2009.
|
|
Item 9B.
|
Other
Information
|
On March 15, 2010, we agreed to enter into a fifth
amendment to our Credit Facility. The fifth amendment will
become effective upon the closing of the acquisition of the HIM
business. The fifth amendment is required because, after giving
effect to the acquisition of the HIM business on a pro forma
basis, and inclusive of the Companys fourth quarter 2009
EBITDA of only $5.9 million, the Companys
consolidated leverage ratio for the preceding four fiscal
quarters would exceed the currently applicable ratio of 2.75 to
1.0. The fifth amendment will increase the maximum consolidated
leverage ratio under the Credit Facility to 3.25 to 1.0 for the
fourth quarter of 2009 (on a pro forma
107
basis), and to 3.50 to 1.0 for the first, second, and third
quarters of 2010, excluding the single date of
September 30, 2010. On September 30, 2010, the maximum
consolidated leverage ratio shall revert back to 2.75 to 1.0.
However, if the Company has actually reduced its consolidated
leverage ratio to no more than 2.75 to 1.0 on or before
August 15, 2010, the consolidated leverage ratio under the
Credit Facility will revert back to 2.75 to 1.0 on
August 15, 2010. On the date that the consolidated leverage
ratio reverts to 2.75 to 1.0 whether August 15,
2010 or September 30, 2010 the aggregate
commitments of the lenders under the Credit Facility shall be
reduced on a pro rata basis from $200 million to
$150 million. In connection with the lenders approval
of the fifth amendment, we will pay an amendment fee of
25 basis points on the amount of each consenting
lenders commitment. We will also pay an incremental
commitment fee of 12.5 basis points based on each
lenders unfunded commitment during the period from the
effective date of the fifth amendment through the date that the
maximum consolidated leverage ratio is reduced to 2.75 to 1.0,
plus a potential duration fee of 50 basis points payable on
August 15, 2010 in the event that the consolidated leverage
ratio has not been reduced to 2.75 to 1.0 by August 15,
2010.
The foregoing summary of the terms of the fifth amendment does
not purport to be complete and is qualified in its entirety by
reference to the fifth amendment, which is filed as
Exhibit 10.22 hereto.
108
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
of Molina Healthcare, Inc.
We have audited Molina Healthcare, Inc.s (the
Companys) internal control over financial
reporting as of December 31, 2009, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (the COSO criteria).
The Companys management is responsible for maintaining
effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over
financial reporting included in the accompanying
Managements Report on Internal Control over Financial
Reporting. Our responsibility is to express an opinion on the
Companys internal control over financial reporting based
on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, Molina Healthcare, Inc. maintained, in all
material respects, effective internal control over financial
reporting as of December 31, 2009, based on the COSO
criteria.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Molina Healthcare, Inc. as of
December 31, 2009 and 2008, and the related consolidated
statements of income, stockholders equity, and cash flows
for each of the three years in the period ended
December 31, 2009 and our report dated March 16, 2010
expressed an unqualified opinion thereon.
Los Angeles, California
March 16, 2010
109
PART III
|
|
Item 10.
|
Directors,
Executive Officers, and Corporate Governance
|
|
|
(a)
|
Directors
of the Registrant
|
Information concerning our directors will appear in our Proxy
Statement for our 2010 Annual Meeting of Stockholders under
Proposal No. 1 Election of Three
Class II Directors. This portion of the Proxy
Statement is incorporated herein by reference.
|
|
(b)
|
Executive
Officers of the Registrant
|
Pursuant to General Instruction G(3) to
Form 10-K
and Instruction 3 to Item 401(b) of
Regulation S-K,
information regarding our executive officers is provided in
Item X of Part I of this Annual Report on
Form 10-K
under the caption Executive Officers of the
Registrant, and will also appear in our Proxy Statement
for our 2010 Annual Meeting of Stockholders. Such portion of the
Proxy Statement is incorporated herein by reference.
Information concerning certain corporate governance matters will
appear in our Proxy Statement for our 2010 Annual Meeting of
Stockholders under Corporate Governance,
Corporate Governance and Nominating Committee,
Corporate Governance Guidelines, and Code of
Business Conduct and Ethics. These portions of our Proxy
Statement are incorporated herein by reference.
|
|
(d)
|
Section 16(a)
Beneficial Ownership Reporting Compliance
|
Section 16(a) of the Exchange Act requires our executive
officers and directors, and persons who own more than 10% of a
registered class of our equity securities, to file reports of
ownership and changes in ownership with the SEC, and to furnish
us with copies of the forms. Purchases and sales of our equity
securities by such persons are published on our website at
www.molinahealthcare.com. Based on our review of the
copies of such reports, on our involvement in assisting our
reporting persons with such filings, and on written
representations from our reporting persons, we believe that,
during 2009, each of our executive officers, directors, and
greater than ten percent stockholders complied with all such
filing requirements on a timely basis.
|
|
Item 11.
|
Executive
Compensation
|
The information which will appear in our Proxy Statement for our
2010 Annual Meeting under the captions Compensation
Committee Interlocks, Non-Employee Director
Compensation, and Compensation Discussion and
Analysis, is incorporated herein by reference. The
information which will appear in our Proxy Statement under the
caption Compensation Committee Report is not
incorporated herein by reference.
The table below, which was inadvertently omitted from our 2009
Proxy Statement, shows the number of shares of restricted stock
held by our named executive officers which vested during fiscal
year 2008.
OPTION
EXERCISES AND STOCK VESTED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
Number of Shares
|
|
Value Realized on
|
|
Number of Shares
|
|
Value Realized on
|
Name
|
|
Acquired On Exercise (#)
|
|
Exercise ($)
|
|
Acquired on Vesting (#)
|
|
Vesting ($)
|
|
J. Mario Molina
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John C. Molina
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark L. Andrews
|
|
|
|
|
|
|
|
|
|
|
1,387
|
|
|
|
43,899
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
24,680
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Terry Bayer
|
|
|
|
|
|
|
|
|
|
|
1,387
|
|
|
|
43,899
|
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James W. Howatt
|
|
|
|
|
|
|
|
|
|
|
550
|
|
|
|
18,431
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
625
|
|
|
|
19,781
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
763
|
|
|
|
21,707
|
(6)
|
110
|
|
|
1. |
|
On March 1, 2008, 1,387 restricted shares vested in favor
of Mr. Andrews at a closing market price of $31.65. |
|
2. |
|
On July 1, 2008, 1,000 restricted shares vested in favor of
Mr. Andrews at a closing market price of $24.68. |
|
3. |
|
On March 1, 2008, 1,387 restricted shares vested in favor
of Ms. Bayer at a closing market price of $31.65. |
|
4. |
|
On February 9, 2008, 550 restricted shares vested in favor
of Dr. Howatt at a closing market price of $33.51. |
|
5. |
|
On March 1, 2008, 625 restricted shares vested in favor of
Dr. Howatt at a closing market price of $31.65. |
|
6. |
|
On May 29, 2008, 763 restricted shares vested in favor of
Dr. Howatt at a closing market price of $28.45. |
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
Information concerning the security ownership of certain
beneficial owners and management will appear in our Proxy
Statement for our 2010 Annual Meeting of Stockholders under
Information About Stock Ownership. This portion of
the Proxy Statement is incorporated herein by reference. The
information required by this item regarding our equity
compensation plans is set forth in Part II, Item 5 of
this report and incorporated herein by reference.
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Information concerning certain relationships and related
transactions will appear in our Proxy Statement for our 2010
Annual Meeting of Stockholders under Related Party
Transactions. Information concerning director independence
will appear in our Proxy Statement under Director
Independence. These portions of our Proxy Statement are
incorporated herein by reference.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
Information concerning principal accountant fees and services
will appear in our Proxy Statement for our 2010 Annual Meeting
of Stockholders under Disclosure of Auditor Fees.
This portion of our Proxy Statement is incorporated herein by
reference.
111
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) The consolidated financial statements and exhibits
listed below are filed as part of this report.
|
|
|
|
(1)
|
The Companys consolidated financial statements, the notes
thereto and the report of the Independent Registered Public
Accounting Firm are on pages 60 through 108 of this Annual
Report on
Form 10-K
and are incorporated by reference.
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets At December 31,
2009 and 2008
Consolidated Statements of Operations Years ended
December 31, 2009, 2008, and 2007
Consolidated Statements of Stockholders Equity
Years ended December 31, 2009, 2008, and 2007
Consolidated Statements of Cash Flows Years ended
December 31, 2009, 2008, and 2007
Notes to Consolidated Financial Statements
|
(2) Financial Statement Schedules
None of the schedules apply, or the information required is
included in the Notes to the Consolidated Financial Statements.
(3) Exhibits
Reference is made to the accompanying Index to Exhibits.
112
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, as amended, the undersigned
registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized, on the
16th day
of March, 2010.
MOLINA HEALTHCARE, INC.
|
|
|
|
By:
|
/s/ Joseph
M. Molina, M.D.
|
Joseph M. Molina, M.D.
Chief Executive Officer
(Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, this report has been signed below by the
following persons on behalf of the registrant and in the
capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Joseph
M. Molina
Joseph
M. Molina, M.D.
|
|
Chairman of the Board, Chief Executive Officer, and President
(Principal Executive Officer)
|
|
March 16, 2010
|
|
|
|
|
|
/s/ John
C. Molina
John
C. Molina, J.D.
|
|
Director, Chief Financial Officer, and Treasurer (Principal
Financial Officer)
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Joseph
W. White
Joseph
W. White, CPA, MBA
|
|
Chief Accounting Officer (Principal Accounting Officer)
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Charles
Z. Fedak
Charles
Z. Fedak, CPA, MBA
|
|
Director
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Frank
E. Murray
Frank
E. Murray, M.D.
|
|
Director
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Steven
Orlando
Steven
Orlando, CPA (inactive)
|
|
Director
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Sally
K. Richardson
Sally
K. Richardson
|
|
Director
|
|
March 16, 2010
|
|
|
|
|
|
/s/ Ronna
Romney
Ronna
Romney
|
|
Director
|
|
March 16, 2010
|
|
|
|
|
|
/s/ John
P. Szabo, Jr.
John
P. Szabo, Jr.
|
|
Director
|
|
March 16, 2010
|
113
INDEX TO
EXHIBITS
|
|
|
|
|
|
|
Number
|
|
Description
|
|
Method of Filing
|
|
|
3
|
.1
|
|
Certificate of Incorporation
|
|
Filed as Exhibit 3.2 to registrants Registration Statement
on Form S-1 filed December 30, 2002.
|
|
3
|
.2
|
|
Amended and Restated Bylaws
|
|
Filed as Exhibit 3.2 to registrants Form 8-K filed
February 17, 2009.
|
|
4
|
.1
|
|
Indenture dated as of October 11, 2008
|
|
Filed as Exhibit 4.1 to registrants Form 8-K filed October
5, 2008.
|
|
4
|
.2
|
|
First Supplemental Indenture dated as of October 11, 2008
|
|
Filed as Exhibit 4.2 to registrants Form 8-K filed October
5, 2008.
|
|
4
|
.3
|
|
Global Form of 3.75% Convertible Senior Note due 2014
|
|
Filed as Exhibit 4.3 to registrants Form 8-K filed October
5, 2008.
|
|
10
|
.1
|
|
2000 Omnibus Stock and Incentive Plan
|
|
Filed as Exhibit 10.12 to registrants Form S-1 filed
December 30, 2002.
|
|
10
|
.2
|
|
2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.13 to registrants Form S-1 filed
December 30, 2002.
|
|
10
|
.3
|
|
Form of Stock Option Agreement under 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.3 to registrants Form 10-K filed March
14, 2007.
|
|
10
|
.4
|
|
2002 Employee Stock Purchase Plan
|
|
Filed as Exhibit 10.14 to registrants Form S-1 filed
December 30, 2002.
|
|
10
|
.5
|
|
2005 Molina Deferred Compensation Plan adopted November 6,
2006
|
|
Filed as Exhibit 10.4 to registrants Form 10-Q filed
November 9, 2006.
|
|
10
|
.6
|
|
2005 Incentive Compensation Plan
|
|
Filed as Appendix A to registrants Proxy Statement filed
March 28, 2005.
|
|
10
|
.7
|
|
Form of Restricted Stock Award Agreement (Executive Officer)
under Molina Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants Form 10-Q filed
August 9, 2005.
|
|
10
|
.8
|
|
Form of Restricted Stock Award Agreement (Outside Director)
under Molina Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants Form 10-Q filed
August 9, 2005.
|
|
10
|
.9
|
|
Form of Restricted Stock Award Agreement (Employee) under Molina
Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants Form 10-Q filed
August 9, 2005.
|
|
10
|
.10
|
|
Amended and Restated Employment Agreement with J. Mario
Molina, M.D. dated as of December 31, 2009
|
|
Filed as Exhibit 10.1 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.11
|
|
Amended and Restated Employment Agreement with John C. Molina
dated as of December 31, 2009
|
|
Filed as Exhibit 10.2 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.12
|
|
Amended and Restated Employment Agreement with Mark L. Andrews
dated as of December 31, 2009
|
|
Filed as Exhibit 10.3 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.13
|
|
Amended and Restated Change in Control Agreement with Terry
Bayer, dated as of December 31, 2009
|
|
Filed as Exhibit 10.4 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.14
|
|
Amended and Restated Change in Control Agreement with James W.
Howatt, M.D., dated as of December 31, 2009
|
|
Filed as Exhibit 10.5 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.15
|
|
Amended and Restated Change in Control Agreement with Joseph W.
White, dated as of December 31, 2009
|
|
Filed as Exhibit 10.6 to registrants Form 8-K filed
January 7, 2010.
|
|
10
|
.16
|
|
Form of Indemnification Agreement
|
|
Filed as Exhibit 10.14 to registrants Form 10-K filed
March 14, 2007.
|
|
10
|
.17
|
|
Amended and Restated Credit Agreement, dated as of March 9,
2005, among Molina Healthcare, Inc., as the Borrower, certain
lenders, and Bank of America, N.A., as Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants current report on
Form 8-K filed March 10, 2005.
|
|
|
|
|
|
|
|
Number
|
|
Description
|
|
Method of Filing
|
|
|
10
|
.18
|
|
First Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of October 5, 2005, among Molina
Healthcare, Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants current report on
Form 8-K filed October 13, 2005.
|
|
10
|
.19
|
|
Second Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of November 6, 2006, among Molina
Healthcare, Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants Form 10-Q filed
November 9, 2006.
|
|
10
|
.20
|
|
Third Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of May 25, 2008, among Molina
Healthcare, Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants Form 8-K filed May
31, 2008.
|
|
10
|
.21
|
|
Fourth Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of
,
2010, among Molina Healthcare, Inc., certain lenders, and Bank
of America, N.A., as Administrative Agent (date to be inserted
on Fourth Amendment Effective Date)
|
|
Filed as Exhibit 10.1 to registrants Form 8-K filed
January 19, 2010.
|
|
10
|
.22
|
|
Fifth Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of
,
2010, among Molina Healthcare, Inc., certain lenders, and Bank
of America, N.A., as Administrative Agent (date to be inserted
on Fifth Amendment Effective Date)
|
|
Filed herewith.
|
|
10
|
.23
|
|
Office Lease with Pacific Towers Associates for 200 Oceangate
Corporate Headquarters.
|
|
Filed as Exhibit 10.34 to registrants Form 10-K filed
March 17, 2008.
|
|
10
|
.24
|
|
Hospital Services Agreement (fee-for-service) by and between
Molina Healthcare of California, a California corporation, and
Pacific Hospital of Long Beach
|
|
Filed herewith.
|
|
10
|
.25
|
|
Hospital Services Agreement (capitation) by and between Molina
Healthcare of California, a California corporation, and
HealthSmart Pacific, Inc., dba Pacific Hospital of Long Beach
|
|
Filed herewith.
|
|
12
|
.1
|
|
Computation of Ratio of Earnings to Fixed Charges
|
|
Filed herewith.
|
|
21
|
.1
|
|
List of subsidiaries
|
|
Filed herewith.
|
|
23
|
.1
|
|
Consent of Independent Registered Public Accounting Firm
|
|
Filed herewith.
|
|
31
|
.1
|
|
Section 302 Certification of Chief Executive Officer
|
|
Filed herewith.
|
|
31
|
.2
|
|
Section 302 Certification of Chief Financial Officer
|
|
Filed herewith.
|
|
32
|
.1
|
|
Certificate of Chief Executive Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
Filed herewith.
|
|
32
|
.2
|
|
Certificate of Chief Financial Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
Filed herewith.
|